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1.  Introduction 
1.1. Cell death pathways in neurons 
Programmed cell death (PCD) is a highly conserved cell death mechanism essential 
for various physiological processes such as maintenance of embryonic development, 
tissue homeostasis and removal of injured cells. Many studies detected the paradigm 
of PCD in neurodegenerative diseases such as Alzheimer’s disease (AD), 
Parkinson’s disease (PD) or Huntington’s disease (HD) and after acute brain 
damage, e.g. caused by cerebral ischemia or traumatic brain injury 1–3. The term 
PCD is a very broad expression and consists of various classifications of different 
modes of cell death 4. The best characterized type of PCD is apoptosis, which was 
first described by Kerr et al. and occurs during tissue development and regulates the 
replacement of senescent and impaired cells. Typical hallmarks associated with 
apoptosis are DNA condensation (pyknosis) and fragmentation, membrane blebbing 
and the formation of apoptotic bodies 5. However, today the term apoptosis can also 
be subdivided into different categories, related to cell death stimuli and biochemical 
features, namely ‘extrinsic apoptosis’ and caspase-dependent or 
caspase-independent ‘intrinsic apoptosis’ 4. Extrinsic apoptosis bypasses the 
mitochondria and is induced by extracellular stress stimuli, which bind to 
transmembrane receptors and thereby initiate the ensuing cell death cascade. 
Various ligands mediate extrinsic apoptosis, such as FAS/CD95 ligand (FASL), tumor 
necrosis factor α (TNFα) and TNF-related apoptosis inducing ligand (TRAIL), by 
binding to their corresponding death receptors FAS/CD95, TNFα receptor 1 (TNFR1) 
and TRAIL receptor (TRAILR) 1-2 6,7 (reviewed in 8). Ligand binding induces the 
generation and stabilization of death receptor oligomers, which leads to 
conformational changes at the cytosolic tail of the receptors resulting in the formation 
of death domains (DD). This leads to the recruitment of different adaptor proteins, 
such as Fas-associated death domain (FADD) or TNF receptor-associated death 
domain (TRADD), connecting the receptor signaling to the apoptotic machinery 9. 
FADD contains a death effector domain (DED) which facilitates the subsequent 
binding of DED of procaspase-8 (-10). The assembly of activated receptor, FADD 
and the procaspases is commonly known as death-inducing signaling complex 
(DISC), which is a platform for caspase activation 10,11. Caspase-8 (-10) activation 
can directly trigger the caspase cascade by proteolytic maturation of the effector 
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caspase caspase-3, which accordingly releases the caspase-activated 
deoxyribonuclease (CAD) from its inhibitor (ICAD) and translocates to the nucleus 
where it induces DNA fragmentation and cell death 12–14. Another important function 
of activated caspase-8 is the cleavage of the pro-apoptotic B-cell-lymphoma-2 (Bcl2) 
protein Bid (Bcl2 interacting domain death antagonist) to its active form (truncated 
Bid, tBid), which links the extrinsic to the intrinsic apoptotic pathway, where 
mitochondria engage the central role of the apoptotic process 4,15. 
In neurons, the intrinsic apoptotic pathway occurs triggered by neurotrophic factor 
withdrawal, increased oxidative stress or overactivation of glutamate receptors. 
These apoptotic stimuli are linked to mitochondrial damage and are associated with 
diverse neurological disorders 2,16,17. They trigger an intricate series of molecular and 
biochemical mechanisms leading to impaired neurological function. These complex 
mechanisms involve the activation of calcium/calmodulin-dependent kinases 
(CaMKs) and mitogen-activated protein kinases (MAPKs), such as extracellular 
signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK), leading to 
altered gene expression which is important for cell survival or damaging 
mechanisms. Transcription factors like the tumor suppressor p53 contribute to the 
recruitment of pro-apoptotic Bcl2 family proteins, Bcl2-associated x protein (Bax) and 
Bcl2 antagonist killer 1 (Bak), to the mitochondria where they induce mitochondrial 
outer membrane (MOM) permeabilization and as a result pore formation. The 
generation of large permeability transition pores (PTP) results in the release of 
pro-apoptotic proteins from the mitochondrial intermembrane space (IMS) to the 
cytosol, such as cytochrom c (Cytc), apoptosis-inducing-factor (AIF), endonuclease G 
(EndoG), high temperature acquired protein A2 (Omi/HrtA2) or second mitochondria-
derived activator of caspases (Smac/Diablo). The release of Cytc leads to the 
apoptosome formation which includes the apoptosis-protease activating factor 
(Apaf1) and dATP leading to the recruitment and activation of caspase-9, which in 
turn activates caspase-3. X-chromosomal linked inhibitor of apoptosis (XIAP) and 
other inhibitors of apoptosis (IAP), which are known to be potent direct inhibitors of 
caspases, are inactivated by Omi/HtrA2 and Smac/Diablo, leading to cell death 18–23.  
Emerging evidence suggests that besides the well-established caspase-dependent 
pathway of PCD, the caspase-independent pathway plays an important role, 
especially in the adult brain. This intrinsic cell death pathway is mediated by 
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mitochondrial alterations including energy depletion, ROS formation and opening of 
the PTP, resulting in the release of AIF and EndoG from the mitochondrial IMS, 
followed by their translocation to the nucleus where they induce large scale 
chromatin condensation and DNA fragmentation 24–26. Triggers of such 
caspase-independent cell death pathways in neurons are for instance glucose 
deprivation or reduced oxygen levels which occur e.g. after cerebral ischemia. This 
leads to energy depletion and ensuing to the depolarization of membranes resulting 
in the activation of voltage-dependent Ca2+-channels. Excitatory amino acids are 
released into the extracellular space which activate ionotropic glutamate receptors 
like N-methyl-D-aspartate- (NMDA), 2-amin-3-(3-hydroxy-5-methylisoxazol-4-yl) 
propionate (AMPA) or kainate receptors. This receptor overactivation leads to an 
elevated Ca2+-influx followed by mitochondrial dysfunction and the subsequent 
release of pro-apoptotic factors from the mitochondrial IMS 27. All these mechanisms 
place mitochondria in the center of apoptotic cell death pathways, which are the 
underlying cause for neuronal dysfunction and death in many neurodegenerative 
disorders. 
1.2. Mitochondria in neuronal cell death 
Mitochondria are semi-autonomous organelles containing their own mitochondrial 
DNA (mtDNA), RNA and protein synthesis machinery. Depending on different 
physiological conditions, mitochondrial fission and fusion processes can lead to 
elongated, tubular-like mitochondria, which build an interconnected network, or to 
small spheres which are associated with enhanced mitochondrial fission. Recent 
evidence suggests that mitochondrial fission and fusion processes are linked to 
mitochondrial distribution, to mitochondrial metabolism and mitochondrial function 28. 
Mitochondria consist of an outer membrane (MOM), the IMS, the mitochondrial inner 
membrane (MIM), where the complexes I, III, IV and V of the electron transport chain 
(ETC) are localized, and the matrix, where the tricarboxylic acid cycle (TCA cycle) 
takes place to provide reducing equivalents (NADH/H+ and FADH2) for oxidative 
phosphorylation (Oxphos) and subsequent ATP production. The most prominent role 
of mitochondria is the generation of energy in form of ATP. Electrons donated from 
the reducing equivalents are transported through the ETC to finally reduce ½ O2 to 
hydrogen peroxide (H2O2). The released energy is used to pump protons into the IMS 
through complex I, III and IV, thereby creating an electrochemical gradient which is 
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coupled to ATP synthesis by complex V. The mitochondrial oxygen consumption rate 
is hence increased when a lot of ATP is produced 28–31. Besides the ability to 
generate ATP, mitochondria are the major source of endogenous ROS levels, which 
include superoxide (O2-), H2O2 and hydroxyl free radical (.OH) 29,32. The hydroxyl 
radical is highly reactive and can induce DNA, protein and lipid damage 33. These 
toxic by-products of Oxphos are neutralized by the antioxidant defense, which 
contains besides non-enzymatic antioxidants like ascorbic acid or tocopherols, 
antioxidant enzymes, such as superoxide dismutases, catalases and glutathione 
peroxidases 34. The imbalance of ROS generation and detoxifying mechanisms can 
cause mitochondrial membrane permeabilization and the impairment of the MMP, 
because in this case mitochondria are subjected directly to large amounts of ROS 
and might therefore be particular susceptible for oxidative stress 33. In addition to 
elevated ROS levels, mitochondrial dysfunction can be caused by increased 
Ca2+-levels or the activation of pro-apoptotic Bcl2 family members 35. The Bcl2 family 
is subdivided in two groups on the basis of their pro- or anti-apoptotic function. 
Anti-apoptotic Bcl2-like proteins are for instance Bcl2, BclxL or Mcl1, while 
pro-apoptotic ‘multi-domain’ proteins include Bax and Bak, and ‘BH3-only’ proteins 
include Bid, Bad and Bim 36. From the pro-apoptotic family members, Bax and Bak 
are the main mediators of MOM permeabilization in response to many apoptotic 
stimuli, as cells lacking Bax and Bak fail to undergo MOM permeabilization and 
apoptosis 37. At least two of the BH3-only proteins, namely Bid and Bim, are able to 
activate Bax and Bak. The active form of Bid (tBid) promotes the oligomerization of 
Bax and Bak at the MOM and thereby induces Cytc release and cell death. Similar 
evidence exists for Bim-mediated Bax/Bak activation and subsequent MOM 
permeabilization 38. However, Bid is also capable of mediating mitochondrial demise 
independent of Bax and Bak through pore formation in the mitochondrial membrane 
due to tBid oligomerization 39.  
Especially in neurons, which are rarely renewed, mitochondrial abnormalities cause 
severe neuronal dysfunction. Defects in mitochondrial function are linked to a variety 
of neurodegenerative diseases, such as PD, AD or amyotrophic lateral sclerosis 
(ALS). Also dominant optic atrophy (DOA) which is an optic neuropathy characterized 
by optic nerves degeneration and Charcot-Marie-Tooth 2A disease (CMT2A) which is 
a peripheral sensorimotor neuropathy characterized by motor deficits are 
consequences of elevated mitochondrial fission or attenuation of mitochondrial fusion 
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30,40,41
. The impairment of the mitochondrial network, which may occur by excessive 
mitochondrial fission and a lack of fusion, leads to the loss of mtDNA, respiratory 
defects, and the generation of detrimental ROS levels 42. Numerous proteins mediate 
mitochondrial fission and fusion processes and defects in this regulation are 
associated with mitochondrial dysfunction and afore mentioned diseases. 
Mitochondrial fission is mainly mediated by dynamin-related protein 1 (Drp1) and 
mitochondrial fission 1 protein (Fis1) 43,44, while mitochondrial fusion is under control 
of mitofusin 1 and 2 (Mfn1, Mfn2) and optical atrophy 1 (Opa1) 45. Mutations in 
human Drp1 can cause early infant mortality, and mutations in Mfn2 and Opa1 can 
cause CMT2A or DOA, respectively 46.  
Mitochondrial organization and distribution in cells corresponds in some extent to the 
cytoplasmic tubular network as the interaction of the cytoskeleton and the 
mitochondria was demonstrated 47. Furthermore, the actin cytoskeleton is involved in 
the movement and positioning of mitochondria and in mitochondrial fission 48. As 
mentioned above, Drp1 is one of the major regulators of mitochondrial fission and its 
activity and translocation to the mitochondria is under control of different triggers. For 
instance, the work of De Vos et al. revealed that the F-actin cytoskeleton is involved 
in the recruitment of Drp1 to the mitochondria. Disruption of the F-actin network 
attenuated the redistribution of Drp1 to the mitochondria and thereby prevented 
mitochondrial fission 49. Mitochondrial shape changes due to Drp1 redistribution from 
the cytosol to the mitochondria are controlled by the phosphorylation status of Drp1 
at two different serine residues. Phosphorylation at Ser616 by cyclin-dependent 
kinase 1 (Cdk1) promotes mitochondrial fission 50 whereas dephosphorylation of 
Drp1 at Ser637 by the Ca2+-dependent phosphates calcineurin regulates the 
translocation to the mitochondria and promotes mitochondrial fission leading to cell 
death 51,52. A polypeptide antagonist of calcineurin was discovered as a potent 
inhibitor of Drp1-dependent mitochondrial fragmentation. The polypeptide PPD1, 
which corresponds to the peptidyl-prolyl isomerase domain of FKBP52, inhibits 
calcineurin activation and thus dephosphorylation of Drp1 at Ser637 and thereby 
prevents cell death at the level of mitochondria 53. These findings depict a pivotal role 
of calcineurin and the F-actin cytoskeleton for the activation/redistribution of Drp1 and 
the subsequent mitochondrial fragmentation. In this study, the interaction of Drp1 and 
actin, the translocation to the mitochondria and the involvement of calcineurin in 
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conditions of glutamate-induced cell death in HT22 cells were a major focus of 
investigation.  
1.2.1. The role of AIF in life and death of neurons 
AIF is a flavoprotein which is encoded in the nucleus and synthesized in the 
cytoplasm as a ~67 kDa precursor protein. Murine AIF is organized in three domains: 
(i) an amino-terminal mitochondrial localization sequence (MLS) of 100 amino acids 
(aa), (ii) a spacer sequence (aa 101-121), a FAD-binding domain (aa 122-262 and 
400-477), a NADH-binding domain (aa 263-399) with two nuclear leading sequences 
(NLS) and (iii) a carboxy-terminal which consist of 136 amino acids. After the import 
of AIF in the mitochondrial IMS, MLS is proteolytically removed resulting in the 
~62 kDa mature form, which changes its configuration incorporating FAD and 
anchoring in the MIM 54–57. Upon induction of apoptosis AIF is cleaved into a ~57 kDa 
truncated protein (tAIF), which translocates to the nucleus and induces DNA 
fragmentation and large scale (~50 bp) chromatin condensation. The interaction of 
AIF with DNA is sequence-independent but is due to a strong positive electrostatic 
potential 58,59. Since AIF lacks nuclease activity to degrade DNA 60, the particular 
mechanism of DNA fragmentation is still elusive. However, recent reports suggested 
that proteins which exhibit nuclease activity are involved in AIF-mediated DNA 
fragmentation. For example, in human cells cyclophilin A (CypA) was discovered as a 
direct binding partner of AIF, which exhibits a latent, Ca2+-dependent nuclease 
activity 61,62. Since both proteins alone are not able to induce DNA degradation it has 
been proposed that the direct interaction of AIF and CypA is necessary to induce 
chromatinolysis 62. More recent findings showed, however, that the histone H2AX is a 
further essential component of the AIF/CypA-containing DNA-degrading complex. 
H2AX is a member of the histone H2A family and is a sensitive marker for DNA 
double strand breaks (DSBs). The phosphorylation of H2AX at Ser139 residue 
following DSBs is the critical step for the interaction with AIF and the formation of the 
DNA-degrading complex 63,64. 
While in some models of cell death the mitochondrial AIF release is 
caspase-dependent 65, AIF release occurs in a caspase-independent manner in 
several important paradigms of PCD. For instance, DNA damage is linked to 
mitochondrial AIF release through activation of p53 24 or via Poly (ADP-Ribose) 
Polymerase 1 (PARP1)-mediated pathways (Parthanatos) 66–68. DNA strand breaks 
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trigger the activation of PARP1 which leads to the depletion of mitochondrial 
nicotinamide adenine dinucleotide (NAD+) and ATP, and subsequently to cell death, 
which could be prevented by PARP1 inhibitors or genetic knockout of PARP1 66. 
Further, it was demonstrated that proteases, such as the Ca2+-activated calpain I, 
induce AIF truncation and the subsequent release from isolated mitochondria 69. In 
addition, the pro-apoptotic protein Bid was associated with mitochondrial AIF release 
after glutamate toxicity in neural cells 70–72. Further, in vivo lethal AIF translocation 
from the mitochondria to the nucleus was observed, for instance, in models of 
neonatal cerebral hypoxia/ischemia 73, TBI 74, epilepsy 75 or transient focal cerebral 
ischemia 76. 
All these findings depict AIF as an important mediator of caspase-independent 
neuronal PCD pathways. Targeting the mitochondrial release of AIF may therefore 
serve as a therapeutic target to prevent diseases where the translocation of AIF to 
the nucleus induces neuronal dysfunction and cell death. Recent findings revealed 
that neuronal cells depleted of AIF by siRNA were resistant to oxygen glucose 
deprivation (OGD) and glutamate-induced cell death 70,77. Moreover, harlequin mice 
(Hq), carrying a mutation that mediates an 80% reduction of AIF expression in all 
tissues including the brain, were protected against hypoxia/ischemia 78, focal cerebral 
ischemia 76,79 and global cerebral ischemia 80. However, it seems that AIF’s redox 
function is essential for cell survival, as it plays a major role in the maintenance of the 
ETC function, the control of ROS generation and mitochondrial integrity, regulated by 
the NADH-oxidase domain 57,81. This becomes apparent in paradigms of long term 
AIF depletion, as for example Hq mice develop ataxia, blindness and loss of 
cerebellar neurons. Such AIF-deficiency is accompanied by increased ROS levels 
and a loss in complex I function, which underlines the pro-survival function of AIF 
77,82–84
. Therefore, AIF plays apparently a central role controlling physiological 
functions of mitochondria that are essential for cellular homeostasis and maintenance 
as well as in mitochondrial cell death pathways that are mediated by the translocation 
of AIF to the nucleus. However, upstream mechanisms of AIF function and the lethal 
translocation to the nucleus are largely unknown. Since some proteases are 
associated with upstream mechanisms of mitochondrial demise and the 
mitochondrial AIF release the involvement of trypsin-like serine proteases in 
paradigms of PCD associated with mitochondrial damage are in the main focus of the 
second part of this work. 
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1.3. Proteases in paradigms of programmed cell death 
Endopeptidases, which represent about 2% of all proteases, are classified due to 
their catalytic active-site residue. The main representatives are metalloproteinases 
(34%), serine proteases (30%) and cysteine proteases (26%). Serine and cysteine 
proteases are named after their nucleophile amino acid in their catalytic triad. 
Proteases mediate the cleavage of peptide bonds in other proteins and thereby 
determine protein folding and hence control many diverse physiological processes, 
such as digestion, blood coagulation, tissue homeostasis, immune response, 
neuronal outgrowth, embryonic development, apoptosis and ageing. However, a 
deregulation of proteases by genetic mutations can cause a variety of hereditary 
diseases, such as haemophilia A or AD, and activation of proteases is linked to many 
forms of cell death 85.  
1.3.1. Caspases 
The finding of the human protease interleukin-1β converting enzyme (ICE or 
caspase-1), resulted in the discovery of several other ICE-like proteases, which were 
renamed ‘cysteine aspartate-specific proteases’, and in short ‘caspases’. Caspases 
exist as zymogens within cells and have to be activated by proteolytic autoactivation, 
transactivation or by other endopeptidases. This activation is mediated by the release 
of the pro-domain and the subsequent separation of the small and large subunit, 
which form subsequently an active tetrameric enzyme 86,87. Caspases are important 
mediators of apoptosis and in this paradigm they can be classified as ‘initiator 
caspases’ (caspase-2, -8, -9, -10), which are activated early in apoptotic pathways 
and exhibit DED or caspase recruitment domains (CARD) and ‘executioner 
caspases’ (caspase-3, -6, -7), which are activated at later time points and execute 
apoptosis 87.  
As described before, the initiator caspase-8 (and -10) 88 are involved in the extrinsic 
apoptotic pathway and are recruited by adaptor proteins like FADD via their DED, 
building the DISC 10. The recruitment of pro-caspase-8 and the subsequent activation 
can be antagonized by the anti-apoptotic cellular FLICE inhibitory protein (cFLIP) 
which binds to FADD via its DED 89. After its activation, caspase-8 mediates Bid 
cleavage, which links the extrinsic to the intrinsic apoptotic pathway, or directly 
activates caspase-3 independently of mitochondrial involvement. The second initiator 
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caspase, caspase-9, is recruited by the CARD domain of Apaf1, which together with 
Cytc and dATP builds a proteasome protein complex and activates pro-caspase-9 90. 
Little is known about the role of caspase-2 in apoptotic cell death pathways. Recent 
findings suggest, however, that the activation of pro-caspase-2 occurs upon nerve 
growth factor deprivation and DNA damage, but is independent of Apaf1 91,92. 
The executioner caspases-3, -6 and -7 are activated by functional initiator caspases 
and execute apoptosis by cleaving downstream substrates such as ICAD, IAPs, 
Rho-associated kinase (ROCK) or PARP 93,94. Caspase-6 has been less intensively 
studied, however, due to its structural properties and its cleavage downstream of the 
initiator caspases it is regarded as an executioner caspase 90. The typical 
caspase-dependent DNA laddering which results in ~180 bp fragments is mediated 
by the activation of CAD through executioner caspases, resulting in cell death 12. 
1.3.2. Non-caspase proteases 
Since the inhibition of caspases with broad-range inhibitors such as z-VAD-fmk does 
not necessarily prevent cell death, growing evidence suggests that other proteases 
are also mediators of apoptotic cell death pathways 95. One representative for a 
non-caspase mediator of cell death is the cytosolic neutral cysteine protease calpain, 
which is Ca2+-dependent and consists of two isoforms, m- and µ-calpain 96. Since 
calpains contribute to the impairment of synaptic transmission in AD 97 and to the 
pathology of spinal cord injury 98, they came into the focus of research in apoptotic 
mechanisms. A large variety of proteins and transcription factors which are linked to 
apoptotic cell death mechanisms such as p53, c-jun and c-fos, were identified as 
calpain substrates. Furthermore, calpain-cleaved Bid and calpain-activated Bax have 
been implicated in mitochondrial permeabilization and the subsequent release of 
Cytc and AIF, which can also be directly cleaved by calpains, from the mitochondrial 
IMS 69,99,100.  
Another group of non-caspase proteases are known as cathepsins which include a 
group of ‘lysosomal proteolytic enzymes’, irrespective of their enzyme class. 
Therefore, apart from cysteine proteases (cathepsin B, C, F, H, K, L, S, W and X) 
also serine proteases (cathepsin A and G) and aspartic proteases (cathepsin E and 
D) are included by this term 101. Cathepsins are involved in many physiological 
processes, however, in the last years they were associated with apoptotic cell death 
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pathways 102,103. To exert their apoptogenic function cathepsins have to be released 
from lysosomes, which requires lysosomal destabilization or permeabilization. 
Possible mechanisms of lysosomal disruption and the subsequent release of 
cathepsins into the cytosol involve the activation of phospholipase A2 104, elevated 
ROS levels 105 or TNFα-mediated apoptosis 106, respectively. The major mediators of 
apoptosis within this protease family are reported to be cathepsins B, L and D 101. 
After being released into the cytosol different substrates are activated. Cathepsin L 
participates in caspase-3 activation, cathepsin B induces the cleavage of Bid and the 
activation of pro-caspases-1 and -11 107, while cathepsin D triggers Bax activation 
which, in turn, mediates mitochondrial AIF release 108.  
1.3.3. Serine proteases 
Serine proteases represent approximately one-third of all known proteases and due 
to their structure they can be divided into two classes: trypsin-like (also termed 
chymotrypsin-like) and subtilisin-like serine proteases. The class of trypsin-like serine 
proteases can be further categorized based on their substrate specificity as 
trypsin-like, chymotrypsin-like or elastase-like serine proteases 85,109. The mammalian 
serine proteases trypsin, chymotrypsin and elastase are the best characterized 
among all serine proteases. The catalytic triad of serine proteases consists of three 
essential amino acids, histidine (His57), aspartate (Asp102) and serine (Ser195), 
which are closely related to each other due to protein folding (Figure 1) 110.  
 
 
 
 
 
Figure 1: Catalytic triad of serine proteases 
Serine proteases exhibit a catalytic triad with three essential amino acid residues involved in the cleavage of 
peptide bonds: histidin 57, aspartate 102, and serine 195. 
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Activation of serine protease cascades are involved in many physiological conditions 
including digestion, blood clotting and development and plasticity of the nervous 
system 111. However, serine proteases were also related to PCD pathways as 
introducing them in tumor cells led to cell death with characteristics of apoptosis 112. 
The major representatives of serine proteases involved in apoptosis are granzyme B 
and the mitochondrial serine protease high temperature required protein A2 
(Omi/HtrA2). Granzyme B is found in cytoplasmic granules of cytotoxic T 
lymphocytes (CTLs) and natural killer (NK) cells and can be released by exocytosis 
113
. The central nervous system (CNS) exhibits the lowest number of CTLs of any 
tissue, however, in neuroinflammatory and neurodegenerative disorders like AD and 
after traumatic and ischemic brain injury the amount of CD8+ CTLs is enriched 114,115. 
Furthermore, motor neuron dysfunction in amyotrophic lateral sclerosis (ALS) is 
linked to increased invasion of CTLs in the spinal cord 116. After the release of 
granzyme B from CTLs it is endocytosed by target cells and mediates apoptosis by 
cleaving/activating downstream substrates, such as pro-caspase-3, Bid, ICAD or 
PARP 117. Moreover, pro-apoptotic proteins, namely Bid, PARP and caspase-3, 
where identified as interaction partners of granzyme B in a model of 
ischemic/reperfusion injury 118.  
The second serine protease associated with neurodegenerative disorders is 
Omi/HtrA2 119,120. Like other pro-apoptotic factors such as AIF, EndoG, Smac/Diablo 
or Cytc, Omi/HtrA2 is released from the mitochondria during apoptosis induced by 
DNA damage, death receptor activation or several other apoptotic stimuli 120. After 
being released into the cytoplasm Omi/HtrA2 binds to the inhibitor of apoptosis 
proteins (IAPs), thus deactivating them and indirectly promoting the activation of 
caspases 121,122. Furthermore, Omi/HtrA2 is able to induce apoptosis in a 
caspase-independent manner due to its protease activity 123. Since the specific 
Omi/HtrA2 inhibitor Ucf-101 showed protective effects in vitro and also in in vivo 
models of ischemia/reperfusion, serine proteases represent promising targets to 
prevent neurological dysfunction 124–126.  
In addition to granzyme B and Omi/HtrA2 the serine proteases trypsin and 
chymotrypsin are also related to apoptotic cell death pathways 112. Recently 
chymotrypsin B was linked to apoptosis via cleavage of Bid and thus inducing Cytc 
release from the mitochondria 127. Furthermore, the serine protease trypsin directly 
Introduction 
  
12 
 
increases intracellular ROS levels arising from the mitochondria and contributing to 
cytotoxicity. As the protease-induced ROS increase and subsequent cell death was 
attenuated by catalase treatment, a decomposer of H2O2, and accelerated by 
aminotriazole (a catalase inhibitor) treatment, Aoshiba and colleagues revealed a 
direct influence of serine proteases on the generation of intracellular ROS levels 
thereby mediating cell death 128. The protective potential of the two serine protease 
inhibitors Nα-Tosyl-L-lysinchlormethylketon hydrochlorid (TLCK) and Np-Tosyl-L-
phenylalanine chloromethyl ketone (TPCK) in sympathetic and hippocampal neurons 
underlines the importance of trypsin- and chymotrypsin-like serine proteases in 
neuronal cell death 129,130. Proteins involved in downstream mechanisms of serine 
protease activation are for instance the degradation of the anti-apoptotic protein 
Bcl-2, the up-regulation/activation of pro-apoptotic proteins such as Bid and Bax, and 
the activation of caspases, all leading to cell death 131–133. Another target of TLCK is 
the tumor suppressor protein p53. p53 plays an essential role in cell-cycle 
progression or apoptosis, which is influenced by many factors, such as cell type or 
stress stimuli 134,135, e.g. oxidative stress induces the accumulation of p53 136. It was 
reported by different groups that the accumulation of p53 was prevented by TLCK 
and the ensuing cell viability was increased 131,137. Chymotrypsin-like serine 
proteases are also involved in another paradigm of PCD, the CD47-mediated PCD 
pathway. This type of cell death is characterized by F-actin network disruption, 
redistribution of Drp1 to the mitochondria, the impairment of the ETC and the 
exposure of phosphatidylserine on the outer leaflet of the plasma membrane 138. 
F-actin disruption and the following cascade are mediated by chymotrypsin-like 
serine proteases as TPCK was able to prevent all these events in chronic 
lymphocytic leukemia cells 138. All these findings contribute to the rising importance of 
serine proteases in cell death mechanisms. In this work trypsin-like serine proteases 
were in the focus of interest in glutamate-induced oxidative stress and associated 
intrinsic pathways of cell death in HT22 cells. Figure 2 exhibits a possible cell death 
mechanism induced by activated trypsin-like serine proteases.  
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Figure 2: Serine proteases in glutamate-induced cell death in HT22 cells 
Glutamate-induced increases in ROS may trigger the activation of serine proteases, which in turn activate Bid and 
lead to the disruption of the F-actin cytoskeleton. Subsequently, Drp1 redistributes to the mitochondria, where it 
associates with Bid and Bax. The ternary complex of Bid, Bax and Drp1 promotes mitochondrial fission, the 
release of AIF from the mitochondria and cell death.  
1.4. The family of Peptidyl-prolyl cis-trans isomerases  
Peptidyl-prolyl cis-trans isomerases (PPIases) catalyze cis-trans isomerization of 
peptide bonds at proline residues and thereby facilitate protein folding of other 
proteins. PPIases were first discovered as the intracellular receptors for the 
immunosuppressive drugs cyclosporine A (CsA), FK506 (tacrolimus) and sirolimus 
(earlier rapamycin), respectively. Today three classes of PPIases are characterized: 
(i) the cyclophilins (ii) FK506-binding proteins (FKBPs) and (iii) the parvulins 139. 
While all three classes exhibit isomerase activity, cyclophilins and FKBPs constitute 
the class of immunophilins, because of their ability to build immunosuppressive 
complexes with the before mentioned drugs, however, parvulins count as 
nonimmunophilins lacking immunosuppressive properties 140,141.  
1.4.1. FK506-binding proteins 
FKBPs are small, predominantly soluble and ubiquitously expressed proteins which 
were discovered as the intracellular binding partner of tacrolimus and rapamycin 
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139,142
. The tacrolimus/FKBP complex competitively binds to the Ca2+- and 
calmodulin-dependent phosphatase calcineurin thereby inhibiting its activity which 
results in attenuated T-cell activation and the consequent immunosuppression 143. 
The characterization of immunophilins has largely focused on cells from the immune 
system, however, FKBPs were also found to be abundantly expressed in brain tissue 
even more than 10 times higher compared to peripheral immune tissue 144. Not only 
immunosuppressive features were linked to FKBPs but also protective effects in 
neuronal cell death pathways. The complex formation of tacrolimus/FKBPs in the 
brain enhances phosphorylation of several proteins, such as nitric oxide synthase 
(NOS), which is due to the inhibitory effect on calcineurin. This increased 
phosphorylation of NOS mediates protective effects against glutamate-induced 
excitotoxicity in cortical neurons 145. Moreover, in vivo studies in models of global and 
transient focal ischemia revealed a crucial role for FKBPs as the treatment with 
tacrolimus exhibits neuroprotective effects. Furthermore, FKBPs are linked to 
neurological disorders such as PD 146–148.  
1.4.2. Parvulins 
Protein interacting with NIMA (never in mitosis A)-1 (Pin1) is the main representative 
of the parvulin subfamily of PPIases. Pin1 was discovered as the first 
nonimmunophilin catalyzing the isomerization of proline bonds. However, in contrast 
to the other family members of the PPIases, Pin1 exerts its isomerase activity only 
when a serine or threonine preceding the target proline is phosphorylated 149. This 
phosphorylation-dependent isomerase activity places Pin1 in a central role of 
signaling pathways in cell proliferation and tumorgenesis 150, in neuronal 
differentiation and survival as well as in the pathology of AD 151,152. The two proteins 
tau and amyloid precursor protein (APP) which are associated with AD pathology 
become phosphorylated by protein kinases as part of their physiological function, 
exhibiting a trans-conformation. A loss of Pin1 function results in elevated cis-ptau 
and cis-pAPP motifs representing the pathological conformations in AD 152. Pin1 is 
sensitive to oxidative stress and the loss of Pin1 function in AD is reported to be due 
to the oxidation of Pin1 which results in decreased isomerase activity and accordingly 
in increased cis-ptau and cis-pAPP levels 153. Thus, Pin1 exhibits a pro-survival role 
in the pathology of AD. However, Pin1 is also linked to neuronal apoptosis by 
activating the mitochondrial apoptotic machinery due to the interaction with the Bcl2 
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family member Bcl-2 interacting mediator of cell death (BimEL). BimEL is located at the 
mitochondria and promotes neuronal cell death after growth factor deprivation or 
activation of the p75 death receptor. JNK-induced phosphorylation of BimEL at Ser65 
induces mitochondrial dysfunction and neuronal cell death 154,155. In neurons Pin1 is 
enriched at the mitochondria and during apoptosis it interacts with pSer65 BimEL 
leading to the stabilization by attenuating the proteasomal degradation of BimEL and 
thereby promotes mitochondrial demise and cell death 156. Since Pin1 is involved in 
the mitochondrial apoptotic machinery in neurons, this work investigates the 
contribution of Pin1 in glutamate-induced cell death and the impact on mitochondrial 
dynamics in HT22 neurons.   
1.4.3. Cyclophilins 
Cyclophilins (Cyps) which represent the third class of PPIases are ubiquitous 
proteins and evolutionarily well conserved. Human Cyps consists of 16 family 
members, among them CypA is the most abundant, which makes up to ~0.1-0.6 % of 
all cytosolic proteins 157. CypA and D (partly CypB) are the two main representatives 
which are involved in cell death pathways. CypB exhibits an amino-terminal signal 
sequence that targets it to the ER 158. In contrary to the other two mentioned 
cyclophilins, CypB has anti-apoptotic features in endoplasmatic reticulum (ER) 
stress-induced cell death pathways. ER stress induces the upregulation of different 
ER chaperons, including CypB. CypB overexpression suppresses apoptosis in H9C2 
cells associated with elevated ROS and Ca2+-levels and depletion of CypB with 
siRNA renders cells more susceptible for ER stress 159. Another important ER stress 
response factor is CCAAT/enhancer-binding protein-homologous protein (CHOP), 
which is upregulated upon ER stress-induced apoptosis or after hypoxia 160. CypB 
interacts with CHOP after hypoxia and cooperates with p300 E4 ligase to modulate 
the ubiquitination of CHOP thereby preventing hypoxia-induced cell death 160. These 
studies demonstrate a pro-survival role for CypB. In contrast, CypD which is part of 
the mitochondrial PTP together with the voltage-dependent anion channel (VDAC) 
and adenine nucleotide translocator (ANT) is associated with cell death 161. It has 
been reported that CypD-deficient mouse embryonic fibroblast are less susceptible to 
H2O2-induced oxidative stress. Furthermore, in an ischemic injury model, where 
Ca2+-overload and oxidative stress mediate cell death, CypD-deficient mice exhibited 
reduced brain infarct size after middle cerebral artery occlusion (MCAO) and 
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reperfusion which denotes a pivotal role for CypD in neuronal cell death induced by 
oxidative stress stimuli 162. Recently, Cyps were furthermore associated with cell 
cycle regulation. In particular, Cyp18 was shown to be involved in p53 regulation 163. 
As previously mentioned in this work, p53 is a tumor suppressor which up- or 
down-regulates several target genes and thereby engages a key role in executing 
cellular response due to different types of stress/stimuli. The most intensively studied 
pathways are cell cycle control, DNA repair and recombination, apoptosis and the 
self-regulation of intracellular levels of p53 164. Cyp18 was discovered as an 
interaction partner of p53 thereby regulating p53-dependent apoptosis. The 
interaction of Cyp18 and p53 reduced the sequence-specific DNA binding of p53, 
whereas the impairment of the Cyp18-p53 complex increased p53-reporter gene 
activity. Inhibition of this interaction resulted in more pronounced accumulation of 
cells in the G2/M cell cycle phase, demonstrating a modulating role for Cyp18 in cell 
cycle regulation 163. 
However, in this study the main focus lies on CypA. CypA is the prototype of the 
cyclophilin family as it was discovered as the first intracellular binding partner of the 
immunosuppressive drug CsA from this family 165. CsA exerts its immunosuppressive 
action via a ternary complex between CsA, CypA and calcineurin, which inhibits the 
phosphates activity of calcineurin and its biological function 143. Besides the 
immunosuppressive properties, CypA is known to be involved in several cellular 
events, such as protein folding and trafficking of proteins, formation and infectivity of 
virions of the human immunodeficiency virus (HIV)-1, folding of neuronal receptors 
and cell division in living cells 157. Most of these pathways are sensitive to the 
inhibitory effect of CsA on CypA. CypA expression is particularly high in brain tissue, 
where it is expressed mainly in the cytoplasm but can also be found in the nucleus 
166
. As mentioned before CypA is involved in cell death pathways as an obligate 
cofactor for AIF-mediated chromatin condensation 62 and it mediates 
excitotoxin-induced apoptosis in rat neuronal B50 cells 167. Cells lacking CypA are 
relatively resistant to AIF-induced cell death. In vitro recombinant AIF and CypA 
exhibit a higher DNase activity than each of the proteins alone 62. Mutant CypA which 
lacks peptidyl-prolyl isomerase activity still cooperates with AIF, mediating chromatin 
condensation. Furthermore, this feature was not abrogated by CsA, indicating that 
isomerase activity is not involved in CypA-mediated cell death and that CsA is not a 
pharmacological tool to investigate this particular cell death pathway 62. Moreover, in 
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in vivo models of CypA knockout mice (CypA-/- mice) the infarct volume after cerebral 
hypoxia-ischemia was reduced by 47% compared to their wild-type littermates 168. It 
is further reported, that AIF translocation to the nucleus in CypA-/- mice was reduced 
and vice versa, in AIF-deficient Hq mice CypA translocation to the nucleus was 
diminished, which suggests that both proteins are required for each other’s 
translocation 168. Recent findings from Tanaka et al. revealed that CypA/AIF complex 
formation and co-translocation to the nucleus mediates motor neuron degeneration in 
a mouse model of ALS 169. All these findings exhibit a crucial role for CypA in 
neuronal cell death. The aim of this study was to examine the contribution of CypA to 
oxidative stress-induced cell death by glutamate in HT22 cells and since the AIF 
release was prohibited in CypA-/- mice, if CypA also targets mitochondrial function 
and integrity. 
1.5. The HT22 cell model 
To investigate the role of Pin1, AIF and CypA and trypsin-like serine proteases in the 
paradigm of oxidative stress-induced neuronal cell death, mouse hippocampal 
neuronal cells (HT22 cells) were used. This cell line is immortalized using a 
temperature-sensitive SV40 T-antigen 170. Since HT22 cells lack ionotropic glutamate 
receptors, high extracellular glutamate concentrations (in millimolar ranges) lead to 
cell death via the inhibition of the xCT-antiporter, which is localized at the plasma 
membrane. This blockage results in decreased intracellular cystine concentrations 
resulting in depleted GSH levels, which leads to the activation of 12/15-Lox and then 
to the generation of elevated ROS levels 72,171. This is accompanied by an increase 
of intracellular Ca2+-levels 172. The accumulation of ROS accordingly triggers the 
translocation of pro-apoptotic proteins, such as Bid, Bax and Drp1 to the 
mitochondria where they induce mitochondrial fission and a second much more 
pronounced increase in ROS levels, generated by the mitochondria. Accordingly, AIF 
is released from the mitochondria and translocates to the nucleus where it promotes 
cell death (Figure 3) 70,71,173. Even though HT22 cells lack NMDA receptors this cell 
line is an established model to study the mechanisms of glutamate-induced oxidative 
stress, because increased intracellular Ca2+-levels and elevated ROS levels are 
common features in neurodegenerative diseases.  
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Figure 3: Schematic mechanism of glutamate-induced cell death in HT22 cells 
HT22 cells express an xCT-antiporter in the cell membrane. High extracellular glutamate concentrations (mM) 
block the antiporter, resulting in elevated intracellular cystine levels which lead to a GSH depletion. Thus, 
12/15-Lox is activated leading to enhanced ROS generation and lipid peroxide production which mediates the 
activation and translocation of pro-apoptotic proteins like Bid, Bax and Drp1 to the mitochondria. This triggers 
mitochondrial AIF release and translocation to the nucleus and subsequently cell death (modified from Tobaben). 
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1.6. Aims of this study 
Oxidative stress and mitochondrial demise are linked to several neurological 
disorders, however, very little is known about the involved mediators upstream and 
downstream of mitochondrial damage and possible regulatory mechanisms of 
post-translational protein modification which may contribute to mitochondrial 
dysfunction. Such post-translational protein modifications may include protein-protein 
interactions, isomerization of proteins and protein cleavage which determine protein 
functions and subcellular localization, thereby regulating cellular homeostasis and 
resilience versus mitochondrial demise and cell death. 
In particular AIF-mediated PCD pathways are linked to neuronal cell death in vitro 
and in vivo. The lethal AIF release from the mitochondria and the subsequent 
translocation to the nucleus is a major feature of caspase-independent neuronal cell 
death after TBI, cerebral focal and global ischemia, epilepsy and after oxidative 
stress. The immunophilin CypA is an important cofactor of AIF to induce 
chromatinolysis. However, the mechanism of cell death induced by the CypA/AIF 
complex is largely unknown. Thus, the first part of this thesis investigated the role of 
CypA in conditions of oxidative stress induced by glutamate and the impact of CypA 
on mitochondrial function. For this purpose, siRNA approaches of CypA were used to 
gain more insight into the particular role of CypA in neuronal cell death. Another 
representative of the PPIase family to which CypA belongs is Pin1. Pin1 is 
associated with the mitochondrial apoptotic machinery and thus another central issue 
of this study was to examine the influence of Pin1 on mitochondrial parameters. For 
this reason, a specific inhibitor (Br57) was used to investigate the influence of Pin1 
on mitochondrial demise and cell death in HT22 cells. 
The second part of this thesis addressed the question if serine proteases are 
involved in oxidative stress-induced cell death pathways in HT22 cells. It is 
well-established that caspases are major contributors to extrinsic as well as intrinsic 
apoptotic pathways. However, recent evidence suggests that also other proteases, 
such as serine proteases are linked to neuronal cell death. To elucidate the influence 
of trypsin-like serine proteases in glutamate-induced cell death the inhibitor TLCK 
was used and the impact on cell viability and several mitochondrial parameters was 
examined. To extend the results obtained from HT22 cells, TLCK was applied to 
mouse embryonic cortical neurons and the impact on cell viability was analyzed. 
Material and methods 
  
20 
 
2. Material and methods 
2.1. Chemicals and reagents 
All standard chemicals were obtained from Sigma-Aldrich (Taufkirchen, Germany) 
and Roth (Karlsruhe, Germany), if not otherwise declared. All buffers and solutions 
were prepared using demineralized, ultrapure water (bidest dH2O) that was prepared 
with the SG Ultra Clear UV plus pure water system (VWR, Darmstadt, Germany) and 
autoclaved with a steam autoclave (Systec V-40, Systec GmbH, Wettenberg, 
Germany). 
2.2. Cell culture materials 
All sterile plastic materials which were used are listed in Table 1. 
Table 1: Plastic materials 
Plastic material Company 
T75 flasks Greiner, Frickenhausen, Germany 
T175 flasks Greiner, Frickenhausen, Germany 
24-well plates Greiner, Frickenhausen, Germany 
96-well plates Greiner, Frickenhausen, Germany 
96-well E-plates Roche, Penzberg, Germany 
8-well ibidi slides  Ibidi, Munich, Germany  
15 ml tubes  Greiner, Frickenhausen, Germany  
50 ml tubes  Greiner, Frickenhausen, Germany 
0.5, 1.5, 2 ml tubes  Sarstedt, Nümbrecht, Germany  
Rubber policeman Sarstedt, Nümbrecht, Germany  
0.22 µm sterile filter  Whatman, Dassel, Germany  
1,5, 10 ml Injekt®  Braun, Melsungen, Germany  
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2.3. Cell culture 
2.3.1. Cultivation of HT22 cells 
HT22 cells were generated by David Schubert (Salk Institute, San Diego, USA) and 
obtained from Gerald Thiel (Homburg/Saar). These cells were originally selected 
from HT4 cells based on glutamate sensitivity and immortalized from primary 
hippocampal neurons using a temperature-sensitive SV-40 T antigen 170. 
HT22 cells were cultured in Dulbecco’s modified Eagle medium (DMEM, Invitrogen, 
Karlsruhe, Germany) supplemented with 10% heat inactivated fetal calf serum, 100 
U/ml penicillin, 100 µg/ml streptomycin and 2 mM stable L-glutamine (all PAA 
Laboratories GmbH, Cölbe, Germany, Table 2) and cultured in 75 cm² flasks in an 
humidified incubator at 37°C and 5% CO2. Twice a week stock cells were split in a 
1:10-1:20 ratio. For splitting and seeding the cells in different plate formats, cells 
were washed once with phosphate buffered saline (PBS, Table 3) to remove the 
growth medium completely. Thereafter, cells were incubated with a Trypsin/EDTA 
solution (1x TE, Table 4) for a few minutes to detach the cells from the bottom of the 
culture dish. By adding the 3-4 fold amount of growth medium, the protease activity of 
trypsin was stopped. The cell suspension was centrifuged at 1,000 rpm for 5 min. and 
after discarding the supernatant, cells were resuspended in fresh growth medium. 
The cell number was determined by counting the cells with a counting chamber 
(Neubauer Zählkammer, Brand, Wertheim, Germany). For experiments the required 
cell number was added into different culture dishes (listed in Table 5) and adjusted 
depending on the cell growth and the passage number. After 24 h of seeding, cells 
were treated with the mentioned cell death inducers and inhibitors of apoptosis (2.3.2 
and 2.3.3) for 4-18 h depending on the following experiments and analysis. For this 
purpose old growth medium was removed and new medium containing the different 
drugs was added.  
 
Table 2: HT22 medium 
DMEM-medium with 4.5 mg/l glucose and 110 mg/l sodium pyruvate  440 ml 
Heat inactivated fetal calf serum (FCS) 50 ml  
L-alanyl-L-glutamine 200 mM 5 ml 
Penicillin 10.000 U/ml / streptomycin 10 mg/ml  5 ml 
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Table 3: Phosphate buffered saline (PBS), pH 7.4 
NaCl 9 g 
Na2HPO4 0.527 g 
KH2PO4  0.144 g 
HCl  q.s. for pH adjustment 
Bidest dH2O ad 1,000 ml 
 
Table 4: Trypsin/EDTA solution (1x TE) 
0.05 % Trypsin (7.500 U/mg) 100 mg 
0.02 % EDTA 40 mg 
1x PBS ad 200 ml 
 
Table 5: Cell numbers and volumes in cell culture dishes 
Cell culture dish Cell number per well Total volume of medium 
per well 
96-well plate ~ 8,000-10,000 cells/well 100 µl 
96-E-plate ~ 8,000-10,000 cells/well 100 µl 
Ibidi slides ~ 16,000-20,000 cells/well 200 µl 
24-well plate ~ 60,000 cells/well 900 µl 
6-well plate ~ 120,000-200,000 cells/well 2 ml 
75 cm2 flask ~ 1,5 Mio cells/flask 15 ml 
175 cm2 flask ~ 3,0-3,5 Mio cells/flask 25 ml 
10 cm2 dish ~ 1,5 Mio cells/dish 10 ml 
14,5 cm2 dish ~ 3,0 Mio cells/ dish 20 ml 
 
2.3.2. Inducers of apoptosis 
A stock solution of glutamate was prepared using DL-glutamic acid monohydrate 
(Sigma-Aldrich, Taufkirchen, Germany) which was dissolved in Earle’s balanced salt 
solution (1x EBSS) or Dulbeccos’s modified eagle medium (DMEM; PAA 
Laboratories GmbH, Cölbe, Germany) to a stock concentration of 1 M. The stock 
solution was stored at -20°C. The working solution with final concentrations of 
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2-7 mM glutamate was directly put on HT22 cells to induce cell death. Depending on 
the experiments cells were harvested or analyzed 4-18 h after induction of cell death.  
For Hydrogen peroxide-induced cell death (H2O2, Sigma-Aldrich, Taufkirchen, 
Germany), a stock solution of H2O2 with a concentration of 30% was diluted in HT22 
medium to final concentrations of 800-900 µM prior to use.  
tBid-induced apoptosis was performed by transfecting HT22 cells with the tBid vector 
as described in 2.4.1.. 
2.3.3. Inhibitors of apoptosis 
Nα-Tosyl-L-lysinchlormethylketon hydrochlorid (TLCK; Sigma Aldrich, Taufkirchen, 
Germany; Figure 4) was dissolved in DMSO at a stock concentration of 10 mM and 
stored at -20°C. TLCK was used at a final concentration of 50 µM in normal growth 
medium, if not otherwise indicated. HT22 cells were co-treated with TLCK except in 
tBid-induced cell death experiments. In these experiments cells were pretreated with 
TLCK for 1 h prior to glutamate challenge.  
 
 
 
Figure 4: Chemical structure of TLCK 
 
Np-Tosyl-L-phenylalaninechlormethylketon (TPCK; Sigma Aldrich, Taufkirchen, 
Germany, Figure 5) was dissolved in DMSO at a stock concentration of 10 mM and 
stored at -20°C. TPCK was used at indicated concentrations and cells were 
co-treated with this inhibitor in culture medium. 
 
 
 
Figure 5: Chemical structure of TPCK 
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Compound Br57 (specific Pin1 inhibitor; kindly provided by Manfred Braun, 
Düsseldorf, Germany; Figure 6) was dissolved in DMSO at stock concentrations of 
10 mM and stored at -20°C 174. 
 
 
 
 
Figure 6: Chemical structure of the Pin1 inhibitor Br57  
Br57 is an aryl 1-indanylketone derivate with an inhibitory efficacy for the Peptidyl-prolyl isomerase Pin1. 
 
Bid inhibitor BI-6c9 (Sigma-Aldrich, Taufkirchen, Germany; Figure 7) was dissolved in 
DMSO at a stock concentration of 10 mM. It was used at a final concentration of 
10 µM in HT22 growth medium as a positive control in different experiments. 
 
 
Figure 7: Chemical structure of the Bid inhibitor BI-6c9 
 
2.4. Chemical and reagents 
2.4.1. Transfection reagents  
Opti-MEM I (Invitrogen, Karlsruhe, Germany) was used for DNA and siRNA 
transfections as basal, antibiotic- and serum-free medium. 
For siRNA complexe formation the transfection reagent Lipofectamin® RNAiMAX 
(Invitrogen, Karlsruhe, Germany) was used. 
Attractene transfection reagent (Qiagen, Hilden, Germany) was used to transfect 
DNA plasmids. In a 24-well format 4.5 µl of attractene were used to transfect 2 µg of 
DNA. 
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2.4.1.1. Plasmid vectors 
The tBid vector was generated as described previously 175. 
The plasmid pcDNA 3.1 was used as a control vector (Invitrogen, Karlsruhe, 
Germany).  
All plasmids were amplified using the QIAGEN Plasmid Plus Midi Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. Plasmid DNA-concentrations 
were defined with a NanoVue Plus Spectrophotometer (Implem, GE Healthcare 
Europe GmbH, Freiburg, Germany). 
2.4.1.2. SiRNA sequences 
CypA siRNA 1 (5’-CUG-AAU-GGC-UGG-AUG-GCA-A-3’) and 2 (5’-UUG-CCA-UCC-
AGC-CAU-UCA-G-3’), which were mixed in equal amounts to a final concentration of 
25 nM, and the nonspecific mutant siRNA (scrambled siRNA, 5’-UAA-UGU-AUU-
GGA-ACG-CAU-A-3’) were obtained from Eurofins (Eurofins MWG Operon, 
Ebersberg, Germany). Particular siRNAs were entitled siCypA and siScr in this work.  
Pin1 siRNA (MISSION® esiRNA, Sgima Aldrich, Taufkirchen, Germany) consists of 
an endoribonuclease-prepared siRNA pool comprised of a heterogeneous mixture of 
siRNAs that all target the same mRNA sequence. As control siRNA for Pin1 
experiments the nonspecific mutant siRNA RLUC (MISSION® esiRNA, Sgima 
Aldrich, Taufkirchen, Germany) was used to equally compare Pin1 siRNA results 
because of the same construction. SiRNAs were entitled esiPin1 and siRLUC in this 
work. 
The second Pin1 siRNA is an ON-TARGET plus mouse Pin1 siRNA-SMAART pool, 
which consists of a mixture of four target sequences (5’-CAA-GUA-UAC-UCU-AGC-
AAA-G-3’; 5’-GAU-UAU-AGC-CAA-ACA-GUC-A-3’, 5’-UAA-GAG-UGC-AUA-CGU-
AUA-A-3’ and 5’-GCA-GAA-ACC-AUU-UGA-GGA-U-3’) and was obtained from 
Dharmacon (Thermo Scientific, Darmstadt, Germany). As control siRNA siScr was 
used and in this work the SMAART pool siRNA was entitled siPin1.  
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2.4.2. Primary antibodies 
All primary antibodies used for western blot analysis are listed in Table 7. They were 
diluted in Tris-buffered saline (TBS, Table 6) containing 0.05 % Tween 20 (TBST) 
and 5 % nonfat skim milk powder or TBST containing 5 % BSA (all Sigma Aldrich, 
Taufkirchen, Germany).  
Table 6: 10x Tris-buffered saline (TBS)  
Trizma® base 24.2 g 
NaCl 292 g 
HCl  q.s. for pH adjustment 
Bidest dH2O ad 1,000 ml 
 
Table 7: Primary antibodies  
Primary antibody Secondary antibody Dilution in Company 
α-Tubulin Mouse 1:50,000 
5 % milk in TBST 
Sigma Aldrich 
Actin Clone: C4 
 
Mouse 1:100,000  
5 % milk in TBST 
MP Biomedicals 
AIF (D-20) 
 
Goat 1:1,000 
5 % milk in TBST 
Sante Cruz 
AIF (E-1) (IP) Mouse 7.5 µg 
ad 200 µl PBST 
Santa Cruz 
Cox-IV 
 
Rabbit 1:1,000 
5 % milk in TBST 
Cell Signaling 
Cyclophilin A  
 
Rabbit 1:1,000 
5 % milk in TBST 
Merck Millipore 
Cyclophilin A  
 
Rabbit 1:1,000  
5 % milk in TBST 
Cell Signaling 
DLP-1 
 
Mouse 1:1,000 
5 % milk in TBST 
BD Transduction 
LaboratoriesTM 
DLP-1 (IP) Mouse 7.5 µg 
ad 200 µl TPBS 
BD Transduction 
LaboratoriesTM 
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Lamin A/C Rabbit 1:1,000 
5 % milk TBST 
Cell Signaling 
MitoProfile® Total 
OXPHOS Rodent 
WB AB Cocktail 
Mouse 1:500 
5 % milk TBST 
Abcam 
TIM23 
 
Mouse 1:1,000 
5 % milk in TBST 
BD Transduction 
LaboratoriesTM 
 
Cell Signaling, Danvers, Massachusetts, USA 
BD Transduction LaboratoriesTM, Heidelberg, Germany 
Sigma Aldrich, Taufkirchen, Germany 
Merck Millipore, Darmstadt, Germany 
MP Biomedicals, Eschwege, Germany  
Santa Cruz, Santa Cruz, California, USA 
Abcam, Cambridge, UK 
2.4.3. Secondary antibodies 
Horse radish peroxidase (HRP) labeled secondary antibodies were obtained from 
Vector Labs (Burlingame, California, USA) and used in a dilution of 1:2,500 in TBS 
containing 0.05 % Tween 20 and 5 % nonfat skim milk powder. 
Conjugated secondary antibodies Alexa 568 and Alexa 488 (Molecular Probes, 
Eugene, USA) were used for immunocytochemistry in a 1:200 dilution in 1x PBS 
containing 3 % horse serum in case of AIF immunostaining and 3 % goat serum for 
CypA immunostaining, respectively (Invitrogen, Karlsruhe, Germany). 
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2.4.4. Kits 
All kits used in this work are listed in Table 8 and were used according to the 
manufacture`s protocol. 
Table 8: Kits 
Kit Company 
Annexin-V-FITC Detection Kit  Promokine, Heidelberg, Germany 
Bodipy (581/591 C11)  Invitrogen, Karlsruhe, Germany 
Dual-Luciferase® Assay Kit Promega, Madison, USA 
Dynabeads® Protein A for 
Immunoprecipitation 
Invitrogen, Karlsruhe, Germany 
Guave® Cell Cycle Reagent Merck Millipore, Darmstadt, Germany 
InviTrap® Spin Universal RNA Mini Kit Stratec Molecular GmbH, Berlin, Germany 
Lipofectamine® RNAiMAX  Invitrogen, Karlsruhe, Germany 
MitoPT ∆Ψm ImmunoChemistry Technologies, 
Bloomington, USA 
Nuclear Extract Kit Active Motif Europe, Rixensart, Belgium 
OxiSelectTM 96-well Comet Assay Kit Biocat GmbH, Heidelberg, Germany 
Pierce BCA Kit  Perbio Science, Bonn, Germany 
QIAGEN Plasmid Plus Midi Kit Qiagen, Hilden, Germany 
SuperScript III One Step RT-PCR System 
with Platinum® Taq  
Invitrogen, Karlsruhe, Germany 
ViaLightTM Plus Cell Proliferation and 
Cytotoxicity BioAssay Kit 
Lonza, Köln, Germany 
XF Cell Mito Stress Test Kit Seahorse Bioscience, Copenhagen, 
Denmark 
 
2.5. Transfection protocols 
2.5.1. SiRNA transfection 
For siRNA transfection, siRNAs for indicated proteins and scrambled siRNA were 
diluted in Opti-MEM I (Invitrogen, Karlsruhe, Germany). Afterwards, 2.4 µl/ml 
Lipofectamin® RNAiMAX were added to the Opti-MEM I/siRNA solution, mixed by 
pipetting a few times and incubated at RT for 20 min. Following, 100 µl of this Opti-
MEM mixture were added to each well of a 24-well plate and a final concentration of 
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10-25 nM was achieved. In 8-well ibidi slides the complete Opti-MEM mixture was 
equally reduced to a final volume of 40 µl for each well and in 6-well plates the 
mixture volume was extended to finally 400 µl. Control cells were treated with an 
Opti-MEM I/Lipofectamin® RNAiMAX mix, respectively. Subsequently, the cell 
suspension with a cell number of 33.000 cells/500 µl for 24-well plates; 17.000 
cells/200 µl for ibidi slides and 120.000 cells/2 ml for 6-well plates was added to the 
transfection mixture and cells were allowed to grow for 48 h before treatment. 
2.5.2. DNA transfection 
HT22 cells were seeded in 24-well plates with a cell density of 40,000 cells/ well. 
After 24 h of seeding cells were transfected with Attractene Transfection Reagent. 
Therefore, 2 µg of DNA plasmid were diluted in Opti-MEM I and 9 µl/ml of attractene 
were added and mixed by pippeting. The mixture was incubated for 20 min. at RT 
and during the incubation time the medium of the 24-well plate was changed. 
Afterwards 60 µl of the Opti-MEM mixture were added dropwise to each well. Control 
cells were treated with an Opti-MEM I/attractene mix and pcDNA 3.1 plasmid was 
used as control vector.  
2.6. Cell viability assays 
2.6.1. MTT assay 
The yellow monotetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) belongs to a group of organic compounds which forms an insoluble, 
purple formazan after its reduction. Not only active mitochondria in living cells are able to 
reduce the MTT salt, but also intracellular vesicles like endosomes and lysosomes were 
identified to do so 176. This colorimetric assay was used in this work to measure the 
enzymatic activity after induction of cell death and/or co-treatment with protective 
substances or after knockdown of particular proteins.  
HT22 cells were seeded in 96-well plates and after 24 h of seeding cells were treated 
with glutamate and/or with different inhibitors of cell death. After 12-17 h, depending 
on the morphological changes of the cell, 20 µl of a 2.5 mg/ml MTT stock solution 
(Sigma Aldrich, Taufkirchen, Germany) prepared in 1x PBS were added to each well 
(final concentration per well: 0.5 mg/ml). Cells were then incubated at 37°C for 1 h 
and the reaction was finished by completely removing the medium containing the 
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MTT salt. Accordingly, cells were put for at least 1 h at -80°C. Cell viability was 
measured after another 1 h at 37°C on a shaker (150 rpm) dissolving the formazan 
crystals in 70 µl DMSO. Absorbance was quantified with a microplate reader 
(FluoStar OPTIMA, BMG Labtech, Offenbach, Germany) at 570 nm and background 
signals at 630 nm were subtracted. Control conditions were set to 100 % cell viability. 
All experiments were repeated at least three times. 
2.6.2. xCELLigence System 
The xCELLigence System (Roche, Penzberg, Germany), which contains a series of 
Real Time Cell Analyzer (RTCA), is a cell-based assay system monitoring biological 
processes of living cells due to changes in the electrical impedance. The system 
relies on a micro-electronic biosensor built into each well of a 96-well plate (E-plate; 
Roche, Penzberg, Germany). This sensor measures the electrical impedance of 
cells, which correlates with cell growth and cell proliferation. As a function of time, the 
normalized cell index (NCI) was used to depict cell growth, cell proliferation and 
changes in cell morphology in a curve. During cell death HT22 cells become round, 
detach from the bottom of the culture E-plate and decreases in the impedance 
measurements can be seen, which is visualized in a decrease in the NCI 177. 
For background determination of the growth medium, 100 µl were added to each well 
of the E-plate. After measuring the background impedance, the medium was 
removed an HT22 cells were seeded at a density of ~8,000 cells/well. Treatment of 
the cells with glutamate and/or different cell death inhibitors was performed after the 
CI reached a value of 1. Using RTCA Software 1.2 (Roche Diagnostics, Penzberg, 
Germany) cell indices were recorded. 
After the experiments E-plates were cleaned by first removing the medium, then 
washing each well with bidest dH2O and afterwards 100 µl of 1x TE were put for 15-
20 min. 1x TE was removed and wells were again washed three times with bidest 
dH2O and following put under UV light for 30 min. to ensure sterility. All experiments 
were repeated at least three times. 
2.6.3. Comet assay 
The comet assay, or single cell gel electrophoresis assay (SCGE), is a common 
technique to measure DNA strand breaks in single cells. Damaged DNA, containing 
fragments and strand breaks, is separated from intact DNA by gel electrophoresis, 
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resulting in a typical ‘comet shape’ under the microscope. To determine DNA 
damage in HT22 cells after glutamate toxicity cells were seeded at a density of 
60,000 cells/well in 24-well plates and after 24 h of growing cells were treated with 
4 mM glutamate for indicated time points. Afterwards, samples were prepared for 
DNA analysis with the OxiSelectTM 96-well Comet Assay Kit (Biocat GmbH, 
Heidelberg, Germany). Briefly, cells were trypsinzed with 1x TE, centrifuged for 5 
min. at 700x g, washed once in ice cold 1x PBS (without Ca2+ and Mg2+) and collect 
in 80 µl of 1x PBS. Samples were stored at -80°C for further experiments or directly 
used. OxiSelectTM comet agarose was heated for 20 min. at 90-95°C in a water bath 
and was then transferred for another 20 min. to a 37°C water bath. Lysis buffer, 
alkaline solution and electrophoresis running solution were prepared prior to use 
according to the manufacturer’s protocol and were chilled to 4°C thoroughly. The 
OxiSelectTM comet slide was warmed up in the 37°C room for 15 min. to promote 
agarose attachment. Following, diluted cell samples were combined with agarose gel 
in a 1.5 ml tube at a 1:10 ratio (v/v; ~50 µl), mixed by pipetting and immediately 
20 µl/well were transferred onto the OxiSelectTM 96-well slide by spreading the 
suspension over the well to ensure complete well coverage . This work was 
performed in the 37°C room to avoid gelation of the samples before they were 
pipetted on the slide. Afterwards, slide was transferred to 4°C in the dark for 30 min. 
to allow agarose attachment and gelation. Then slide was immersed for 30-60 min. at 
4°C in a small basin containing pre-chilled lysis buffer (~50-100 ml/slide) and  
following lysis buffer was replaced with pre-chilled alkaline solution (~50-100 ml/slide) 
and put for 30 min. at 4°C in the dark. Subsequently, alkaline electrophoresis was 
performed in a horizontal electrophoresis chamber. The running time was 45 min. at 
25 V and the electrophoresis volume was adjusted to produce a current setting of 
300 mA. Afterwards, the slide was immersed for 2 min. in pre-chilled bidest dH2O, 
repeated twice and was accordingly put for 5 min. in cold 70% ethanol. Ethanol was 
removed and slide was air-dried in the dark. Once the agarose and slide were 
completely dry 50 µl/well of diluted Vista Green DNA dye were added and incubated 
at RT for 15 min. Then slides were analyzed using an epiflourescence microscope 
(DMI6000B, Leica, Wetzlar, Germany) with a 20x objective. DNA damage was 
quantified by counting the displacement between the genetic material of the nucleus 
(‘comet head’) and the resulting ‘tail’. For each condition 200 nuclei were counted 
and assigned to the category ‘with tail’ or ‘w/o tail’. FITC was excited at 488 nm and 
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emission was detected through a 530 ± 40 nm band pass filter. Control cells were set 
up to 100% and all experiments were repeated three times. 
2.7. ATP assay 
Adensoin triphosphate (ATP) can be used to evaluate the functional integrity of living 
cells since each cell contains and requires ATP to stay alive. Detection of cell 
proliferation and cytotoxicity is mediated by an indirect ATP measurement, which is 
based on a bioluminescent assay. Every cell injury leads to a decrease in 
cytoplasmic ATP levels, which can be measured by an enzymatic response of ATP 
and luciferin according to the following reaction: 
ATP + Luciferin + O2                                               Oxyluciferin + AMP + PPi + CO2 + Light 
To determine ATP levels in HT22 cells ~9,000 cells/well were seeded in white 96-well 
plates (Greiner, Frickenhausen, Germany) and after 24 h of seeding, cells were 
treated with glutamate and/or cell death inhibitors. After 15-16 h of glutamate 
challenge, ATP levels were detected by luminescence measurements with the 
ViaLightTMPlus Kit (Lonza, Köln, Germany) according to the manufacture`s protocol. 
Briefly, the culture plate was removed from the incubator and was cooled down to RT 
for 5 min. Nucleotide releasing reagent was put on the cells for 10 min. and 
afterwards the ATP monitoring reagent was added for another 2 min. Then the 
luminescence was detected immediately (FluoStar OPTIMA, BMG Labtech, 
Offenbach, Germany) and the emitted light intensity of control cells was set up to 
100 %. All experiments were repeated at least three times. 
2.8. OCR measurements 
To gain insight into cellular metabolism and to assess mitochondrial respiration, the 
oxygen consumption rate (OCR) was measured with the seahorse XF96 system 
(Bioscience, Copenhagen, Denmark). For this purpose, the XF Cell Mito Stress Test 
Kit was used. HT22 cells were seeded at a density of 10,000 cells/well in special 
XF96-well microplates and after growing over night, cell death was induced with 
glutamate (16 h, 4 mM) and different inhibitors were applied simultaneously. Before 
measurements were performed growth medium was replaced with ~180 µl of assay 
medium (with 4.5 g/L glucose as the sugar source, 2 mM glutamine, 1 mM pyruvate, 
pH 7.35) and cells were incubated for 60 min. at 37°C. Three baseline 
Luciferase 
      Mg2+ 
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measurements were recorded before cells were metabolically perturbed by the 
addition of three different compounds in sequence. First, oligomycin was added in 
Port A (20 µl) at a final concentration of 3 µM. Oligomycin is an ATP coupler, which 
inhibits ATP synthesis by blocking the proton channel of the ATP synthase 
(complex V). Due to this inhibition the proton gradient increases followed by a slower 
electron transport, which is accompanied by a decrease in oxygen consumption. The 
second compound FCCP (22.5 µl in Port B) was applied at a concentration of 0.4 µM. 
FCCP is an uncoupler of the electron transport chain resulting in a decreased proton 
gradient and a collapse of the MMP, leading to a rapid consumption of oxygen, 
exhibited in rising OCR. The third application was a combination of Rotenone and 
Antimycin A (25 µl in Port C), which was added at a concentration of 1 µM. Rotenone 
is a complex I inhibitor and Antimycin A inhibits complex III, resulting in a complete 
shutdown of mitochondrial respiration, illustrated in an OCR decrease. Three 
measurements were performed after the addition of each compound (4 min. mixing 
followed by 3 min. measuring). Measurements were done by Amalia Dolga. All 
experiments were repeated three times (n=6). 
2.9. FACS-analysis 
2.9.1. FITC AnnexinV/propidium iodide staining 
FITC conjugated AnnexinV (AV) and propidium iodide (PI) are dyes usually used for 
FACS-analysis to quantitatively determine the amount of cell death. The membrane 
phospholipid phosphatidylserin (PS) is normally localized at the inner leaflet of the 
plasma membrane of living cells. During apoptosis or programmed cell death, PS is 
translocated to the outer leaflet while the plasma membrane stays intact. AV is a 
calcium-dependent phospholipid binding protein, which is not able to permeate intact 
cell membranes. Thus early apoptotic cells can be distinguished from late apoptotic 
and necrotic cells (only AV positive). Late stages of apoptosis and necrotic cell death 
are accompanied by the loss of plasma membrane integrity and thereby AV is able to 
bind also to late apoptotic and necrotic cells. To differentiate between apoptotic and 
necrotic cells a second dye, PI, is used. Viable cells with intact plasma membranes 
exclude PI, whereas damaged cells are permeable for PI. Accordingly, early 
apoptotic cells are AV positive and PI negative, whereas late apoptotic cells and 
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necrotic cells are AV and PI positive. In this work the amount of early and late 
apoptotic cells (AV and PI positive) was illustrated in bar graphs.  
Cells were seeded in 24-well plates and treated with indicated concentrations of 
glutamate and inhibitors. Afterwards cells were harvested with 1x TE, washed once 
with 1x PBS and were then incubated in the dark with a solution containing FITC AV 
and PI for 5 min. at RT (AnnexinV FITC Detecion Kit, Promokine, Promocell, 
Heidelberg, Germany). Following, samples were put on ice and cell death was 
determined using FACScan (BD, Bioscience, Heidelberg, Germany) for siRNA CypA 
transfected cells and Guava EasyCyteTM Flow Cytometer (Merck Millipore, 
Darmstadt, Germany) for all other experiments, respectively. FITC AV was excited at 
488 nm and emission was detected through a 530 ± 40 nm band pass filter. PI was 
excited at 488 nm and fluorescence emission was detected using a 680 ± 30 nm 
band pass filter. To exclude cell debris, cells were gated by forward versus side 
scatter and 10,000 events per sample were collected from 3-4 independent samples 
per condition. All experiments were repeated at least three times. 
2.9.2. Detection of lipid peroxides  
C11-BODIPY581/591 is a fluorescent dye sensitive to lipid peroxidation and antioxidant 
efficacy in living cells. Its fluorescent properties are located in the red range of the 
visible spectrum (emission maximum 595 nm) and upon free radical-induced 
oxidation a shift from red to green can be detected by FACS-analysis. To measure 
lipid peroxidation in HT22 cells after glutamate challenge, 60,000 cells/well were 
seeded in 24-well plates and after at least 24 h of growing cell death was induced. 
After indicated time points cells were loaded with 2 µM C11-BODIPY581/591 
(Invitrogen, Karlsruhe, Germany) for 1 h in 0.5 ml growth medium. Afterwards, cells 
were trypsinized with 1x TE, centrifuged for 5 min. at 1,000 rpm, washed once with 
1x PBS and were re-suspended in 300 µl 1x PBS for FACS-analysis on a Guava 
EasyCyteTM Flow Cytometer (Merck Millipore, Darmstadt, Germany) by using 488 nm 
UV line argon laser for excitation and lipid peroxidation emission was recorded at 530 
nm (green) and at 585 nm (red). To exclude cell debris, cells were gated by forward 
versus side scatter and 10,000 events per sample were collected from 3-4 
independent samples per condition. All experiments were repeated at least three 
times. 
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2.9.3. Assessment of mitochondrial membrane potential 
To determine changes in the MMP in HT22 cells after glutamate exposure the Mito 
PT ∆Ψm Kit (Immunochemistry Technologies, Hamburg, Germany) was used. For 
this purpose cells were seeded in 24-well plates at a density of 60,000 cells/well and 
were treated after at least 24 h of growing with glutamate. SiRNA transfected cells 
were seeded at a density of 33,000 cells/well and were allowed to grow for at least 
48 h. After indicated time points cells were harvested by trypsinization with 1x TE, 
centrifuged for 5 min. at 1,000 rpm and to detect the loss of MMP, the lipophilic, 
cationic fluorescening dye tetramethylrhodamine ethyl ester (TMRE) was added at a 
final concentration of 200 nM in normal growth medium. Cells were then put for 20 
min. at 37°C and afterwards centrifuged for 5 min. at 1,000 rpm, washed once in 1x 
PBS and were re-suspended in TMRE assay buffer. The lipophilic and cationic 
properties of TMRE allow the dye to concentrate within the intact and negatively 
charged mitochondria and thereby exhibiting red fluorescence. A decrease in the 
MMP is accompanied by a reduction in the red fluorescence, which was detected by 
Guava EasyCyteTM Flow Cytometer (Merck Millipore, Darmstadt, Germany) using 
excitation at 550 nm and detecting emission at 570 nm. To exclude cell debris, cells 
were gated by forward versus side scatter and 10,000 events per sample were 
collected from 3-4 independent samples per condition. All experiments were repeated 
at least three times. 
2.9.4. Cell cycle determination 
The DNA content of cells varies in the different stages of the cell cycle. By labeling 
cellular DNA with propidium iodide (PI) cell cycles can be discriminated, as resting 
cells (G0/G1 phase) contain less DNA, cells in S phase have increased DNA amount 
and  after replication of all chromosomes (G2/M phase) cells exhibit the double 
amount of DNA, resulting in increased PI intercalation and thus fluorescence intensity 
is enhanced. To evaluate the stages of cell cycles HT22 cells were transfected with 
25 nM of siCypA in 24-well plates (33,000 cells/well) and were allowed to grow for 
48 h. Accordingly, cells were washed once with cold 1x PBS, collected by 
trypsinization with 1x TE, centrifuged at RT for 5 min. at 450x g, were again washed 
in 1x PBS and afterwards fixed in ice-cold 70% ethanol, which was added dropwise 
to cell samples. Cells were refrigerated in 70% ethanol for at least 1 h (up to 12 h) at 
4°C and subsequently centrifuged (RT, 5 min., 450x g) and washed once with 
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1x PBS. Following cells were stained with the Guava cell cycle reagent (200 µl for 
each sample) for 30 min. at RT and analyzed by FACS measurements. PI was 
excited at 488 nm and fluorescence emission was detected using a 680 ± 30 nm 
band pass filter with the Guava EasyCyteTM Flow Cytometer (Merck Millipore, 
Darmstadt, Germany). To exclude cell debris, cells were gated by forward versus 
side scatter and 10,000 events per sample were collected from 3-4 independent 
samples per condition. Experiments were repeated at least three times. 
2.10. Immunocytochemistry 
2.10.1. Staining of mitochondria 
Visualization of mitochondrial morphology was performed using the dye MitoTracker 
DeepRed (MitoTracker® DeepRed FM, Invitrogen, Karlsruhe, Germany), a red 
fluorescent dye which stains mitochondria in living cells and can be used for 
mitochondrial localization. A stock of 50 µM was prepared in DMSO and a final 
concentration of 200 nM was used in all experiments. Cells were seeded in 8-well 
ibidi slides and were, prior to glutamate challenge, incubated for 20 min. at 37°C with 
growth medium containing MitoTracker DeepRed. Additionally, a counterstaining of 
the nuclei was accomplished using 4′, 6-Diamidin-2-phenylindol (DAPI, 1 µg/ml), a 
blue fluorescent dye which accumulates in AT-riche regions of the DNA. After 
staining of mitochondria, the medium was removed and cells were treated or not with 
glutamate. Accordingly, cells were washed carefully with 1x PBS, fixed with 4 % PFA 
for 20 min. at RT in the dark and washed again three times with 1x PBS. Cells were 
stored in 1x PBS at 4°C until use. Images were obtained with an epiflourescence 
(DMI6000B, Leica, Wetzlar, Germany) or concfocal laser scanning microscope 
(Axiovert 200, LSM Image Software, Carl Zeiss, Jena, Germany) with a 63 x 1.4 NA 
oil immersion objective. MitoTracker DeepRed fluorescence was excited at a 
wavelength of 633 nm (band pass filter) and emission was detected at 670 nm (long 
pass filter). 
2.10.2. Evaluation of mitochondrial morphology 
To investigate mitochondrial morphology alterations in HT22 cells after 
glutamate-induced cell death, mitochondria were divided in 3 categories as described 
before 71. Category I represents elongated mitochondria as seen in control samples, 
category II depicts intermediate mitochondria spread all over the cytosol and 
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category III exhibits fragmented mitochondria surrounding the nucleus. HT22 cells 
were seeded in 8-well ibidi slides at a density of 20,000 cells/well. After one day of 
growing (siRNA CypA transfected cells two days), cells were stained with 
MitoTracker DeepRed prior to glutamate exposure and were fixed after indicated time 
points of glutamate treatment. At least 500 cells per condition were counted blind for 
quantification analysis and all experiments were repeated at least three times. For 
counting experiments the epiflourescence microscope equipped with a DCF360FX-
camera (DMI6000B, Leica, Wetzlar, Germany) was used.  
2.10.3. Immunocytochemistry 
To detect the localization of CypA and AIF during apoptosis, HT22 cells were seeded 
in 8-well ibid slides at a density of 17,000 cells/well. After 24 h of growing glutamate 
was applied and after indicated time points cells were fixed with 4 % PFA and 
permeabilized with a solution of 0.4 % Triton-X-100 in 1x PBS (Sigma-Aldrich, 
Taufkirchen, Germany) for 5 min. Afterwards, blocking solution was applied (in case 
of AIF analysis 3 % horse serum in 1x PBS and in case of CypA analysis 3 % goat 
serum in 1x PBS (both Invitrogen, Karlsruhe, Germany)) for 30 min. at RT. Cells were 
then exposed to according first antibodies at a dilution of 1:200 in blocking buffer 
over night at 4°C and the next day for another 2 h at RT. Subsequent, corresponding 
secondary antibodies were applied for 1.5 h at RT in the dark followed by a washing 
step with 1x PBS, which was repeated twice. For AIF examination anti-goat Alex 568 
and for CypA detection anti-rabbit Alexa 488 secondary antibodies (Molecular 
Probes, Eugene, USA) were used. DAPI was applied for counterstaining of the 
nuclei. Images were acquired using a confocal laser-scanning microscope (Axiovert 
200, Carl Zeiss, Jena, Germany) and light was collected through a 63x 1.4-NA oil 
immersion objective. DAPI fluorescence was excited at 364 nm and emission was 
achieved by a 385 nm long pass filter. For digital imaging the LSM Image Browser 
4.2.0 software (Carl Zeiss, Jena, Germany) was used. Confocal images for AIF and 
CypA immunocytochemistry were taken from Amalia Dolga and Nunnziana Doti. 
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2.11. Protein analysis 
2.11.1. Western blot sample preparation 
2.11.1.1. Total protein lysates 
For western blot analysis total cell protein lysates were used to investigate protein 
regulation during cell death. Cells were seeded in 6-well plates at a density of 
150,000-180,000 cells/well, in case of transfection 120,000 cells/well, and were 
allowed to grow for at least one day, transfected cells for two days. Following, cells 
were treated with different glutamate concentrations and/or cell death inhibitors. After 
indicated time points cells were harvested by trypsinization with 1x TE, washed once 
with 1x PBS and lysed in 50-100 µl protein lysis buffer (Table 9). All steps were 
performed on ice. Cells were kept for another 15 min. on ice and subsequently stored 
at –80°C. Prior to further use, cell lysates were thawn up, centrifuged at 10,000 g for 
10 min. at 4°C to remove cell debris and membrane fragments. The supernatant was 
used for western blot analysis. 
Table 9: Protein lysis buffer pH 7.8 
0.25 M D-Mannitol 4.56 g 
0.05 M Trizma® base 0.788 g 
1 mM EDTA 0.038 g 
1 mM EGTA 0.038 g 
HCl  q.s. for pH adjustment 
Bidest dH2O ad 100 ml 
 
This stock solution was stored at -20°C in 10 ml aliquots. Prior to use the solution was 
completed with: 
DTT (100 mM) 0.1 ml 
Triton-X 100 0.1 ml 
1 tablet per 10 ml of Complete mini protease 
inhibitor cocktail 
 
1 tablet per 10 ml of phosphatase inhibitor  
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Protease and phosphates inhibitor tablets were obtained from Roche (Mannheim, 
Germany). All other substances listed in Table 9 were obtained from Sigma Aldrich 
(Taufkirchen, Germany). 
2.11.1.2. Mitochondrial fractionation 
HT22 cells were fractionated to enrich mitochondrial proteins for western blot 
analysis. Briefly, ~10 million cells (equates to three 175 cm2 flasks) per condition 
were plated and after 24 h treated with glutamate. All following steps were performed 
at 4°C. After indicated time points cells were harvested by scrapping with a rubber 
policeman, washed twice in cold 1x PBS and re-suspended in 0.5 ml Buffer 1. Cells 
were disrupted using a glass douncer (25 passes) followed by 15 passes with a 20G 
needle. Afterwards cells were centrifuged at 4°C for 10 min. at 900x g and 
supernatant 1 (S1) was retained. Cell pellet was again homogenized in 0.5 ml 
Buffer 1 with the glass douncer and the 20G needle, centrifuged and supernatant 2 
(S2) was combined with S1 and following centrifuged at 4°C for 10 min. at 16,800x g. 
Supernatant was discarded and cell pellet was washed twice with 500 µl Buffer 1 and 
finally re-suspended in 80 µl Buffer 1 for protein analysis.  
Table 10: Buffer 1 for mitochondrial fractionation pH 7.5 
250 mM Sucrose 4.279 g 
20 mM HEPES 0.2383 g 
3 mM EDTA 0.0558 g 
HCl q.s. for pH adjustment 
Bidest dH2O ad 50 ml 
 
Buffer 1 was always fresh prepared and supplemented with 1 tablet per 10 ml of 
Complete mini protease inhibitor cocktail prior to use. 
2.11.1.3. Nuclear fractionation 
The nuclear extraction was performed with the Nuclear Extract Kit (Actif Motif 
Europe, Rixensart, Belgium) to investigate the translocation of particular proteins 
during glutamate-induced cell death from the mitochondria/cytosol to the nucleus. For 
each condition three 75 cm2 flasks were used with a cell density of 1 million cells per 
flask. After growing and indicated time points of cell death induction, the medium of 
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each flask was collected, centrifuged for 5 min. at 1,000 rpm and the cell pellets were 
combined with the cell lysates resulting from the cell collection. For cell collection, the 
remaining monolayer in the flask was washed with 5 ml ice-cold PBS/phosphatase 
inhibitors (provided in the kit) and afterwards 3 ml were added and cells were 
collected by gently scrapping with a rubber policeman. Following, cells were 
centrifuged at 500 rpm for 5 min. at 4°C and the supernatant was discarded. To get 
the cytoplasmic fraction, the cell pellet was re-suspended in 400 µl 1x Hypotonic 
Buffer by pipetting up and down several times and was incubated for 15 min. on ice. 
Accordingly, 20 µl Detergent was added, cell suspension was vortexed at highest 
speed and centrifuged for 30 seconds at 14,000x g at 4°C. The resulting supernatant 
included the cytoplasmic fraction and was stored at -80°C until further use. The cell 
pellet was washed with 1x Hypotonic Buffer and afterwards re-suspended in 80 µl 
Complete Lysis Buffer and vortexed 10 seconds. The suspension was incubated for 
30 min. on ice on a rocking platform at 150 rpm, vortexed again for 30 seconds and 
centrifuged for 10 min. at 14,000x g at 4°C. The nuclear fraction (supernatant) was 
stored at -80°C until further use. 
2.11.2. Quantification of protein amount 
To determine the protein amount in different samples the bicinchoninic acid assay 
(BCA assay) was used. This assay relies on 2 reactions: First, Cu2+ ions are reduced 
to Cu+ ions by peptide bonds in proteins under alkaline conditions in a temperature 
depending step. This step is proportional to the protein amount and was performed at 
60°C. Secondly, 2 molecules of bicinchoninic acid build a complex with 1 Cu+ ion, 
forming a purple-colored product 178. 
The Pierce BCA Kit (Perbio Science, Bonn, Germany) was used for the protein 
amount determination. One hundred µl of a 1:50 mixture of reagent B: reagent A 
were prepared and 2.5 µl of protein samples were added and mixed by vortexing. 
Afterwards, samples were incubated at 60°C for 30 min. on a platform shaker 
(650 rpm). Each sample was pipetted into a 96-well plate (Nunc, Wiesbaden, 
Germany) and absorption was measured at 590 nm using a microplate reader 
(Fluostar OPTIMA, BMG Labtech, Offenburg, Germany). A standard curve containing 
0-200 µg/100 µl bovine serum albumin (Perbio Science, Bonn, Germany) was used 
to calculate the protein amount in each sample. 
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2.11.3. Immunoprecipitation 
For IP experiments 2.5 mg of total protein lysates were used. According to the 
manufacture`s protocol (Invitrogen, Karlsruhe, Germany) magnetic Dynabeads A 
were tagged with 7.5 µg primary antibody diluted in 200 µl 1x PBS containing 0.02 % 
Tween 20 (PBST) and incubated for 15 min. on a rotator at RT. Afterwards, the 
beads-antibody complex was washed with PBST and fresh prepared BS3 crosslinker 
(2.5 mM) was added at a final volume of 1 ml PBST and incubated for 30 min. at RT 
on the rotator. Again, a washing step was performed and quenching buffer was put at 
a final concentration of 50 mM (Tris-HCl pH 7.4) for another 15 min. at RT on the 
rotator. After a further washing step protein samples (2.5 mg) were added to the 
dynabeads-antibody complex in a total volume of 800 µl. The incubation time 
accounted 2 h and was performed for 1 h at 4°C and the second hour at RT on a 
rotator. Following, the dynabeads-antibody-antigen complex was washed three times 
with PBST and then boiled with 70 µl 2.5x SDS for 10 min. at 95°C. The protein 
lysate was removed and stored at -80°C until further use for western blot analysis. As 
a flow through control 25-50 µg protein amount were loaded on the gel. 
2.11.4. Gel electrophoresis and western blot analysis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a model 
system to separate proteins due to their molecular weight in an electrical field. This 
method is used to fractionate proteins by their size.  
The solutions listed in the following tables were used for SDS-PAGE: 
Table 11: 0.5 M Tris pH 6.8 
Tris-HCl 7.88 g 
HCl q.s. for pH adjustment 
Bidest dH2O ad 100 ml 
 
Table 11: 1.5 M Tris pH 8.8 
Tris-HCl 23.6 g 
HCl q.s. for pH adjustment 
Bidest dH2O ad 100 ml 
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Table 12: 10 % Ammoniumpersulfat (APS) 
Ammoniumpersulfat 1 g 
Bidest dH2O ad 10 ml 
 
Table 13: 10 % Sodium dodecyl sulfate (SDS) 
SDS 1 g 
Bidest dH2O 10 ml 
 
Table 14: 12.5 % Separation gel 
1.5 M Tris pH 8.8  2.5 ml 
10 % SDS 0.1 ml 
10 % APS 0.05 ml 
30 % Acrylamid/Bis solution 37, 5:1 4 ml 
TEMED 0.01 ml 
Bidest dH2O ad 10 ml 
 
Table 15: 3.5 % Stacking gel  
0.5 M Tris pH 6.8 2.5 ml 
10 % SDS 0.1 ml 
10 % APS 0.05 ml 
30 % Acrylamid/Bis solution 37, 5:1 1.2 ml 
TEMED 0.01 ml 
Bidest dH2O ad 10 ml 
 
Table 16: 10x Electrophoresis buffer 
Trizma® base 30 g 
Glycine 144 g 
SDS 10 g 
Bidest dH2O ad 10 ml 
The 10x electrophoresis buffer was diluted 1:10 with bidest dH2O before use. 
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Table 17: 5x SDS sample buffer 
1.5 M Trizma® HCl pH 6.8 4 ml 
Glycerol 10 ml 
β-Mercaptoethanol 5 ml 
SDS 2 g 
1 % Bromophenol blue 1 ml 
 
The solutions listed in the following tables were used for western blot analysis: 
Table 18: 10x Transfer buffer 
Trizma® base 30 g 
Glycine 144 g 
HCl q.s. for pH adjustment 
Bidest dH2O ad 1,000 ml 
 
The 10x transfer buffer was diluted 1:10 with bidest dH2O before use. 20 % methanol 
was added to 1x transfer buffer for wet blotting. 
Table 19: 1x TBS/Tween 20 (TBST) 
10x TBS 100 ml 
Tween 20 0.5 ml 
Bidest dH2O ad 1,000 ml 
 
Table 20: 5 % Blocking buffer 
Skim milk powder 25 g 
TBST ad 500 ml 
 
 
 
 
Material and methods 
  
44 
 
Table 22: Stripping buffer 
Glycine 15 g 
SDS 1 g 
Tween 20 10 ml 
HCl q.s. for pH adjustment 
Bidest dH2O ad 1,000 ml 
 
Depending on the incidence of the protein to be analyzed, 25-70 µg total protein 
amount were loaded on the gel. Gels were prepared using BIO-RAD (München, 
Germany) gel casting stand and casting frames with a 12.5 % polyacrylamide 
separation gel and a 3.5 % polyacrylamide stacking gel (Table 14 and 15). Protein 
samples were loaded with 5x SDS sample buffer(Table 17), filled up with bidest dH2O 
to equal total volumes and were heated for 5-8 min. at 95°C on a shaking platform 
(650 rpm). To identify the molecular weight of the particular proteins, 5 µl of 
PageRulerTM Plus Prestained Ladder (Fermentas, St. Leon-Rot, Germany) were 
added on the gel next to the protein samples. Gel electrophoresis was performed first 
at 60 V for 20-30 min. to get samples through the stacking gel and was then 
increased to 120-130 V until the required separation of the proteins was reached. 
Subsequently, proteins were blotted on a polyvinylidenfluorid membrane (PVDF, Bio-
Rad, München, Germany). For this purpose, the PVDF membrane was incubated for 
1-2 min. in methanol and afterwards for another 10 min. in 1x transfer buffer 
containing 20 % methanol. During this time, the gel and filter papers were also 
incubated in 1x transfer buffer. Blotting was performed in a Mini Trans-Blot® 
Electrophoretic Transfer Cell (Bio-Rad, München, Germany) for 20-22 h at 20 mA per 
gel at 4°C. The next day, membrane was washed for 5 min. with 1x TBS and 
afterwards blocked with 5 % milk blocking buffer for 1 h at RT. Following, the first 
antibody (Table 7) was added to the membrane and incubated over night at 4°C. The 
next day, the antibody was incubated for another hour at RT and after a 5 min. 
washing step with 1x TBST, the membrane was probed with the corresponding 
HRP-conjugated secondary antibody (Vector Laboratories, Burlingame, USA) for 1 h 
at RT and washed again 3 times for 15 min. with 1x TBST. Thereafter, the membrane 
was put in a chemiluminescent substrate solution HRP-Juice (PJK GmbH, 
Kleinblittersdorf, Germany) and after 1-2 min. chemiluminescent signals were 
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detected by the semi-automated Chemidoc-XRS Imaging System (Bio-Rad, 
München, Germany) and quantified with the Quantity One software (Bio-Rad, 
München, Germany). For equal protein loading and quantification of protein amounts 
actin was used in total lysates. For mitochondrial fractions Tim 23 and for nuclear 
fractions Lamin A/C was used as loading control. 
2.12. RNA analysis 
2.12.1. RNA sample preparation 
For RNA extraction and analysis cells were seeded in 6-well plates at a density of 
200,000 cells/well and afterwards RNA extracts were prepared using the InviTrap® 
Spin Universal RNA Mini Kit (Stratec Molecular GmbH, Berlin, Germany). Briefly, 
medium was discarded, cells were washed once with 1x PBS and Lysis Solution TR 
containing 1 % β-mercaptoethanol was added. Cells were collected with a rubber 
policeman and lysates were pipetted directly onto a DNA-Binding Spin Filter, 
incubated for 1 minute and centrifuged for 2 min. at 11,000x g to remove cell debris. 
The Spin Filter was discarded and ethanol was added to the RNA containing lysate to 
extract nucleic acids. Then the whole sample was put onto a RNA-RTA Spin Filter, 
incubated for 1 minute and centrifuged for 1 minute at 11,000x g. The flow-through 
was discarded and Wash Buffer R1 was applied on the Spin Filter, centrifuged for 1 
minute at 11,000x g and the flow-though again discarded. The same procedure was 
performed tiwce with Wash Buffer R2 to remove immoderate electrolytes. To 
eliminate any traces of ethanol a centrifugation step for 4 min. at maximum speed 
was followed. To elute the total RNA from the RNA-RTA Spin Filter, Elution Buffer R 
was pipetted onto the membrane, incubated for 2 min. and centrifuged for 1 minute at 
11,000x g. RNA samples were stored at -80°C until further use. All buffers used for 
this procedure were applied in the kit. 
2.12.2. RNA amount determination 
The NanoVue Plus Spectrophotometer (Implem, GE Healthcare Europe GmbH, 
Freiburg, Germany) was used to quantify the total RNA amount of the RNA samples. 
A wavelength of 260 nm was used to detect RNA levels and the quality of the purified 
RNA was determined at the reference wavelength of 280 nm. 
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2.12.3. Reverse transcriptase polymerase chain reaction (RT-PCR) 
RT-PCR is the combination of two methods to detect RNA expression levels. First, 
RNA is transcribed into complementary DNA (cDNA) using the enzyme reverse 
transcriptase and secondly the resulting cDNA is amplified by the enzyme DNA-
polymerase in a PCR. This one-step PCR was performed using SuperScript III One 
Step RT-PCR System with Platinum® Taq (Invitrogen, Karlsruhe, Germany). Primers 
used for the RT-PCR were obtained from Eurofins (Eurofins MWG Operon, 
Ebersberg, Germany) and are listed in Table 23.  
Table 23: Primer sequences used for RT-PCR 
Primer Sequence 
CypA forward 5`-CCACCGTGTTCTTCGACATCACG -3`  
CypA reverse 5`-GCTGGTCTTGCCATTCCTGACCC-3`  
GAPDH forward 5`-CGTCTTCACCACCATGGAGAAGGC-3`  
GAPDH reverse 5`-AAGGCCATGCCAGTGAGCTTCCC-3`  
PIN1 forward 5`-CTGGGAGAAGCGTATGAGTC-3`  
PIN1 reverse 5`-GTGAGGCCAGAGATTCAAAG-3`  
CypB forward 5`-GACTTCATGATCCAGGGTGG-3` 
CypB reverse 5`-CCAGGAGGTCTTGACTGTGG-3` 
CypD forward 5`-AGGAGGGAGGTCCATCTACG-3` 
CypD reverse 5`-ACATCCATGCCCTCTTTGAC-3` 
 
The samples used for RT-PCR were prepared as listed in Table 24 and 25. 
Table 24: Sample preparation for GAPDH  
2x Reaction buffer 12.5 µl 
Sample 100-500 ng 
Forward primer (5 µM) 1 µl 
Reverse primer (5 µM) 1 µl 
Taq polymerase 0.5 µl 
RNase free water ad 25 µl 
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Table 25: Sample preparation for CypA, CypB, CypD and PIN1 
2x Reaction buffer 12.5 µl 
Sample 100-500 ng 
Forward primer (5 µM) 1 µl 
Reverse primer (5 µM) 1 µl 
Taq polymerase 1 µl 
RNase free water ad 25 µl 
 
The RT-PCR steps for the amplification were set as listed in Table 26-29. 
Table 26: RT-PCR cycler program for murine GAPDH 
60°C 30 min. 
95°C 2 min. 
95°C 30 sec. 
57°C 1 min.                 x 26 
70°C 2 min.                  
70°C 10 min. 
4°C ∞ 
 
Table 27: RT-PCR cycler program for murine CypA 
60°C 30 min. 
95°C 2 min. 
95°C 30 sec. 
67°C 30 sec.                 x 25 
70°C 1 min.                  
70°C 10 min. 
4°C ∞ 
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Table 28: RT-PCR cycler program for murine CypB and CypD 
60°C 30 min. 
95°C 2 min. 
95°C 30 sec. 
55°C 30 sec.                 x 27 
70°C 1 min.                  
70°C 10 min. 
4°C ∞ 
 
Table 29: RT-PCR cycler program for murine PIN1 
60°C 30 min. 
95°C 2 min. 
95°C 30 sec. 
54°C 1 min.                   x 24 
70°C 1 min.                  
70°C 10 min. 
4°C ∞ 
2.12.4. Agarose gel electrophoresis 
The PCR amplification products were visualized by an ethidiumbromid (EtBr) 
staining, which is a fluorescent agent that intercalates in DNA and can be then 
detected under UV-light. For this purpose the PCR samples were supplemented with 
5 µl 10x loading dye and separated by agarose gel electrophoresis using 1.5 % 
agarose (Sigma Aldrich, Taufkirchen, Germany) suspended in 1x Trsi-Acetat-EDTA 
buffer (50x TAE stock, view Table 30). The agarose was dissolved in 1x TAE by 
heating in a microwave and after applying the suspension into a gel frame, 2 µl of a 
10 mg/ml EtBr stock were added to 50 ml suspension and were stirred. After the gel 
became solid samples were added into the pockets of the gel and were allowed to 
run for 30-60 min. at 80 V. As a reference marker for size identification GeneRuler 
100 bp Plus DNA Ladder (Thermo Scientific, Dreieich, Germany) was loaded on the 
gel. Separated PCR products were detected under UV-light (excitation 260 nm) with 
the Chemidoc Imaging System (Bio-Rad, München, Germany) and pictures were 
analyzed with the Quantity One software (Bio-Rad, München, Germany). 
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Table 30: 50x TAE buffer 
Trizma® base 242 g 
Glacial acetic acid 57.1 ml 
0.5 M EDTA pH 8.0 10  ml 
Bidest dH2O ad 1,000 ml 
 
2.13. Statistical analysis 
All data are given as means + standard deviation (SD). Statistical comparisons 
between multiple groups was performed by analysis of variance (ANOVA) followed 
by Scheffé’s post hoc test or Bonferroni test. Calculations were achieved with the 
WinSTAT Standard Statistical Software (R. Fitch Software, Bad Krozingen, 
Germany). 
 
 
 
 
 
 
Results 
  
50 
 
3. Results 
3.1. Glutamate sensitivity of HT22 cells 
HT22 cells are immortalized mouse hippocampal neurons growing in an adherent 
monolayer with spindle shaped morphology. Despite lacking NMDA receptor 
expression, HT22 cells exhibit a high sensitivity to glutamate. The sensitivity of HT22 
cells to glutamate varies depending on the cell density and the passage number of 
cells. Therefore, glutamate concentrations were used in a range from 2-7 mM and 
depending on the performed experiments time points were adjusted. After induction 
of apoptosis with glutamate HT22 cells round up and detach from the culture plate 
(Figure 8). Cell death occurred in a time- and dose-dependent manner, as cell 
viability analysis revealed determined by MTT assay (Figure 8A). Cell proliferation 
was detected by real-time impedance measurement using the xCELLigence system. 
A decrease of the Normalized Cell Index (NCI) due to a loss in impedance is 
associated with cell death induced by glutamate (Figure 8B). 
 
 
Figure 8: Glutamate-induced oxidative stress leads to decreased cell viability in HT22 cells 
A: Glutamate treatment led to a decrease in cell viability in a concentration- and time-dependent manner as 
determined by the MTT assay (n=8). B: Photomicrographs (100x magnification) revealed alterations in the cell 
morphology after glutamate toxicity. HT22 cells were treated with different concentrations of glutamate and cell 
impedance was measured over time with the xCELLigence system and a loss in impedance which occurred after 
7-9 h of treatment implicated cell death (n=6). Experiments were repeated at least three times and results are 
given as mean + SD. 
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DNA damage and fragmentation have been considered a hallmark of apoptosis, 
which occurs at a late and irreversible stage of cell injury after ischemia. However, 
DNA strand brakes induced by ROS represent an early event after neuronal injury 
179
. The evaluation of DNA strand breaks after glutamate exposure in HT22 cells 
revealed a time-dependent increase in DNA fragmentation (Figure 9). The COMET 
assay was used to investigate DNA damage induced by glutamate. For this purpose, 
two categories were defined to quantify the displacement between the genetic 
material of the nucleus (‘comet head’) and the resulting ‘tail’, which occurred after 
DNA strand breaks (‘with tail’ or ‘w/o tail’, Figure 9A). HT22 cells were seeded in 
24-well plates and after indicated time points the COMET assay was performed. After 
staining the DNA with Vista Green DNA dye, nuclei were visualized under an 
epifluorescence microscope (20x objective) and 200 nuclei were counted per 
condition. Glutamate exposure resulted in moderate DNA damage at early time 
points and was increased after 8-10 h, and after 14 h of treatment more than 55 % of 
cells exhibited DNA fragmentation (Figure 9B). The DNA damage inducing agent 
etoposide was used as positive control (21 h, 50 µM). 
 
  
 
 
 
 
 
 
Figure 9: Time course of DNA damage after glutamate toxicity  
A: Two categories (‘with tail’ and ‘w/o tail’) were defined to analyze DNA fragmentation induced by glutamate. 
Control cells exhibited no tail formation, while glutamate exposure led to a tail formation, which indicated DNA 
strand breaks. After indicated time points the COMET assay was performed and visualized DNA was assigned to 
the category ‘with tail’ (right panel) or ‘w/o tail’ (left panel). B: Quantification of 200 nuclei per condition revealed a 
moderate increase in DNA damage at early time points, which rose in a time-dependent manner (n=3). Etoposide 
was used as positive control. Experiments were repeated three times and results are given as mean +SD (***p< 
0.001; **p< 0.01; *p< 0.05; ANOVA, Bonferroni test).  
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3.2. Mitochondrial dysfunction induced by glutamate  
Glutamate exposure leads to a detrimental increase in ROS and due to this to high 
levels of lipid peroxides in HT22 cells (Figures 17 and 32; 72). This feature of 
oxidative stress was accompanied by changes in the mitochondrial morphology and 
by enhanced mitochondrial fission. To quantify these changes, mitochondria were 
divided in three categories (Figure 10A). In healthy HT22 cells mainly category 1 
mitochondria can be observed. They appear elongated and are spread all over the 
cytosol, forming a tubular network. Intermediate category 2 mitochondria are rounded 
up, but are still distributed in the cell body, while cells show normal morphological 
features and are still attached on the bottom of the culture plate. In contrary to living 
cells, apoptotic and damaged cells exhibit primarily category 3 mitochondria, which 
are fragmented and surround the nucleus. To evaluate the changes in mitochondrial 
morphology, cells were seeded in 8-well ibidi slides and prior to treatment they were 
stained for 30 minutes with the mitochondrial dye MitoTracker DeepRed. Following, 
glutamate was applied and after indicated time points cells were fixed with 4 % PFA. 
For quantification analysis 500 cells were counted blind per condition. The number of 
category 1 mitochondria was decreased, while the number of category 3 
mitochondria was significantly increased after glutamate exposure, which is in line 
with decreased cell viability (Figure 10B).  
  
Figure 10: Categorization and quantification of mitochondrial morphology  
A: Confocal images (63x objectives) represented MitoTracker DeepRed stained mitochondria which exhibited 
different mitochondrial morphology structures. Category 1: elongated, category 2: intermediate and category 3: 
fragmented mitochondria. B: Quantification of mitochondrial categories after glutamate toxicity (2 mM, 14 h) 
revealed elevated mitochondrial fragmentation which was represented in an increase of category 3 mitochondria. 
For each condition 500 cells were counted blind. Experiments were repeated three times and results are given as 
mean +SD. (***p< 0.001; ANOVA, Scheffé’s test).  
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Another hallmark associated with cell death in HT22 cells is the loss of MMP. To 
analyze the impact of glutamate on MMP, cells were seeded in 24-well plates and 
after 24 h cells were treated with 3 mM glutamate. After 15 h of treatment the 
medium of the culture plate was collected for each sample and cells were trypsinized 
and combined. Afterwards all samples were stained with TMRE for 20 minutes and 
washed once in 1x PBS. Since TMRE stains only healthy mitochondria, a decrease in 
red fluorescence could be detected in damaged cells by FACS-analysis (Figure 11). 
This decrease implicated a loss of MMP in HT22 cells due to oxidative stress, which 
is in accordance with elevated mitochondrial fission. 
 
Figure 11: Glutamate toxicity results in impaired MMP 
HT22 cells were treated with glutamate (15 h, 3 mM) and afterwards stained for 20 min. with TMRE and 
subsequently analyzed by FACS-analysis, which illustrated a loss in MMP after glutamate toxicity (n=4). 
Experiments were repeated three times and results are given as mean +SD. (***p< 0.001; ANOVA, Scheffé’s 
test).  
 
3.3. AIF and CypA are mediators of glutamate-induced cell death in 
HT22 cells 
3.3.1. Translocation of AIF and CypA to the nucleus after glutamate 
toxicity 
One of the pivotal occasions of apoptotic processes is the opening of the 
mitochondrial permeability transition pore, which is under control of Bcl-2 family 
members, inducing the release of pro-apoptotic proteins from the mitochondrial 
intermembrane space, such as Cytc or AIF 180–182. Under physiological conditions, 
AIF is anchored in the inner mitochondrial membrane and upon induction of 
apoptosis it is released from the mitochondria and translocates to the nucleus where 
it induces, in a caspase-independent manner, DNA degradation and chromatin 
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condensation 54,58,59. In HT22 cells this phenomenon was first described by 
Landshamer et al. and later on by others, that high extracellular glutamate 
concentrations induce the release and the translocation of AIF from the mitochondria 
to the nucleus resulting in cell death 70,72,183. To illustrate the localization and after 
glutamate exposure the translocation of AIF in this study, cells were placed in 8-well 
ibidi slides and after glutamate treatment and fixation with 4% PFA, cells were 
incubated with an AIF primary antibody, afterwards with the corresponding 
conjugated secondary antibody and following images were acquired using a confocal 
microscope. DAPI was used for counterstaining of the nuclei. Under control 
conditions AIF is localized in the mitochondria. However, after glutamate toxicity AIF 
was released from the mitochondria and translocated within 12 h to the nucleus 
(Figure 12A). These findings were confirmed by western blot analysis of nuclear 
extracts. In control conditions AIF was not detected in the nucleus, while after 10-
12 h of glutamate exposure AIF protein levels increased in nuclei (Figure 12B).  
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Figure 12: Glutamate-induced translocation of AIF to the nucleus 
A: Confocal images (63x objective) exhibited the translocation of AIF (red) from the mitochondria to the nucleus 
(DAPI, blue) after glutamate exposure (2 mM) in a time-dependent manner. B: Western blot analysis of nuclear 
extracts illustrated an increase in nuclear AIF after 10-12 h of glutamate treatment (2 mM). Lamin A/C was used 
as nuclear marker and CoxIV was used as mitochondrial marker to exclude mitochondrial cross-contamination; 
TE: total extract 
 
Recent evidence suggests that AIF alone is not able to induce chromatinolysis and 
that therefore CypA is needed 62. In HT22 cells, CypA is mainly localized in the 
cytosol, however, it can be also found in the nucleus under control conditions. Within 
6-8 h after the onset of glutamate CypA translocates to the nucleus (Figure 13). 
Interestingly, CypA translocation occurred before AIF translocation, indicating that 
CypA and AIF translocated independent of each other to the nucleus.  
A 
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Figure 13: CypA translocation to the nucleus is induced by glutamate  
A: Confocal images (63x objective) revealed the translocation of CypA (red) from the cytosol to the nucleus 
(DAPI, blue) after glutamate exposure (2 mM) in a time-dependent manner. B: CypA translocation to the nucleus 
was confirmed by western blot analysis of nuclear extracts after glutamate treatment (2 mM). Lamin A/C was 
used as nuclear marker and tubulin was used as a cytosolic marker to exclude cross-contamination. Bar graphs 
depict protein amounts of CypA in the nucleus and in the cytosol (n=3). Results are given as mean +SD. (***p< 
0.001; *p< 0.05; ANOVA, Scheffé’s test).  
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3.3.2. CypA and AIF build a pro-apoptotic complex after glutamate 
toxicity 
The physical and functional interaction of AIF and CypA was discovered by Candé 
and colleagues. Since both proteins alone are not able to mediate chromatinolysis, 
the formation of a pro-apoptotic complex of AIF and CypA is required to induce 
chromatin condensation 62. 
Under physiological conditions, CypA and AIF do not co-localize in HT22 cells as it 
was visualized by confocal images and determined by immunoprecipitation (IP) 
experiments (Figure 14). However, upon glutamate toxicity AIF and CypA do not only 
translocate to the nucleus but also co-localize in the nucleus as confocal pictures 
revealed (Figure 14A). IP experiments confirmed the interaction of CypA and AIF 
after glutamate exposure. CypA was not detected as interaction partner of AIF in 
control conditions, while after glutamate challenge the interaction could be observed 
(Figure 14B). The IP experiment was also performed vice versa. Immunoprecipitation 
of CypA and the following western blot analysis of co-immunoprecipitated AIF 
revealed that in control conditions AIF was not bound to CypA, while after glutamate 
toxicity AIF could be detected as interaction partner of CypA (Figure 14C). 
Taken together, these findings revealed that AIF and CypA translocate to the nucleus 
and interact after glutamate toxicity in HT22 cells. 
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Figure 14: AIF and CypA build a pro-apoptotic complex after glutamate challenge 
A: Glutamate (12 h, 2 mM) induced the translocation of AIF (red) and CypA (green) to the nucleus (DAPI, blue), 
which was illustrated by confocal images (63x objective). Upper panels show control conditions while lower 
panels exhibit glutamate-induced translocation of both proteins to the nucleus and the pro-apoptotic complex 
formation (yellow). B: Immunoprecipitation analysis of AIF protein (2.5 mg of total protein lysates) confirmed the 
interaction of AIF and CypA after glutamate exposure (12 h, 2 mM). The left panel illustrates western blot analysis 
of the AIF pulldown. The interaction of AIF and CypA was detected only after glutamate exposure. The right panel 
shows western blot analysis of total protein lysates with tubulin as loading control. C: Reversed experimental set 
up of IP experiments shown in figure B. Pull down of CypA and following western blot analysis of AIF after 
glutamate challenge.    
 
3.4. The particular role of CypA in glutamate-induced cell death 
Since AIF has no DNase activity and the interaction of AIF and CypA is necessary to 
induce cell death, the next issue was to investigate the role of CypA in 
glutamate-induced cell death in HT22 cells. For this purpose the knockdown of CypA 
was achieved by small interfering RNA (siRNA) transfection of HT22 and the impact 
on cell viability and mitochondrial function was verified. 
3.4.1. CypA siRNA prevents cell death in HT22 cells 
The cyclophilin family consists of different isozymes among them CypA, B and D are 
the main representatives which are known to be involved in different cell death 
A 
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mechanisms. ER-localized CypB exhibits pro-survival features and is associated with 
ER stress-induced apoptosis 159. CypD, a major regulator of the mitochondrial 
permeability transition pore, is involved in pore opening which is triggered by 
elevated Ca2+-levels or oxidative stress and thereby mediates the release of pro-
apoptotic factors leading to cell death 184.  
To prove the specificity of the CypA siRNA (siCypA), mRNA levels of all three 
cyclophilins were analyzed by RT-PCR. Only CypA mRNA levels were depleted 
compared to CypB and CypD, which demonstrated the specificity of the siCypA 
(Figure 15A and B). The knockdown of CypA at the protein level was analyzed by 
western blot analysis (Figure 15C). SiCypA was used at a concentration of 25 nM 
and scrambled siRNA (siScr), a nonsense sequence of the siRNA target sequence, 
was used as negative control in all experiments.  
 
Figure 15: CypA knockdown on mRNA and protein levels 
A: RT-PCR analysis of cyclophilin mRNA revealed a specific knockdown of CypA compared to CypB and CypD. 
The transfection was performed with 25 nM siCypA for 48 h. GAPDH was used as loading control. B: Western 
blot analysis showed the knockdown of CypA at the protein level. 25 µg were loaded on the gel and actin was 
used as loading control. 
 
To evaluate the impact of CypA silencing after glutamate challenge in HT22 cells, cell 
viability was measured by MTT assay. While glutamate treatment resulted in 
depleted cell viability below 25%, CypA silencing could prevent this decrease and 
restored cell viability up to 80% of control levels (Figure 15A). Furthermore, 
morphological alterations due to glutamate treatment were prevented (Figure 16B). 
This protective effect was confirmed by AnnexinV/propidium iodide (AVPI) staining 
and subsequent FACS-analysis. After 12 h of glutamate treatment nearly 40% of cell 
death was detected in controls and cells transfected with scrambled siRNA. CypA 
silencing reduced cell death almost to control levels (Figure 16C). In this experiment 
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the Bid inhibitor BI-6c9 was used as positive control. In addition the protective effect 
of CypA depletion was confirmed by real-time impedance measurements with the 
xCELLigence system (Figure 16D). After glutamate exposure measured cell 
impedance started to decrease within 6-7 h of treatment which resulted in cell death. 
After another 3-5 h the cell index was completely decreased in glutamate-treated 
cells. In contrast, glutamate-induced loss in NCI could completely be prevented by 
silencing of CypA (12 h, 2 mM; Figure 16D). 
Overall, these data indicate a crucial role for CypA in glutamate-induced cell death, 
as silencing of CypA results in increased cell viability and depicts a protective effect 
of morphological alterations in HT22 cells. 
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Figure 16: Silencing of CypA increases cell viability after glutamate toxicity in HT22 cells 
A: After 48 h of siCypA transfection cells were treated with 2 mM glutamate for 12 h and cell viability was 
determined by MTT assay. Vehicle- and siScr-treated control cells exhibited a decrease in cell viability, which 
could be prevented by CypA depletion (n=8). B: Microphotographs exhibit control-like cell morphology of CypA 
knockdown cells after glutamate exposure. C: FACS-analysis of transfected HT22 cells after AVPI staining 
revealed an increase in cell death of glutamate-treated controls, which was prevented by CypA silencing. D: Cells 
were seeded and transfected in 96-well E-plates (4.000 cells/well) and after 48 h cell death was induced by 
glutamate. Cell impedance was detected by real-time measurements with the xCELLigence system, which 
depicted decreased cell viability in vehicle- and siSc- treated control cells compared to siCypA-treated cells (n=6). 
Experiments were repeated three times and results are given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test). 
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3.4.2. Lipid peroxidation is decreased after glutamate toxicity and CypA 
silencing 
In HT22 cells glutamate toxicity leads to enhanced formation of ROS and increased 
lipid peroxidation, causing neuronal cell death. As described by Tobaben et al. a 
two-step increase in ROS occurs after glutamate toxicity. The first slight increase in 
lipid peroxidation was detected within the first 6 h, while the much more pronounced 
second increase occurred at later time points (~8-17 h) 72. To analyze the impact of 
CypA on lipid peroxidation, cells were stained with BODIPY after indicated hours of 
glutamate challenge and following analyzed by FACS-analysis. Silencing of CypA 
decreased lipid peroxidation after 10 h of glutamate exposure. However, levels of 
lipid peroxides could not be decreased to control levels (Figure 17A and B).  
This indicates that CypA depletion abolishes the second (mitochondrial) increase in 
ROS without affecting the first ROS increase. 
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Figure 17: Glutamate-induced lipid peroxidation was decreased after CypA silencing 
A: HT22 cells were transfected with 25 nM siCypA in 24-well plates and after 48 h treated with 3 mM glutamate 
for 14 h. Glutamate induced the production of lipid peroxides, which was reduced in conditions of siCypA 
treatment (n=3). B: Quantification of cells with lipid peroxides. Experiments were repeated three times and results 
are given as mean +SD (***p< 0.01; ANOVA, Scheffé’s test). 
 
3.4.3. CypA silencing prevents mitochondrial AIF release, the 
impairment of the MMP and reduces mitochondrial fission  
As previous results depicted, the interaction of CypA and AIF is necessary to induce 
cell death in HT22 cells. The next issue of interest was to analyze the translocation of 
AIF from the mitochondria to the nucleus after CypA depletion and glutamate 
exposure. For this purpose, cells were seeded in 8-well ibidi slides and were treated 
after 48 h with 2 mM glutamate for 12 h. Accordingly, immunocytochemistry was 
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performed to visualize AIF and nuclei, which were counterstained with DAPI. Images 
were taken with a confocal microscope (63x objective). Upon glutamate treatment 
AIF translocated to the nucleus in siScr-treated cells. However, after CypA silencing 
AIF was not released from the mitochondria (Figure 18) 
 
Figure 18: CypA silencing prevents AIF release from the mitochondria after glutamate toxicity 
Confocal images (63x objective) demonstrated the release of AIF (red) from the mitochondria to the nucleus 
(DAPI, blue) after glutamate toxicity (2 mM, left panels). This release of AIF was prevented in CypA knockdown 
cells (right panels).  
 
Recent studies suggest that intrinsic death pathways are linked to extensive 
mitochondrial fragmentation 4,185–187,188. To gain more insight into the role of CypA 
acting upstream of mitochondrial levels, as the lethal AIF release was prohibited by 
CypA silencing, the present study examined, whether CypA has even regulatory 
effects on mitochondrial dynamics after glutamate challenge in HT22 cells. The 
depletion of CypA levels with siRNA prevented mitochondrial fission induced by 
glutamate and prohibited the characteristic shift from elongated mitochondria 
(category 1) to small, highly fragmented organelles (category 2 and 3, Figure 19).  
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Figure 19: Silencing of CypA prevents glutamate-induced mitochondrial fragmentation 
A: HT22 cells were transfected with 25 nM siCypA in 8-well ibid slides and after 48 h cells were stained with 
MitoTracker DeepRed for 30 min. and subsequently treated with 2 mM glutamate for 12 h. Confocal images (63x 
objective) showed glutamate-induced mitochondrial fragmentation, which was prevented by siCypA. B: 
Quantification of mitochondrial categories revealed a decrease in category 3 and an increase in category 1 
mitochondria in CypA knockdown cells compared to vehicle- or siScr-treated control cells. For each condition 500 
cells were counted blind. Experiments were repeated three times and results are given as mean +SD (**p< 0.01; 
ANOVA, Scheffé’s test). 
 
The loss of MMP is a major feature of glutamate-induced cell death in HT22 cells that 
is associated with mitochondrial fragmentation and precedes the lethal release of AIF 
and execution of caspase-independent cell death 70,71,173. Since CypA is assumed to 
work upstream of mitochondrial demise after glutamate challenge, the impact of 
CypA on MMP was analyzed by TMRE staining and subsequent FACS-analysis. The 
impairment of the MMP was detected by a loss in red TMRE-fluorescence, which 
occurred after 17 h of glutamate treatment (Figure 20). This apoptotic feature was 
abolished after CypA silencing (Figure 20). Carbonylcyanide-3-
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chlorophenylhydrazone (CCCP) was used as positive control to illustrate the loss of 
MMP.  
 
 
Figure 20: CypA knockdown restores MMP 
After 48 h of siCypA transfection HT22 cells were treated with 3 mM glutamate for 17 h and were afterwards 
stained with TMRE for 20 min. SiCypA treatment prevented the impairment of the MMP induced by glutamate. 
Experiments were repeated three times and results are given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test). 
 
These findings implicate, that CypA is not only acting as a downstream mediator of 
mitochondrial demise, but also acts upstream of mitochondrial levels, as CypA siRNA 
prevented glutamate-induced AIF release, preserved mitochondrial morphology 
alterations and prevented the impairment of the MMP.   
 
3.4.4. Influence of CypA silencing on cell cycle phases 
The protective effect of CypA silencing in HT22 cells in conditions of oxidative stress 
and the impact on mitochondrial morphology and function have been discovered in 
this study. However, the mechanism is still elusive. Cyclophilins were linked in the 
last years as molecular targets to affect cell cycle phases 163,189. Hence, the impact of 
CypA silencing on the different cell cycle phases was investigated using the Guava® 
Cell Cycle Assay. After transfection of HT22 cells in 24-well plates with CypA siRNA 
for 48 h, cells were stained and subsequently analyzed by FACS-analysis. This 
experiment revealed that CypA silencing had no impact on cell cycle phases (Figure 
21). Nocodazol induced a G2/M cell cycle arrest and was used as a positive control. 
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These results imply that in HT22 cells CypA has no influence on the cell cycle and 
that depletion of CypA and the resulting protective effect after glutamate challenge is 
not due to changes in cell cycle phases. 
 
 
Figure 21: CypA siRNA does not alter cell cycle phases in HT22 cells 
A: HT22 cells were transfected with 25 nM siCypA and after 48 h cell cycle phases were determined by PI 
staining and FACS-analysis. Silencing of CypA did not alter stages of cell cycle phases in HT22 cells. B: 
Assessment of cell numbers in each cell cycle phase (n=3). Nocodazol treated cells arrested with a G2/M phase 
DNA content and were used as a positive control. Experiments were repeated three times and results are given 
as mean +SD.   
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3.4.5. The role of H2AX in glutamate toxicity in HT22 neurons 
Recently, besides CypA another important binding partner of AIF has been 
discovered, namely the histone H2AX. Baritaud and colleagues revealed H2AX as 
‘the missing link’ in AIF-mediated caspase-independent cell death. H2AX is 
necessary for the interaction of AIF and CypA in cell death pathways induced by 
extensive DNA-damage, which is provoked by alkylating substances, such as 
1-methyl-2-nitro-1-nitrosoguanidine (MNNG) 63. To evaluate the role of H2AX in 
glutamate toxicity in HT22 cells, the histone was depleted by siRNA transfection 
(Figure 22A) and afterwards cells were treated with 7 mM glutamate. As the MTT 
assay revealed the depletion of H2AX had no impact on cell viability after glutamate 
exposure. The same decrease in cell viability was measured in H2AX knockdown 
cells as in vehicle-treated control cells (Figure 22B). This finding was confirmed by 
real-time impedance measurements with the xCELLigence system, demonstrating 
that silencing of H2AX exhibited no protective effect against oxidative stress-induced 
cell death in HT22 cells (Figure 22C). 
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Figure 22: H2AX siRNA does not prevent glutamate-induced cell death in HT22 cells 
A: H2AX mRNA levels were depleted by siRNA transfection and analyzed by RT-PCR. The transfection was 
performed with 20 nM siH2AX for 30 h and GAPDH was used as loading control. B: SiH2AX transfected HT22 
cells were treated with 7 mM glutamate and cell viability was determined by MTT assay (15.5 h). Silencing of 
H2AX did not rescue cells from cell death (n=8). C: XCELLigence measurements depicted that a downregulation 
of H2AX did not provide protective effects upon glutamate treatment (n=6). Experiments were repeated three 
times and results are given as mean +SD. 
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3.5. The involvement of the PPIase Pin1 in neuronal cell death 
The family of PPIases consists beside cyclophilins also of the parvulin Pin1, which is 
known to mediate the activation of the mitochondrial apoptotic pathway 156,190. Since 
previous results of this work revealed an important role for the immunophilin CypA in 
glutamate-induced cell death, the next step was to evaluate the contribution of Pin1, 
as another member of the PPIase family, to cell death in HT22 cells. 
3.5.1. Pin1 inhibition promotes cell survival 
Pin1 was identified to be an interacting partner of the Ser65-phosphorylated BH-3 
only protein BimEL, thereby stabilizing BimEL, which results in neuronal apoptosis by 
activating the mitochondrial machinery 156. To evaluate the role of Pin1 in 
glutamate-induced cell death in HT22 cells, the Pin1 inhibitor Br57 was applied with 
or without glutamate and the impact on cell viability was analyzed. In the presence of 
glutamate, Br57 led to an increase in cell viability as determined by the MTT assay 
and real-time impedance measurements with the xCELLigence system (Figure 23A). 
Furthermore, morphological alterations due to glutamate were prevented (Figure 23). 
This protective effect was confirmed by AVPI staining and subsequent 
FACS-analysis, which revealed a decrease in cell death after Pin1 inhibition and 
glutamate exposure (Figure 23B).  
These data indicate an important role for Pin1 in glutamate toxicity, as the Pin1 
inhibitor Br57 led to sustained increased cell viability and reduced cell death. 
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Figure 23: Pin1 inhibition with Br57 provides protective effects against glutamate toxicity 
A: HT22 cells were treated with 50 µM Br57 with or without 3 mM glutamate and after 15.5 h cell viability was 
analyzed by MTT assay (left panel, n=8) and real-time impedance measurements with the xCELLigence system 
(right panel, n=6). As both methods confirm, Br57 was able to significantly increase cell viability. B: Cell death 
was determined by AVPI staining and subsequent FACS-analysis. Br57 decreased cell death after glutamate 
toxicity (14 h, 4 mM). Quantification of double positive stained cells (lower right panel, AV and PI positive, n=4). 
Experiments were repeated three times and results are given as mean +SD (***p< 0.01; ANOVA, Scheffé’s test). 
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3.5.2. Pin1 inhibition shifts mitochondrial morphology towards 
intermediate category 2 mitochondria and restores the MMP 
It has been observed that Pin1 is associated with mitochondrial death pathways 156. 
To gain further insight into Pin1-mediated cell death and the impact on mitochondrial 
morphology, Br57 was applied for 17 h in the presence or absence of glutamate 
(5 mM) and mitochondrial morphology alterations were evaluated by counting 500 
cells per condition blind. The glutamate-induced shift from category 1 to category 3 
mitochondria in control cells could be prevented by Pin1 inhibition. However, the 
quantification of mitochondrial morphology revealed a strong shift towards 
intermediate category 2 mitochondria independent of glutamate treatment (Figure 
24A and B). Both, in Br57 treated control cells and in conditions of glutamate 
treatment, Pin1 inhibition led to an increase in category 2 mitochondria to nearly 80% 
(Figure 24B). On the basis of the observed alterations in mitochondrial morphology 
induced by the Pin1 inhibitor Br57, the next step was to analyze the influence of Br57 
on the MMP. As described above glutamate toxicity led to an impairment of the MMP 
in HT22 cells. FACS-analysis of HT22 cells revealed a protective effect of Br57 as 
the inhibition of Pin1 prevented the loss of MMP induced by glutamate (15.5 h, 4 mM, 
Figure 24C). However, as maybe expected based on previous results of changes in 
mitochondrial morphology, MMP-analysis did not show any differences. Br57-treated 
control cells showed equal MMP compared to non-treated control cells.  
These findings depict a protective effect of Br57 against glutamate-induced 
mitochondrial fragmentation and the loss of MMP. However, Pin1 inhibition resulted 
in pronounced mitochondrial fission with a shift towards category 2 mitochondria, 
which was nevertheless accompanied by increased cell viability.   
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Figure 24: Br57 alters mitochondrial morphology and restores MMP after glutamate toxicity in HT22 cells 
A: Confocal images (63x objective) of MitoTracker DeepRed stained mitochondria illustrated a pronounced shift 
towards category 2 mitochondria of Br57-reated cells (independent of glutamate treatment). B: Quantification of 
mitochondria revealed a decrease in mitochondrial fragmentation after Pin1 inhibition and glutamate exposure 
(15 h, 4 mM), however an increase of category 2 mitochondria was observed. For each condition 500 cells were 
counted blind. C: Br57 prevented the impairment of MMP after glutamate toxicity (15.5 h, 4 mM) determined by 
FACS-analysis of TMRE stained HT22 cells (n=4). Experiments were repeated three times and results are given 
as mean +SD (###/***p< 0.001; ANOVA, Scheffé’s test). 
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3.5.3. Pin1 inhibition prevents ATP depletion and maintains 
mitochondrial respiration after glutamate toxicity 
The present data demonstrated the impact of Pin1 on mitochondrial morphology and 
on MMP. To investigate the role of Pin1 on mitochondrial metabolism, ATP levels 
were analyzed after Br57 and glutamate treatment. Glutamate toxicity (15.5 h, 4 mM) 
led to a strong decrease in ATP levels, which could be attenuated by the inhibition of 
Pin1 with Br57. However, the inhibition of Pin1 alone resulted in a slight decrease of 
about 20% in ATP levels in Br57-treated control cells (Figure 25A). Since the main 
ATP production and energy generation is produced by the process of Oxphos in the 
inner mitochondrial membrane 29, the influence of Pin1 on mitochondrial respiration 
was examined by measuring the oxygen consumption rate (OCR) with the 
XF96-Seahorese system as described before 191. HT22 cells were seeded in 
XF96-well microplates and after glutamate (16 h, 3 mM) and/or Br57 treatment, 
growth medium was replaced with assay medium and cells were incubated for 60 
min. at 37 °C. Three baseline measurements were recorded before the addition of 
the different compounds. Oligomycin, which is an inhibitor of ATP synthase was 
added in Port A (20 µl) at a final concentration of 3 µM. Inhibiting the ATP synthase 
results in a decreased dissipation of the proton gradient, which in turn leads to a 
decline in the OCR. FCCP, an uncoupler of the electron transport chain (22.5 µl in 
Port B) was applied at a concentration of 0.4 µM, reducing the proton gradient, which 
results in an enhanced OCR. Rotenone/Antimycin A, inhibitors for complex I and III 
(25 µl in Port C) were finally added at a concentration of 1 µM to block the whole 
mitochondrial respiratory chain, leading to a complete decrease in OCR 192. Br57 
alone increased the mitochondrial basal respiration and as also detected with this 
method, the ATP production was reduced in Br57-treated control cells (Figure 25B, 
area A-B). In the presence of glutamate Br57 increased maximal respiration 
compared to glutamate treated control cells (Figure 25B, area B-C).  
These data contribute to the assumption that Pin1 inhibition directly affects 
mitochondrial metabolism and function. 
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Figure 25: Br57 prevents ATP depletion and influences mitochondrial respiration after glutamate toxicity 
A: HT22 cells were treated with different concentrations of Br57 with or without 4 mM glutamate and after 15.5 h 
ATP levels were determined by luminescence measurements. Glutamate-induced ATP depletion was prohibited 
with Br57 (n=8). Br57 treatment alone led to an ATP decrease of ~20 % (n=8). B: Br57 elicited an increase in 
basal respiration and reduced the ATP production in control cells. In the presence of glutamate, Br57 prevented 
the impairment of maximal respiration compared to glutamate-treated control cells. The right graph exhibits 
normalized values. Experiments were repeated three times and results are given as mean +SD (###/***p< 0.001; 
ANOVA, Scheffé’s test). 
 
3.5.4. Pin1 siRNA cannot prevent glutamate-induced cell death 
Previous results suggested that Pin1 is a mediator of glutamate-induced 
mitochondrial fission and cell death in HT22 cells. To study particular the role of Pin1, 
the next experiment was to analyze the impact of Pin1 silencing on cell viability. For 
this purpose, two different siRNAs were used to deplete Pin1 mRNA and protein 
levels (esiPin1 obtained from Sigma and siPin1 obtained from Dharmacon). Both 
siRNAs reduced Pin1 mRNA as well as protein levels in HT22 cells (Figure 26A). In 
contrast to the protective effect of the Pin1 inhibitor Br57, silencing of Pin1 failed to 
rescue HT22 cells from glutamate-induced cell death as determined by the MTT 
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assay (Figure 26B). However, contrarily to expectations, addition of Br57 to Pin1 
depleted cells increased cell viability after glutamate toxicity (Figure 26B, black bars).  
Taken together, these findings revealed that Pin1 plays an important role in 
mitochondrial fission and fusion processes as well as in cell death pathways as the 
inhibition of Pin1 with Br57 provided neuroprotection, preserved MMP and attenuated 
ATP depletion after glutamate toxicity. However, in contrary to these findings the 
specific knockdown of Pin1 with siRNA failed to rescue HT22 cells from cell death.  
 
  
Figure 26: Pin1 siRNA does not rescue cells from glutamate-induced cell death 
A: RT-PCR analysis revealed a downregulation of Pin1 mRNA levels after siRNA transfection for 48 h (two 
siRNAs were used) and western blot analysis confirmed the knockdown on the protein level. GAPDH and actin 
were used as loading control for RT-PCR and western blot experiments, respectively. B: Both siRNAs failed to 
rescue cells from cell death induced by glutamate as determined by the MTT assay (15 h, 5 mM; n=8). The 
addition of Br57 to Pin1 depleted cells showed complete protection against glutamate-induced cell death. Results 
depicted in left panels are obtained with esiPin1 (easy siRNA from Sigma Aldrich, siRLUC was used as control 
siRNA), while right panels are obtained with SMART pool® siPin1 (Dharmacon, Thermo Scientific). Experiments 
were repeated at least three times and results are given as mean +SD. 
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3.6. Trypsin-like serine proteases as mediators of 
glutamate-induced cell death in HT22 cells 
The activation of proteases, such as caspases, calpains or cathepsins in signaling 
pathways of PCD is well-established 4,107,193–196. However, increasing evidence 
suggests that also other proteases are major contributors to intrinsic pathways of 
PCD, namely serine proteases, such as Omi/HtrA2, granzyme B, chymotrypsin or 
trypsin 112,195,197. The present study investigated the impact of activated trypsin-like 
serine proteases on cell survival and mitochondrial function in response to oxidative 
stress induced by glutamate in HT22 cells. To gain insight into the role of serine 
proteases in glutamate toxicity, two inhibitors were applied in the following 
experiments. Nα-Tosyl-L-lysine-chlormethyl ketone hydrochloride (TLCK) is an 
irreversible inhibitor of trypsin, but it is also reported that TLCK inhibits other 
proteases, such as plasmin and thrombin (10 mM TLCK to 100 units/ml of thrombin) 
or kinases, such as Protein Kinase C (IC50= 1 mM) and the catalytic subunit of the 
Cyclic AMP-dependent Protein Kinase, amongst others 198–201. Np-Tosyl-L-
phenylalanyl chloromethyl ketone (TPCK) inhibits irreversibly α-chymotrypsin and 
chymotrypsin-like serine proteases. However, TPCK exhibits no activity for trypsin 
and trypsin-like serine proteases 202.   
3.6.1. The trypsin-like serine protease inhibitor TLCK provides 
neuroprotection in HT22 cells and primary cortical neurons 
In the current experiment, the protective potential of the serine protease inhibitor 
TLCK against glutamate toxicity was investigated. The impact of serine protease 
inhibition after glutamate challenge on cell viability was determined by MTT assay 
and real-time impedance measurements with the xCELLigence system. TLCK 
increased cell viability after 17 h of glutamate treatment (3 mM) and the loss of cell 
impedance was prevented (Figure 27A). To further confirm this neuroprotective 
effect, cell death was examined by AVPI staining and following FACS-analysis. Cells 
were treated with 3 mM glutamate for 13 h with or without 50 µM TLCK. Afterwards, 
cells were stained for 5 min with AVPI and subsequently analyzed by FACS. The 
quantification of double positive stained cells (AV and PI positive) represented the 
amount of cell death in each condition. Cell death was completely decreased by 
TLCK treatment after glutamate toxicity (Figure 27B).  
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Figure 27: TLCK provides protective effects upon glutamate treatment  
A: HT22 cells were treated with TLCK and after glutamate exposure (3 mM) cell viability was determined by 
real-time impedance measurements with the xCELLigence system (n=6, left panel) and MTT assay (17 h, n=8, 
right panel). TLCK increased cell viability in a concentration-dependent manner. B: Glutamate-induced 
morphological alterations were prevented by TLCK. Cell death was detected by FACS-analysis after glutamate 
toxicity (13 h, 3 mM) and as quantification of AVPI positive stained cells revealed, TLCK prohibited oxidative 
stress-induced cell death (n=4). Experiments were repeated three times and results are given as mean +SD 
(***p< 0.001; ANOVA, Scheffé’s test). 
 
To examine whether serine protease activation occurs early or late in response to 
oxidative stress, TLCK was applied 2, 4 and 6 h after the onset of glutamate and cell 
viability was analyzed by the xCELLigence system over time. A post-treatment with 
TLCK up to 2 h prevented cell death, while 4 and 6 h of post-treatment did not 
increase cell viability, which indicated an initial activation of serine proteases in 
conditions of glutamate treatment (Figure 28). 
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Figure 28: TLCK increases cell viability after glutamate toxicity up to 2 h of post-treatment 
A: Real-time detection of cell impedance exhibited a protective effect of TLCK after glutamate toxicity in 
post-treatment conditions up to 2 h (n=6). B: Bar graph evaluation after 12 h of the xCELLigence recordings (right 
black arrow) from figure 28A. TLCK significantly increased cell viability in conditions of co-treatment and up to 2 h 
of post-treatment contrary to cells exposed to glutamate and post-treatment after 4 and 6 h. Experiments were 
repeated three times and results are given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test). 
 
To translate this protective effect of serine protease inhibition into more physiological 
conditions, primary cortical mouse neurons were used to test the protective potential 
of TLCK. Since HT22 cells lack NMDA and AMPA/kainate receptors, this model of 
oxidative stress imitates only partial the mechanism of neuronal cell death occurring 
in neurodegenerative diseases. The activation of ionotropic glutamate receptors by 
glutamate leads to elevated intracellular Ca2+-levels and following mitochondrial 
damage that triggers the extensive production of detrimental ROS levels. To analyze 
the effect of TLCK, primary cortical neurons were cultured for 8-10 days and following 
cells were treated with 25 µM glutamate for 17 h. Cell viability was afterwards 
determined by the MTT assay. TLCK led to increased cell viability in primary cortical 
neurons in a concentration-dependent manner (Figure 29). 
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Figure 29: TLCK increases cell viability in primary cortical neurons after glutamate-induced exitotoxicity 
A: Primary mouse cortical neurons were treated on day 10 for 17 h with 25 µM glutamate and two different 
concentrations of TLCK (25, 50 µM). As determined by the MTT assay, TLCK provided neuroprotective effects. 
Experiments were repeated three times and results are given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test).  
 
In contrary to the protective potential of TLCK, TPCK had no protective effects 
against glutamate toxicity in HT22 cells. Interestingly, TPCK decreased cell viability in 
a concentration-dependent manner (Figure 30). These results suggest that 
trypsin-like serine proteases but not chymotrypsin-like serine proteases are involved 
in glutamate-induced cell death in HT22 cells. Therefore, TLCK was used in all 
further experiments. 
 
 
Figure 30: TPCK cannot prevent glutamate-induced cell death in HT22 cells 
HT22 cells were treated for 17 h with 3 mM glutamate and the impact of TPCK on cell viability was determined by 
MTT assay. TPCK failed to rescue HT22 cells from glutamate-induced cell death, even exhibited toxic effects at 
higher concentrations (n=8). Experiments were repeated three times and results are given as mean +SD. 
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3.6.2. Serine proteases act upstream of Bid 
The pro-apoptotic protein Bid is an important mediator of caspase-independent 
pathways of neuronal cell death in HT22 cells and an important regulator of 
mitochondrial demise 70,71. Since serine proteases were linked to Bid activation and 
thereby inducing cell death 127,203, the next issue of interest was to investigate if 
TLCK-sensitive serine proteases act upstream or downstream of Bid activation in 
HT22 cells. For this purpose, cells were pre-treated with 50 µM TLCK for 1 h and 
following transfected with the tBid plasmid (2 µg/well, 18 h) to induce apoptosis as 
described previously in the work of Grohm et al. 71. After 17 h of tBid treatment cell 
death was examined by AVPI staining and subsequently FACS-analysis. TLCK was 
not able to prevent cell death induced by tBid, indicating that activation of trypsin-like 
serine proteases occurred upstream of Bid activation (Figure 31). 
 
 
Figure 31: TLCK cannot prevent tBid-induced cell death 
A: HT22 cells were pre-treated with 50 µM TLCK for 1 h prior to tBid transfection. After 18 h cells were stained 
with AVPI and cell death was detected by FACS-analysis. TLCK did not provide protective effects against 
tBid-induced cell death (n=4). CDNA 3.1 was used as control plasmid. B: Quantification of FACS received dot 
plots of double positive stained cells. Experiments were repeated three times and results are given as mean +SD. 
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3.6.3. TLCK abolishes glutamate-induced lipid peroxidation  
In HT22 cells glutamate exposure results in depleted GSH levels leading to cell 
death. Since GSH is one of the major endogenous radical scavengers in cells, its 
depletion is associated with increased detrimental ROS accumulation and lipid 
peroxide production. As the work of Tobaben showed, a first increase in lipid 
peroxidation within the first hours after glutamate exposure was followed by a second 
much more pronounced increase that was associated with irreversible mitochondrial 
damage and cell death72. To investigate the influence of serine protease activation on 
lipid peroxide production in conditions of oxidative stress, HT22 cells were treated in 
the presence or absence of TLCK with 3 mM glutamate for 10 h. Lipid peroxidation 
was examined by FACS-analysis of Bodipy stained cells. TLCK blocked lipid 
peroxide production completely, even to control levels (Figure 32). This strong 
decrease of lipid peroxidation after glutamate toxicity indicates that TLCK acts even 
before the first wave of ROS increase.  
 
 
Figure 32: Glutamate-induced lipid peroxidation was completely blocked by TLCK 
A: HT22 cells were treated for 10 h with glutamate (3 mM) with or without TLCK and were afterwards stained with 
2 µM BODIPY reagent for 1 h. Determination of lipid peroxide production was achieved by FACS-analysis. TLCK 
inhibited glutamate-induced lipid peroxidation. B: Quantification of FACS dot plots (n=4). Experiments were 
repeated three times and results are given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test).  
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Recently it was reported by Takahashi et al., that TLCK exhibits antioxidative 
properties and due to this feature TLCK rescued H9C2 cells from H2O2-induced cell 
death 204. Since glutamate-induced lipid peroxidation was completely abolished by 
TLCK (Figure 32), the hypothesis that TLCK may act as an antioxidant in glutamate 
toxicity and thereby rescues HT22 cells from cell death was assumed. To examine 
the protective potential of TLCK in H2O2-induced cell death, cell viability was 
determined by MTT assay after 15.5 h of treatment. H2O2 decreased cell viability in a 
concentration-dependent manner and TLCK was not able to prevent it, leading to the 
conclusion that TLCK is not acting as an antioxidant in this cell death model system 
(Figure 33). 
 
Figure 33: TLCK cannot prevent H2O2-indcued cell death in HT22 cells 
HT22 cells were treated with different concentrations of H2O2 and 50 µM TLCK. Cell viability was determined by 
MTT assay after 15.5 h of treatment. The serine protease inhibitor TLCK did not prevent the decrease of cell 
viability induced by H2O2 (n=8). Experiments were repeated three times and results are given as mean +SD. 
 
3.6.4. TLCK prevents glutamate-induced mitochondrial fragmentation, 
loss of MMP and preserves mitochondrial respiration 
Mitochondrial fragmentation, the loss of MMP and depleted ATP levels are 
associated with glutamate-induced cell death in HT22 cells. As previous results 
demonstrated, TLCK seems to act in an initial phase of oxidative stress-induced cell 
death. To evaluate the influence of serine protease inhibition on mitochondrial 
parameters, mitochondrial morphology alterations were first analyzed. After TLCK 
and glutamate exposure (13.5 h, 2 mM) quantification of mitochondrial categories 
was performed as described before in this study (see 1.2). Trypsin-like serine 
protease inhibition with TLCK prohibited mitochondrial fragmentation induced by 
Results 
  
84 
 
glutamate, which was exhibited by a significant decrease of category 3 mitochondria 
(Figure 34A). Another important feature of oxidative stress-induced cell death in 
HT22 cells is the impairment of the MMP. Since mitochondrial alterations due to 
oxidative stress could be inhibited by TLCK, the next step was to examine the impact 
of activated serine proteases on MMP. FACS-analysis of TMRE stained cells 
revealed that TLCK was able to prevent the loss of MMP induced by glutamate (13 h, 
3 mM, Figure 34B). The uncoupler of the MMP, carbonylcyanide-3-
chlorophenylhydrazone (CCCP), was used as positive control. 
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Figure 34: TLCK prohibited glutamate-induced mitochondrial morphology alterations and the loss of MMP 
A: Glutamate-induced mitochondrial morphology alterations were illustrated by confocal images (63x objective) of 
MitoTracker DeepRed stained mitochondria. Quantification of mitochondrial categories after glutamate toxicity 
(15 h, 2 mM) revealed an increase of category 1 mitochondria and a decrease of category 3 mitochondria in the 
presence of TLCK. For each condition at least 500 cells were counted blind. B: MMP was analyzed by TMRE 
staining and following FACS measurements. Glutamate treatment (12.5 h, 3 mM) led to an impairment of the 
MMP, which was illustrated by a loss in red fluorescence (peak shift to the left). TLCK was able to preserve MMP 
impairment compared to glutamate treated controls (n=4). CCCP was used as positive control. Quantification of 
TMRE stained cells is illustrated in the bar graph below. Experiments were repeated three times and results are 
given as mean +SD (***p< 0.001; ANOVA, Scheffé’s test).  
A 
B 
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As demonstrated by previous results, TLCK was able to prevent the impairment of 
MMP. To have a closer look directly on the energy metabolism and respiratory 
capacity of HT22 cells after glutamate toxicity and the impact of serine proteases, the 
next issue was to evaluate ATP levels and mitochondrial respiration in response to 
oxidative stress. HT22 cells were treated for 15 h with 3 mM glutamate and different 
concentrations of TLCK. Accordingly, ATP levels were determined by luminescence 
measurements. TLCK impeded ATP depletion completely (Figure 35A). To gain 
further insight into mitochondrial function related to the respiratory capacity, the 
XF96-Seahorse system was used to measure the OCR over time as described in 
1.5.3. Glutamate induced a reduction in the basal respiration and decreased ATP 
production, which was prevented by TLCK. Further, maximal respiration was 
increased after TLCK treatment compared to glutamate treated control cells (Figure 
35B). 
In consequence of these results, trypsin-like serine proteases are supposed to act 
upstream of mitochondrial demise and preserve mitochondrial respiratory capacity. 
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Figure 35: TLCK prevents ATP depletion and preserves mitochondrial respiratory capacity 
A: ATP levels were detected by luminescence measurements after glutamate toxicity in HT22 cells. 
Glutamate-induced (16 h, 3 mM) ATP depletion was abolished by TLCK (n=8). B: Seahorse measurements 
revealed reduced basal respiration, reduced ATP production and decreased maximal respiration after glutamate 
exposure (16 h, 4 mM), which were preserved by serine protease inhibition with TLCK (n=8). The right panel 
exhibits the normalized curve. Experiments were repeated three times and results are given as mean +SD (***p< 
0.001; ANOVA, Scheffé’s test).  
 
3.6.5. The impact of TLCK on actin/Drp1 interaction and the 
redistribution of Drp1 to the mitochondria after glutamate toxicity 
There is some evidence suggesting that the actin cytoskeleton is involved in the 
movement and positioning of mitochondria and in mitochondrial fission 47–49,205. One 
major regulatory protein which is associated with mitochondrial fission is Drp1 206. 
Recent data implies that Drp1-dependent mitochondrial fission is regulated by actin 
dynamics, as disruption of F-actin (filamentous) attenuates the recruitment of Drp1 to 
the mitochondria and mitochondrial fission 49. The work of Barbier et al. shows that 
the F-actin network disruption and the subsequent redistribution from Drp1 to the 
mitochondria, which results in cell death, is caused by the activation of 
B 
A 
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chymotrypsin-like serine proteases 138. To examine the influence of trypsin-like serine 
proteases on F-actin disruption and on Drp1 redistribution to the mitochondria, HT22 
cells were treated for 16.5 h with 5 mM glutamate and 50 µM TLCK and 
subsequently IP experiments were performed. Drp1 was immunoprecipitated and 
co-immunoprecipitated actin protein levels were analyzed by western blot analysis. 
Glutamate induced a disruption of actin/Drp1 interaction, which was not prevented by 
serine protease inhibition with TLCK (Figure 36A and B). To evaluate if TLCK has 
nevertheless an influence on the translocation of Drp1 to the mitochondria after 
glutamate exposure, western blot analysis of mitochondrial extracts were performed. 
Serine protease inhibition with TLCK could not abolish glutamate-induced 
translocation of Drp1 to the mitochondria (Figure 36C and D).  
Taken together, these results demonstrate that trypsin-like serine proteases have no 
impact on the interaction of actin and Drp1 and that the redistribution from Drp1 to 
the mitochondria after glutamate toxicity is not prohibited by TLCK. 
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Figure 36: TLCK cannot impede Drp1/actin disruption and Drp1 translocation to the mitochondria  
A: Glutamate-induced (17 h, 4 mM) release of Drp1 from the actin cytoskeleton was not prevented by TLCK as IP 
experiments depicted. Drp1 was immunoprecipitated and co-immunoprecipitated actin levels were analyzed. The 
left panel exhibits IP experiments and the right panel western blot analysis of total protein amounts. Bar graphs 
depict the quantification of the optical density from actin/Drp1 protein levels obtained from western blots (n=5). B: 
Drp1 translocation to the mitochondria after glutamate exposure was not attenuated by TLCK as western blot 
analysis of mitochondrial extracts illustrated. Quantification of optical density obtained from western blots (n=5). 
Tim23 was used as loading control for mitochondrial proteins.  
 
3.6.6. The influence of serine proteases on Drp1/CypA interaction 
Previous results of this work demonstrated that CypA plays a crucial role in 
glutamate-induced cell death in HT22 cells. As Drp1-dependent mitochondrial fission 
is associated with glutamate toxicity and the interaction of CypA and Drp1 was 
reported by Cereghetti et al., the next issue was to investigate the interaction of CypA 
and Drp1 in HT22 cells 51,173. For this purpose, IP experiments were performed where 
Drp1 was immunoprecipitated and co-immuonprecipitated CypA protein levels were 
detected by western blot analysis. In control conditions Drp1 interacted with CypA. 
However, this interaction was diminished after glutamate toxicity (Figure 37). 
Interestingly, serine protease inhibition with TLCK increased the interaction of Drp1 
and CypA (Figure 37). 
A 
B 
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Figure 37: Glutamate-induced disruption of Drp1/CypA interaction is prevented and even increased after 
TLCK treatment 
A: IP experiments revealed a decreased Drp1/CypA interaction after glutamate toxicity (17 h, 3 mM), which was 
abolished in the presence of TLCK. TLCK exhibited an even more pronounced interaction of both proteins. The 
left panel shows IP experiments with immunoprecipitated Drp1 and co-immunoprecipitated CypA levels analyzed 
by western blot analysis. The right panel shows western blot analysis of total protein amounts. 
 
It was reported that another binding partner of Drp1 is the phosphatase calcineurin, 
which regulates Drp1-mediated mitochondrial fission by dephosphorylating Drp1 on 
serine residue 637 51,52. Calcineurin activity is linked to neuronal cell death 207 and 
since chymotrypsin regulates calcineurin activity, the speculation was that TLCK 
promotes its protective effect due to calcineurin inhibition. To first analyze, if 
calcineurin contributes at all to cell death in HT22 cells the calcineurin inhibitor 
tacrolimus was used to investigate the impact of calcineurin inhibition on cell viability. 
However, tacrolimus did not provide any protective effects after glutamate toxicity as 
determined by MTT assay (Figure 38).   
Taken together, these results imply that trypsin-like serine proteases have an 
influence on the interaction between Drp1 and CypA. Though, this effect seems not 
to be due to modulatory effects on calcineurin activity. 
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Figure 38: Tacrolimus cannot prohibit glutamate-induced cell death in HT22 cells 
A: The calcineurin inhibitor tracolimus failed to prevent the glutamate-induced (16 h, 4 mM) decrease of cell 
viability as determined by MTT assay (n=8). Experiments were repeated three times and results are given as 
mean +SD. 
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4. Discussion 
The principal aim of this study was to investigate the role of post-translational protein 
modifications in intrinsic pathways of neuronal cell death with particular focus on 
mitochondrial integrity and function. Such post-translational modifications may 
involve isomerization, cleavage or phosphorylation of proteins which determine 
protein-protein interactions or their subcellular localization and function. This 
modification regulates their role at key decision points in PCD pathways, e.g. at the 
mitochondria and in the nucleus. In particular, this study revealed a major role for 
CypA as a regulator of mitochondrial AIF release and further, the influence of Pin1 on 
the mitochondrial fission and fusion balance and on mitochondrial integrety. 
Moreover, this work depicts an important role for trypsin-like serine proteases in 
paradigms of PCD, their influence on protein-protein interactions and their implication 
in the subcellular redistribution of other proteins. 
The first part of this study investigated the contribution of two members of the PPIase 
family to glutamate-induced cell death in HT22 cells, namely CypA and Pin1. The 
involvement of CypA was analyzed by siRNA experiments and the results of this 
thesis suggest that CypA plays a crucial role in oxidative stress-induced cell death 
upstream of mitochondrial AIF release. Silencing of CypA prevented 
glutamate-induced cell death and attenuated mitochondrial morphology alterations. 
Moreover, the critical AIF release from the mitochondria and the subsequent 
translocation to the nucleus was prohibited by CypA depletion, which resulted in 
increased cell viability. Further, lipid peroxidation was significantly reduced by 
siCypA. This is the first time it has been demonstrated, that CypA is not only a 
downstream mediator of mitochondrial demise which then leads to cell death, but that 
it also acts upstream of mitochondrial damage and that CypA silencing rescues 
mitochondrial integrity. The role of the second family member, Pin1, which is 
associated with the mitochondrial cell death machinery, was investigated by applying 
a specific inhibitor of Pin1 (Br57) to the HT22 cell model. The specific inhibition of 
Pin1 revealed a protective effect as cell viability was increased after glutamate 
toxicity. Additionally, this study demonstrated that Br57 changed mitochondrial 
morphology towards pronounced mitochondrial fission, however, mitochondrial 
fragmentation was abolished. This feature was accompanied by a slight decrease in 
ATP production. 
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The data of the second part provide evidence that trypsin-like serine proteases are 
major contributors to oxidative stress-induced cell death in HT22 cells and primary 
cortical neurons. TLCK, an inhibitor of trypsin-like serine proteases, increased cell 
viability in HT22 cells and primary neurons after glutamate toxicity. Furthermore, 
TLCK prevented glutamate-induced lipid peroxidation and attenuated the loss of ATP 
in HT22 cells. Moreover, serine protease inhibition preserved the MMP and abolished 
mitochondrial morphology alterations due to glutamate treatment. However, TLCK 
failed to prevent tBid-induced cell death in HT22 cells indicating that serine protease 
activation occurs upstream of Bid activation. Additionally, as IP data of this work 
demonstrated, serine proteases have no influence on the interaction of Drp1 at the 
cytoskeleton. The release of Drp1 and the subsequent redistribution to the 
mitochondria occurred after glutamate toxicity, however, this was not prevented by 
TLCK treatment. But serine proteases have an impact on the interaction of Drp1 and 
CypA.  
Taken together, the first part of this work shows that CypA and Pin1 contribute to cell 
death pathways induced by glutamate in HT22 cells and that both proteins act 
upstream or at the level of mitochondria. The second part implies an important role 
for trypsin-like serine proteases as mediators of glutamate-induced cell death in 
HT22 cells and primary cortical neurons and that protease activation occurs 
upstream of Bid activation in HT22 cells. 
4.1. Mitochondrial fragmentation induced by glutamate in HT22 
cells 
Mitochondria exert life-and-death decisions in cells because mitochondrial function is 
relevant for normal bioenergetics, maintenance of Ca2+ homeostasis, free radical 
generation and energy production. Mitochondrial dynamics are regulated by the 
mitochondrial fission and fusion rate, which is under control of numerous GTPases. 
Mitochondrial fission is essential for growing and dividing cells to generate new 
organelles, while fusion is stimulated by energy demand and rescues stress by 
complementing functional and dysfunctional mitochondria. Particularly in neurons, 
mitochondria engage a central role because the high energy demand of these cells to 
maintain neuronal function, such as neurotransmitter synthesis, is provided mainly 
through Oxphos in the IMM. In the present study, cell death induced by glutamate 
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resulted in strong mitochondrial fragmentation, which was associated with elevated 
mitochondrial fission and accompanied by the impairment of the MMP.  
HT22 cells lack ionotropic glutamate receptors such as NMDA or AMPA/kainate 
receptors. However, they are sensitive to high extracellular glutamate concentrations, 
which induced the generation of elevated ROS levels associated with mitochondrial 
fragmentation and ensuing DNA damage. It was reported that the mitochondrial AIF 
release and the subsequent translocation to the nucleus is a critical step in this 
caspase-independent neuronal cell death pathway. Moreover, as demonstrated in 
this work, the translocation of CypA from the cytosol to the nucleus and the pro-
apoptotic complex formation of AIF and CypA is required to induce cell death in HT22 
cells (Figure 12-14). Thus, the maintenance of mitochondrial function and the 
prohibition of mitochondrial AIF release were shown in this thesis to be important 
targets to prevent neuronal cell death. 
4.2. CypA in the paradigm of glutamate-induced cell death in HT22 
cells 
4.2.1. CypA – a regulator of mitochondrial AIF release 
One major aspect of this study addressed the mitochondrial AIF release and the 
translocation to the nucleus where it induced chromatin condensation, which was 
shown by video recordings after glutamate toxicity in HT22 cells 70. Silencing of AIF 
provided protective effects in HT22 cells and primary neurons, which make the AIF 
release a promising target for neuroprotection 70,77. Since AIF requires CypA to 
induce chromatinolysis, this thesis provided evidence that inhibition of the CypA-AIF 
axis led to decreased cell death. This was supported by several findings. First, 
downregulation of CypA extremely reduced the susceptibility of HT22 cells to 
oxidative stress. Second, the typical hallmark of increased lipid peroxidation in 
response to glutamate was abolished. Third, mitochondrial fragmentation and the 
impairment of the MMP were significantly attenuated and fourth the key event in 
caspase-independent cell death, the mitochondrial AIF release, was prohibited. One 
of the most puzzling issues of AIF-mediated cell death involves the question if AIF 
translocation to the nucleus is dependent or not on its interaction with CypA in the 
cytosol. To date, two different mechanistic pathways have been proposed to explain 
the relocation of AIF to the nucleus. The first model suggests that AIF and CypA 
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translocate independent of each other to the nucleus where they induce 
chromatinolysis by generating a DNA-degrading complex with H2AX. In 
MNNG-treated MEFs AIF simultaneously interacts with CypA and H2AX. Strikingly, 
the association of AIF and H2AX in the nucleus occurred even in the absence of 
CypA but in this case DNA damage was reduced. In contrast, AIF required H2AX to 
cooperate with CypA 208. A second model proposes that AIF translocation to the 
nucleus depends on its interaction with CypA in the cytosol. This hypothesis is based 
on the observation that nuclear AIF translocation was reduced in CypA-/- mice after 
HI and conversely, in Hq mice lacking AIF, nuclear translocation of CypA was 
diminished 168. These controversially discussed mechanisms indicate that the 
caspase-independent apoptotic pathway is dependent on the cell type and the 
apoptotic inducing stimulus.  
The present study confirmed the previously described nuclear translocation of AIF 
induced by glutamate in HT22 cells (Figure 12; 70). In addition, the translocation of 
CypA to the nucleus and the interaction of AIF and CypA due to oxidative stress was 
demonstrated (Figure 13 and 14). However, in this model system the histone H2AX is 
not required to induce cell death as silencing of H2AX did not provide any protective 
effects (Figure 22). Another important finding of this work is the unequal 
time-dependent translocation of CypA and AIF to the nucleus in HT22 cells. 
Interestingly, CypA relocation to the nucleus was observed at earlier time points than 
AIF release from the mitochondria appeared. After 6-8 h upon glutamate challenge 
CypA levels were increased in the nucleus, while AIF translocation occurred 10-12 h 
after the onset of glutamate. Moreover, silencing of CypA abrogated mitochondrial 
AIF release completely, indicating a pivotal role for CypA in the nuclear translocation 
of AIF in glutamate-induced cell death in HT22 cells. These findings were 
substantiated by the work of Doti et al. that even targeting CypA in the cytosol by an 
AIF-peptide, which prohibits the interaction of AIF and CypA, prevented the 
translocation of AIF to the nucleus 209. These results suggest that on the one hand 
CypA serves as a carrier for AIF and on the other hand that nuclear CypA may 
exhibit a platform for a feedback loop to the mitochondrial AIF release. 
4.2.2. The role of CypA upstream of mitochondrial demise 
High extracellular glutamate concentrations lead to increased ROS accumulation and 
to elevated lipid peroxide production, which is accompanied by mitochondrial 
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fragmentation and the loss of MMP in HT22 cells as demonstrated in this study and 
previously shown by others (Figure 10 and 11; 71,72). Lipid peroxidation occurred in a 
biphasic manner after glutamate toxicity. An initial moderate increase appeared after 
6-8 h of glutamate challenge followed by a second much more pronounced boost 
after 8-18 h arising from the mitochondria 72. This work demonstrated that delivering 
of siCypA in HT22 cells before glutamate exposure abrogated the second boost of 
lipid peroxidation, while the initial increase was not affected (Figure 17). The 
inhibition of lipid peroxidation by siCypA was accompanied by decreased 
mitochondrial fragmentation and preserved MMP, which is in accordance with 
previous results showing that AIF release from the mitochondria was prohibited 
(Summary of results are depicted in Figure 39). However, the mechanism through 
which CypA silencing provides protective effects is still unknown. One possible 
mechanism could be through regulating cell cycle arrest and cell cycle transition. 
PPIases are known to be involved in the modulation of cellular pathways such as cell 
cycle regulation. In particular Pin1 regulates the stability of p53 and thereby gives rise 
to cell cycle arrest 210. Cyp18, another member of the PPIase family, was identified 
as another interaction partner of p53. The impairment of the Cyp18-p53 interaction 
results in an accumulation of cells in the G2/M cell cycle phase. Moreover, Cyp18 
knockout cells underwent increased p53-dependent apoptosis, suggesting an 
anti-apoptotic potential of Cyp18-p53 interaction 163. In tumor lung cancer cells, CypA 
was identified to induce the up-regulation of cyclin D1 and cyclin-dependent kinase 4 
(cdk4), whose activity is required for cell cycle G1/S transition, which resulted in cell 
cycle progression 189. In fact, these findings revealed a pro-survival role for PPIases 
by modulating cell cycle phases, however, in the case of glutamate-induced cell 
death in HT22 cells there is no evidence that CypA has an influence at all on cell 
cycle arrest/progression/transition (Figure 21).  
These findings demonstrated that CypA acts upstream of mitochondrial demise but 
downstream of the first moderate lipid peroxide increase. On the basis of these data, 
the hypothesized mechanism of glutamate-induced cell death in HT22 cells includes 
as a first step the translocation of CypA to the nucleus thereby creating a platform for 
the second step which involves the mitochondrial AIF release and the subsequent 
translocation to the nucleus. This assumption was substantiated by the fact that 
silencing of CypA prevented mitochondrial fragmentation and mitochondrial AIF 
release. However, it should be mentioned that other possible mechanisms cannot be 
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eliminated, because the exact mechanism is still elusive. Indeed, this model of 
glutamate-induced cell death does not clarify why CypA silencing administrated 
mitoprotection and prevented the lethal AIF release from the mitochondria, rather 
than acting downstream at the level of AIF translocation to the nucleus. However, 
these new findings heightened the important role of CypA in neuronal cell death as 
targeting CypA prevented mitochondrial demise and impeded the crucial step in 
caspase-independent cell death pathways, the mitochondrial release of AIF. Since 
mitochondrial damage marks ‘a point of no return’ in paradigms of PCD, 
mitoprotection is a more attractive target for neuroprotection than inhibiting cell death 
downstream of mitochondrial demise. 
 
Figure 39: The role of CypA in glutamate-induced cell death in HT22 cells 
High extracellular glutamate concentrations led to depleted GSH levels which induced the generation of ROS and 
lipid peroxide production. Following glutamate exposure CypA and AIF translocated to the nucleus where they 
induced chromatinolysis (black arrows illustrate the action of glutamate). CypA silencing prevented the lethal AIF 
release from the mitochondria, preserved the impairment of the MMP and abolished the second boost of lipid 
peroxidation resulting in cell survival (red arrows depict consequences of CypA depletion). 
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4.3. The impact of Pin1 on mitochondrial dynamics and cell death 
Regarding the family of peptidyl-prolyl cis-trans isomerases, the next issue of this 
work dealt with the impact of another family member, Pin1, on mitochondrial 
dynamics and cell death induced by glutamate in HT22 cells. Barone and colleagues 
reported that Pin1 promotes neuronal cell death via a c-Jun dependent mechanism 
211
. Moreover, Pin1 was associated with the mitochondrial apoptotic machinery 
especially in neurons. Since these findings exhibit an important role for Pin1 in 
neuronal cell death, this work strengthens the evidence that Pin1 is linked to cell 
death pathways in neurons. This was supported by the finding that Pin1 inhibition 
reduced cell death and that this protective effect was accompanied by changes in 
mitochondrial function and alterations of mitochondrial morphology. This was verified 
by the proof that Pin1 inhibition with a specific inhibitor, Br57, rescued cells from cell 
death and increased cell viability (Figure 23). Moreover, Pin1 inhibition led to 
decreased ATP production in control conditions and increased small sphere-shaped 
category 2 mitochondria were observed (Figure 24 and 25). Pin1 is highly expressed 
in proliferating cells as well as in neurons. It has been reported that in non-neural 
cells Pin1 is mainly localized in the nucleus 212. However, in neuronal cells a 
significant amount of Pin1 is staked to the mitochondria 190. The pro-apoptotic protein 
BimEL which is localized at the mitochondria triggers, after its JNK-induced 
phosphorylation at ser65, apoptosis particularly in neurons. Pin1 interacts with 
pSer65 BimEL thereby stabilizing it by inhibiting the proteasomal degradation of 
BimEL. A neuronal specific JNK signaling scaffold protein JIP3, which is localized at 
the mitochondria, is known to be an interaction partner of Pin1. This is the cause why 
Pin1 is also tethered to the mitochondrial membrane in neurons. Under this aspect, 
Pin1 is in close proximity to its substrate BimEL and due to different apoptotic stimuli 
Pin1 dissociates from JIP3 and concomitantly interacts with pSer65 BimEL at the 
mitochondria thereby promoting cell death
 
156
. Since Pin1 activates the mitochondrial 
apoptotic machinery and thus promotes cell death, the findings of this study, that 
Pin1 inhibition prevented cell death and more important that this was accompanied 
by mitochondrial alterations, were not completely unexpected. The observation that 
Pin1 inhibition with Br57 resulted in enhanced mitochondrial fission, illustrated in 
elevated category 2 mitochondria, is in line with the decrease in ATP production. To 
maximize the capacity of Oxphos under stressful conditions mitochondria become 
more fused and ATP production is increased 213. Consequently, enhanced 
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mitochondrial fission is associated with depleted ATP levels. The results of this work 
are therefore in agreement with these facts and underline the pivotal role of Pin1 on 
mitochondrial metabolism. Interestingly, measurements of the MMP after Pin1 
inhibition revealed no changes compared to control conditions. It was reported that a 
loss in mitochondrial fusion is associated with reduced respiratory capacity and 
reduced maximal respiration 214. The findings of this study are in accordance with 
these facts. After Pin1 inhibition with Br57, not only decreased ATP levels and 
elevated mitochondrial fission were monitored, but also decreased mitochondrial 
respiratory capacity and diminished maximal respiration in control conditions (Figure 
25). However, a full decrease like it occurred in glutamate treated cells was 
prevented by Pin1 inhibition. The certainty that Pin1 affects mitochondrial morphology 
and mitochondrial function was demonstrated in this thesis. However, the mechanism 
why elevated mitochondrial fission, depleted ATP levels and decreased respiratory 
capacity were outcomes of Pin1 inhibition is still elusive. Till now insufficient studies 
provide evidence for the impact of Pin1 on mitochondrial dynamics and to investigate 
the exact mechanism of how Pin1 regulates alterations in mitochondrial morphology 
and metabolism, more investigations have to be done.  
One of the most enigmatic findings of this study was the observation that in contrast 
to Pin1 inhibition with Br57, Pin1 silencing with siRNA did not provide protective 
effects against glutamate-induced cell death. Two different siRNAs were used to 
examine the particular role of Pin1 on cell viability. However, as both experiments 
revealed Pin1 silencing did not rescue HT22 cells from cell death (Figure 26). Beyond 
that, the combination of siPin1 with Br57 resulted in increased cell viability even up to 
control levels, which is contradictory (Figure 26). There are several possibilities to 
explain this phenomenon. The first and easiest would be that the inhibitor Br57 is not 
specific for Pin1. However, as shown in the publication from Daum et al. Br57 
exhibited a strong inhibitory effect of hPin1 with Ki values in the sub-micromolar 
range. The inhibition of hPin1 by Br57 was determined in a protease-free PPIase 
assay and Br57 was one of the most potent inhibitors of this work 174. Different 
compounds of this work which also exhibited hPin1 inhibitory effects were tested in a 
luciferase reporter gene assay with a p53 response element in MCF7 cells. After 
DNA damage due to chemotherapeutic drugs or other stimuli the phosphorylated 
form of p53 interacts with Pin1. In this pathway, increased activity and higher 
proteolytic stability of p53 was observed due to conformational changes induced by 
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Pin1. The compounds tested in this model were able to reduce p53 stability and 
activity of the p53 reporter gene. Similarly, co-transfected Pin1-negative mutant 
MEFs with an expression construct for an inactive Pin1 variant failed to stabilize and 
activate p53, which underlines the specificity for these inhibitors. Moreover, it has to 
be mentioned that the compounds tested in MCF7 cells have a ten times less 
inhibitory potency than Br57 174. The second possibility could be due to the fact that 
the biological activity of PPIases does not directly correlate with their concentration. 
For instance, the yeast homolog of Pin1, Ess1, exhibits in lowest concentrations a 
pro-survival function, whereas the complete knockdown of Pin1 is lethal. Thus, the 
achieved knockdown of Pin1 in this study may not be sufficient to decrease Pin1 
levels to an extent that protective effects can be determined. Another issue could be 
that although Pin1 levels were depleted, remaining Pin1 was enough to execute 
lethal effects which were inhibited by Br57. This inhibitory effect of Br57 on the 
biological activity of depleted Pin1 levels resulted in increased cell viability.  
Taken together, this part exhibits a crucial role for Pin1 in cell death pathways 
induced by oxidative stress in HT22 cells. Moreover, Pin1 has a direct influence on 
mitochondrial dynamics as Pin1 inhibition induced an increase in mitochondrial 
fission which was accompanied by a slight decrease in ATP production. Furthermore, 
decreased respiratory capacity was observed and nevertheless, all these effects led 
to increased cell viability. To identify the exact mechanism of Pin1’s mitochondrial 
activity more investigations have to be done, however, the impact at the level of 
mitochondria and the resulting decrease of cell death with Br57 are promising targets 
for mitoprotection and thereby neuroprotection.  
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4.4. The role of trypsin-like serine proteases in glutamate-induced 
cell death in HT22 cells 
4.4.1. Serine protease inhibition provides protective effects in HT22 
cells 
The second part of the present study demonstrated a significant protective effect by 
inhibition of trypsin-like serine proteases, suggesting that the activation of such 
proteases contributes to delayed neuronal cell death. This evidence was supported 
by several findings showing that an irreversible inhibitor of trypsin-like serine 
proteases, TLCK, abolished mitochondrial dysfunction and increased cell viability. In 
particular, lipid peroxidation was completely reduced and mitochondrial morphology 
alterations due to glutamate toxicity were prevented. Moreover, the impairment of the 
MMP was preserved and HT22 cells and primary cortical neurons were less 
susceptible to glutamate. In general, many proteases are linked to neurological 
disorders and are associated with apoptosis, aging and several other diseases 85. 
Among all proteases, caspases are the best-studied contributors to PCD pathways, 
while little is known about the involvement of non-caspase death regulators, such as 
calpains, lysosomal cathepsins and serine proteases. However, in the last years they 
have been associated with different paradigms of PCD and moved into the focus of 
apoptotic research 13,215–217. In this work, from all proteases serine proteases engage 
a central role as mediators of oxidative stress-induced cell death in HT22 cells.  
So far, serine proteases have been implicated in different model systems of apoptotic 
cell death pathways. The serine protease chymotrypsin B was shown to be involved 
in TNFα-induced cell death in rat liver cells. The translocation of lysosomal 
chymotrypsin B into the cytosol and the subsequent cleavage/activation of Bid were 
triggered by TNFα. Bid cleavage resulted in a rapid release of mitochondrial Cytc 
which was followed by cell death. In this work, the knockdown of chymotrypsin B by 
RNA interference and the irreversible chymotrypsin inhibitor TPCK provided 
protective effects 218. In another model of cell death it was shown that neuronal cells 
underwent apoptosis upon treatment with the microtubule-disrupting agent colchicine. 
TLCK prevented nuclear fragmentation and provided protective effects, whereas 
TPCK failed to rescue cells from cell death 130. In this mode of cell death caspases 
were also identified as mediators of apoptosis, however, TLCK exhibited a much 
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more pronounced protective effect than the general caspase inhibitor z-VAD-fmk. 
Also in paradigms of oxidative stress-induced cell death serine proteases play a 
crucial role. In retinal cells H2O2 induced enhanced expression of the mitochondrial 
serine protease Omi/HtrA2 which subsequently translocated to the cytosol where it 
promoted apoptosis in a caspase-mediated pathway. The specific Omi/HtrA2 inhibitor 
Ucf-101 as well as RNA interference reduced the cytosolic translocation of 
Omi/HtrA2, attenuated caspase-3 activation and prevented cell death. These findings 
suggest that the serine protease Omi/HtrA2 is involved in oxidative stress-induced 
cell death in a caspase-dependent manner 219. However, Omi/HtrA2 can also 
mediate cell death through caspase-independent mechanisms via its serine protease 
activity 220. Moreover, in the model system of glutamate-induced cell death in HT22 
cells Ucf-101 exhibited protective effects as shown by the work of Landshamer 125. 
Furthermore, in a model of focal cerebral ischemia the inhibitor Ucf-101 provided 
protective effects, indicating a pro-apoptotic function for Omi/HtrA2 in ischemic 
neuronal cell death 124. Additionally, Ucf-101 protected neurons against cerebral 
oxidative injury 221. Contrarily to these pro-apoptotic properties, mice lacking the 
Omi/HtrA2 gene die within 30 days after birth, suggesting a neuroprotective role of 
Omi/HtrA2 in neurons 222. All these investigations place serine proteases in an 
emerging role as mediators of PCD, although the contribution and execution of cell 
death pathways are dependent on cell types and apoptotic inducing stimuli. This 
study confirmed the contribution of trypsin-like serine proteases to neuronal PCD 
pathways. In HT22 cells TLCK exhibited a strong protective effect against 
glutamate-induced cell death (Figure 27). The activation of serine proteases in this 
model seemed to be in a very initial phase, as TLCK prevented cell death only in 
post-treatment conditions up to 2 h. Future application of TLCK after 4 and 6 h after 
the onset of glutamate failed to rescue HT22 cells from cell death (Figure 28). This 
implicates that trypsin-like serine proteases are mediators of oxidative stress-induced 
cell death in HT22 cells and are activated in the beginning of this pathway. So far, the 
proposed deleterious role of serine proteases is based on results obtained in HT22 
cells. To extend these findings to more physiological conditions the impact of TLCK 
was examined in primary cortical neurons. TLCK exhibited protective effects on cell 
viability in primary neurons, where glutamate-induced excitotoxicity led to apoptosis 
(Figure 29). This insight underlines the rising importance of serine proteases as 
relevant executioners of neuronal cell death in conditions of oxidative stress. 
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Chymotrypsin-like serine proteases (CSPs) the second subfamily of serine 
proteases, closely related to trypsin-like serine proteases, was associated with 
neuronal damage induced by ischemia. The work of Hara et al. showed that transient 
forebrain ischemia led to increased neuronal cell death in the CA1 region of the 
hippocampus in mice. The administration of the irreversible CSP inhibitor, TPCK, 
produced a distinct neuroprotective effect when given 1 h before or after the ischemic 
insult. Even when applied up to 24 h after ischemia TPCK prevented neuronal 
damage 129. In contrary to these observations, the work of Movsesyan et al. clearly 
demonstrated that chymotrypsin-like serine proteases are not involved in neuronal 
cell death after TBI. TBI was associated with a progressive, time-dependent increase 
of CSPs activity in injured rat cortices, however, elevated trypsin-like serine protease 
activity was not detected. This implicates that cell death induced by TBI is mediated 
through activated CSPs. The administration of TPCK to rats after TBI did not affect 
cognitive recovery and even exacerbated motor dysfunction. Moreover, higher doses 
of TPCK exhibited cytotoxic effects in rat cortical neurons and other cell lines 223. The 
results obtained from this work are in accordance with the findings from Movsesyan. 
In the HT22 model system TPCK did not prevent cell death induced by glutamate. 
Interestingly, TPCK even decreased cell viability in higher concentrations (Figure 30). 
Taken together, these findings demonstrated that trypsin-like serine protease 
activation contributes to glutamate-induced cell death in HT22 cells, whereas CSPs 
do not play a major role in this paradigm of PCD. 
4.4.2. Serine protease activation – a target upstream of the 
pro-apoptotic protein Bid 
Previous results of this work demonstrated that serine proteases were activated at an 
early time point after glutamate exposure. Initial events of glutamate-induced cell 
death in HT22 cells involve the first boost in ROS, resulting in elevated lipid 
peroxidation and the subsequent activation and translocation of Bid to the 
mitochondria 72. Recently, the lysosomal serine protease chymotrypsin B was linked 
to oxidative stress-induced cell death pathways mediating its apoptogenic function 
via the cleavage of Bid. H2O2-induced lysosomal membrane permeabilization 
resulted in the redistribution of chymotrypsin B to the cytoplasm where it 
activated/cleaved Bid 127. These findings led to the question, do trypsin-like serine 
proteases mediate their pro-apoptotic function upstream or downstream of Bid 
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activation? As the results of this study revealed, tBid-induced cell death was not 
prevented by TLCK (Figure 31). This finding fits to the observation that also in other 
model systems serine proteases led to the activation of Bid thereby potentiating 
apoptosis. The afore-mentioned early occurring feature of glutamate-induced cell 
death in HT22 cells is the initial increase in lipid peroxidation. It has to be mentioned 
that the specific Bid inhibitor BI6c9 provided strong protective effects in HT22 cells 
accompanied by the restoration of mitochondrial function. However, the primary ROS 
increase was not prevented by BI6c9 application in the presence of glutamate, which 
indicates that Bid activation occurs downstream of this feature 72. TLCK was shown 
to precede its anti-apoptotic properties upstream of Bid activation and furthermore, 
even upstream of the first increase in ROS as TLCK completely abolished lipid 
peroxidation. In the presence of glutamate TLCK reduced lipid peroxide production 
even to control levels (Figure 32). These findings led to the assumption that TLCK 
may provide its protective effects by antioxidative properties. The work of Takahashi 
et al. revealed an antioxidative action of TLCK. H2O2-induced cell death in 
GSH-depleted cardiomyocytes and the production of ROS were significantly 
prevented by TLCK treatment, however, other serine protease inhibitors failed to do 
so 204. The current study provided evidence that TLCK did not protect HT22 cells 
against H2O2-induced cell death (Figure 33). Based on these results, if TLCK exhibits 
antioxidative features, at least in this model system these properties seem not to 
contribute to the protective potential of TLCK as the same decrease of cell viability 
was observed in TLCK co-treated cells as in H2O2-treated control cells.   
All these findings depict a pivotal role for trypsin-like serine proteases in conditions of 
oxidative stress-induced cell death in HT22 cells. Moreover, the activation of serine 
proteases occurs at a very initial phase upstream of Bid activation in this paradigm of 
PCD. 
4.4.3. Serine proteases contribute to mitochondrial dysfunction 
The present data demonstrated a crucial role for trypsin-like serine proteases in cell 
death pathways induced by oxidative stress. As mentioned above, mitochondrial 
fission and the loss of MMP are associated with caspase-independent pathways of 
neuronal cell death in HT22 cells. Mitochondrial dysfunction is mediated by the 
translocation of Bid to the mitochondria and the subsequent crucial AIF release, 
resulting in decreased cell viability 70,72. The present study provided evidence that in 
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oxidative stress-induced cell death activation of trypsin-like serine proteases occurred 
upstream of the mitochondrial checkpoint. This was supported by the findings that 
TLCK prevented mitochondrial morphology alterations and preserved MMP (Figure 
34). Glutamate induced a strong fragmentation of mitochondria which resulted in 
elevated levels of category 3 mitochondria. This increase was attenuated by TLCK, 
indicating an important role for trypsin-like serine proteases on mitochondrial 
dynamics. These findings are in accordance with those from Rideout et al. who 
revealed an involvement of trypsin-like serine proteases in DNA damage-induced cell 
death in neuronal cells upstream of mitochondrial Cytc release. 
Camptothecin-induced cell death resulted in impaired MMP following Cytc release 
and subsequently cell death. TLCK could prevent these events and rescued 
embryonic cortical neurons from cell death 137. Another finding which strengthens the 
observation that trypsin-like serine proteases are activated upstream of the 
mitochondrial demise in HT22 cells is the fact that TLCK prevented ATP depletion 
which is a common feature in glutamate-induced cell death. ATP production was 
completely restored by serine protease inhibition with TLCK and furthermore, the 
impairment of the mitochondrial respiratory capacity and the decrease in 
mitochondrial respiration were significantly prevented (Figure 35). Indeed, the entire 
data on serine proteases which are demonstrated in this study revealed a pivotal role 
for trypsin-like serine proteases in PCD pathways induced by oxidative stress. 
Moreover, the mitoprotective effect places these proteases in a prominent position as 
new therapeutical targets for neurological disorders, where mitochondrial dysfunction 
causes neuronal cell death. However, why and how the inhibition of serine proteases 
prevents mitochondrial damage and increases cell death is largely unknown. The 
most pronounced effect of TLCK is indeed the inhibition of trypsin-like serine 
proteases, but TLCK has also shown a variety of actions beside the inhibitory effect 
on activated trypsin-like serine proteases, i.e. inactivation of protein kinase C 201 or 
blockage of cyclic AMP-dependent protein kinase 199. Furthermore, it is reported that 
another property of TLCK is the inhibition of nuclear factor 'kappa-light-chain-
enhancer' of activated B-cells (NF-κB) activation, which occurs due to different 
stimuli, i.e. interleukin 1β treatment and subsequently leads to cell death 224,225. 
Although, TLCK interferes with NF-κB activation, the protective effect did not seem to 
be due to this mechanism in HT22 cells, as NF-κB activation after glutamate 
challenge did not appear in this model of oxidative stress and hence did not 
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contribute to cell death 230. It is further mentioned that serine proteases have been 
implicated as functioning both upstream and downstream of caspases and that for 
instance serine proteases such as Omi/HtrA2 or granzyme B were identified as 
caspase activators 132,133,226. Also chymotrypsin-like serine proteases where identified 
as caspase activators, as TPCK suppressed the activation of caspase-9 in apoptosis 
during hypoxia-reoxygenation in rat kidney cells 132. However, as shown by 
Landshamer et al. caspase activation is not required for glutamate toxicity in HT22 
cells as demonstrated by the findings that caspase-8 and caspase-2 inhibitors as well 
as the general caspase inhibitor z-VAD-fmk failed to rescue cells from oxidative 
stress-induced cell death 70,125. Despite recent observations indicating a possible 
inhibitory effect of activated caspase-3, caspase-6 and caspase-7 of TLCK, these 
findings play a minor role in the model system of PCD in HT22 cells, as it is 
caspase-independent and nevertheless TLCK exhibited protective effects in 
conditions of glutamate toxicity 227. Thus the protective effect seemed not to be due 
to the inhibition of the caspase-cascade cell death pathway in HT22 cells. Another 
interesting target of TLCK is the tumor suppressor protein p53. p53 depicts an 
essential role in cell-cycle progression and apoptosis which is influenced by several 
factors, such as cell type and stress stimuli 134,135. Different studies revealed a 
protective effect of TLCK by preventing the accumulation of p53 and thereby 
attenuating cell death 131,137. The work of Diemert demonstrated a protective effect of 
pifithrin-α, an inhibitor of p53, in the model of glutamate toxicity in HT22 cells, which 
may assume that the possible mechanism of TLCK’s protective effect is due to the 
p53 pathway 230. However, silencing of p53 with siRNA failed to rescue 
glutamate-induced cell death in HT22 (data not published), which contradicts this 
hypothesis. 
Although, the target of action of TLCK and the exact mechanism how serine protease 
inhibition prevents cell death and rescues mitochondrial function is still elusive, this 
study depicted a prominent role for serine proteases as mediators of oxidative 
stress-induced cell death in HT22 cells. 
4.4.4. The impact of serine proteases on protein interactions 
Up to now, the data of this thesis demonstrated an important role for trypsin-like 
serine proteases in PCD pathways in HT22 cells. In particular, the mitochondria were 
the main focus of this research and in this context the influence of activated serine 
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proteases on mitochondrial function and fission and fusion processes was 
investigated. As mentioned before, mitochondrial shape in living cells can range from 
sphere-shaped morphology to tubular network structures. Since mitochondria 
produce the largest amount of energy for cellular processes, the distribution within 
cells can be very heterogeneous. They are often enriched at cellular sites where their 
metabolic function is required, like at synaptic terminals for instance. This 
mitochondrial movement is also under the control of the cytoskeleton. Eukaryotic 
cells contain three major kinds of cytoskeletal filaments: microfilaments (actin 
filaments), intermediate filaments and microtubules 228. A growing body of evidence 
suggests that the actin cytoskeleton is involved in the positioning of mitochondria and 
also in mitochondrial fission processes. Recently it was reported that actin 
participates in mitochondrial clustering, ROS production and cell death upon death 
receptor activation 229. Moreover, the work of Barbier et al. demonstrated that 
modulation of F-actin dynamics regulate a particular type of cell death, namely 
caspase-independent type III PCD. This form of PCD was investigated in B-cells from 
patients with chronic lymphocytic leukemia and is mediated by CD47 ligation which 
leads to the activation of CSPs, followed by F-actin disruption and the subsequent 
redistribution of Drp1 from the cytoplasm to the mitochondria. Interestingly, the 
application of TPCK inhibited actin disruption and the following Drp1 translocation to 
the mitochondria which indicate that chymotrypsin-like serine proteases mediated this 
pathway of PCD. Moreover, this implies a connection of actin dynamics with Drp1, 
which is one of the major regulators of mitochondrial fission and cell death. In 
contrast to these findings, De Vos et al. revealed that upon F-actin disruption Drp1 
translocation to the mitochondria was attenuated in CV1 cells 49. Although, these 
findings go in opposing directions, possibly due to different cell types and cell death 
stimuli, both investigators exhibited a pivotal role for F-actin in mitochondrial 
recruitment of Drp1 followed by mitochondrial fission and cell death. And furthermore, 
these events, at least evidenced in one case, seem to be mediated by serine 
proteases. This study demonstrated an interactive connectivity between Drp1 and 
actin which was lost after glutamate treatment, indicating a release of Drp1 from the 
actin cytoskeleton. Moreover, glutamate induced a redistribution of Drp1 from the 
cytoplasm to the mitochondria in conditions of oxidative stress in HT22 cells (Figure 
36). Unfortunately, these steps could not be prevented by the application of the 
serine protease inhibitor TLCK. This implies that Drp1 is in fact connected with the 
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actin cytoskeleton and that glutamate induces a release and translocation of Drp1 to 
the mitochondria, however, these events are not mediated by trypsin-like serine 
proteases in conditions of glutamate toxicity in HT22 cells. 
As demonstrated in the first part of this study, CypA is involved in the pathway of 
glutamate-induced cell death in HT22 cells. Interestingly, the work of Cereghetti et al. 
showed that Drp1 interacts with CypA in the cytosol. In addition, calcineurin was as 
well identified as an interaction partner of Drp1. Dephosphorylation of Ser637 of Drp1 
by calcineurin regulates Drp1 translocation to the mitochondria and promotes 
mitochondrial fission resulting in apoptosis. Moreover, the interaction of CypA and 
Drp1 is lost by induction of calcineurin activity. These results demonstrate that the 
Drp1-CypA-calcineurin axis is involved in mitochondrial fission and disruption of this 
ternary complex leads to cell death 51. The present study revealed that Drp1 interacts 
with CypA and that this interaction is diminished after glutamate treatment in HT22 
cells. Surprisingly, the inhibition of trypsin-like serine proteases with TLCK led to a 
much more pronounced interaction of Drp1 and CypA than it was observed in control 
conditions (Figure 37). Despite the increased interaction of Drp1 and CypA, the 
redistribution of Drp1 from the cytoplasm to the mitochondria was not abolished by 
TLCK. As mentioned above, calcineurin mediates Drp1 dephosphorylation and 
translocation to the mitochondria and thereby induces mitochondrial fission. The work 
of Zhao et al. evidenced that calcineurin activity is regulated by the activation of 
CSPs. Active CSPs cleave the autoinhibitory subunit of calcineurin thereby activating 
it and accounting for the translocation of Drp1 from the cytoplasm to the mitochondria 
resulting in apoptosis (data not published, poster 100, ECDO 2013, Paris). In HT22 
cells, however, calcineurin did not contribute to cell death induced by glutamate as 
tacrolimus, a calcineurin inhibitor, did not provide protective effects against glutamate 
toxicity (Figure 38).  
Taken together, the second part of this thesis revealed a pivotal role for trypsin-like 
serine proteases in the paradigm of PCD in HT22 cells. Further, mitoprotection and 
complete restoration of mitochondrial function was achieved by serine protease 
inhibition with TLCK. Moreover, it was demonstrated that trypsin-like serine proteases 
act upstream of Bid activation and additionally, in HT22 cells the activation occurred 
in a very initial phase even before the first increase in ROS. However, the exact 
mechanism behind the protective effect of TLCK is still elusive. It could be 
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demonstrated though, that trypsin-like serine proteases are not involved in the 
release of Drp1 from the actin cytoskeleton and in the redistribution of Drp1 to the 
mitochondria as TLCK did not prevent these events. Moreover, it was shown that 
serine proteases have an influence on the interaction of Drp1 and CypA, however, 
the remaining questions are how and why is the interaction of these proteins 
increased. Further, this study demonstrated that calcineurin is not involved in 
glutamate-induced cell death in HT22 cells. But it has to be mentioned that 
trypsin-like serine proteases exhibit a potential target for therapeutical approaches in 
neurological diseases because the inhibition seems to abolish cell death features in 
an initial phase and thereby may rescue cell death before the so called ‘decision 
points’ of life and death in cells (Figure 40, scheme of serine protease-mediated cell 
death). 
 
Figure 40: Serine protease-mediated cell death and the impact of TLCK 
Glutamate-induced GSH depletion which resulted in increased ROS accumulation and mitochondrial dysfunction 
led to cell death in HT22 cells (black arrows depict the action of glutamate). Serine protease inhibition with TLCK 
prevented all features associated with mitochondrial dysfunction and decreased cell death. Trypsin-like serine 
proteases act upstream of Bid activation and TLCK did not prevent the release of Drp1 from the actin 
cytoskeleton and the following redistribution to the mitochondria but increased the interaction of Drp1 and CypA. 
Lipid peroxidation was completely abolished by TLCK treatment placing serine proteases in a more initial phase 
of this cell death pathway (red arrows/marks illustrate the consequence of serine protease inhibition).  
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5. Summary 
Many neurological disorders and neurodegenerative diseases are associated with 
mitochondrial abnormalities. Mitochondria are essential organelles regulating the 
energy metabolism of the cell, thereby, determining essential cellular functions and 
viability. This accounts particularly for neurons which show a pronounced energy 
demand and where mitochondria play a pivotal role in balancing the 
Ca2+ homeostasis, controlling ROS formation and providing most of the energy for 
neurotransmitter metabolism and maintenance of the membrane potential. Further, 
mitochondria are essential organelles controlling the ‘point of no return’ in intrinsic 
pathways of programmed cell death where the decision between cellular life and 
death involves post-translational protein modifications determining mitochondrial 
dysfunction and release of detrimental proteins such as AIF. Therefore, major aims of 
the present thesis included the characterization of the key regulators of protein 
modifications that occur upstream of mitochondrial demise and AIF release. In this 
context, the role of two PPIases, CypA and Pin1, and the involvement of serine 
proteases in paradigms of PCD were investigated. Most experiments were performed 
in an immortalized neuronal cell line (HT22 cells) which depicts a well-established 
model to study caspase-independent cell death induced by glutamate. The most 
prominent feature in this model of cell death is the mitochondrial AIF release and the 
subsequent translocation to the nucleus where it induces chromatinolysis. To 
substantiate the importance of these results further experiments were performed in a 
model of glutamate-induced excitotoxicity in primary cortical neurons.  
The findings of the first part of this study revealed a prominent role for CypA in 
glutamate-induced mitochondrial AIF release and cell death. Glutamate toxicity 
resulted in the translocation of CypA to the nucleus where it built a pro-apoptotic 
complex with AIF, thereby inducing chromatinolysis. Silencing of CypA protected 
HT22 cells against glutamate toxicity. Moreover, the depletion of CypA preserved 
mitochondrial fission and the loss of MMP and also prevented the release of AIF from 
the mitochondria. Furthermore, lipid peroxidation arising from the mitochondria was 
attenuated which supported increased cell viability.  
Further experiments addressed the involvement of a second family member of 
PPIases, Pin1, in neuronal cell death pathways. The inhibition of Pin1 with Br57 
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resulted in decreased susceptibility of HT22 cells to glutamate toxicity. This increase 
in cell viability was attended by changes at the level of mitochondria. Pin1 inhibition 
led to enhanced mitochondrial fission, but further, complete mitochondrial 
fragmentation induced by glutamate was attenuated. This elevated mitochondrial 
fission rate was accompanied by a slight decrease in ATP levels in Br57-treated 
controls, however, the strong ATP depletion that occurred after the glutamate 
challenge was prevented and the impairment of MMP was abolished.  
In summary, these findings depict a pivotal role for CypA and Pin1 in 
glutamate-induced cell death in HT22 cells upstream of mitochondrial demise. Since 
this model exhibits common features of neurological disorders the results obtained 
here may give a platform to investigate new neuroprotective strategies. 
The second part of this thesis dealt with the impact of activated trypsin-like serine 
proteases on cell viability and mitochondrial function. Inhibition of serine proteases 
with TLCK resulted in increased cell viability in HT22 cells and in primary cortical 
neurons. Furthermore, this work revealed that activation of trypsin-like serine 
proteases occurred upstream of Bid activation and moreover, in a very initial phase of 
this PCD pathway in HT22 cells. Further, lipid peroxidation was blocked and 
mitochondrial morphology alterations were prevented. In addition, ATP depletion and 
the impairment of the MMP were preserved and the decrease in mitochondrial 
respiration after glutamate toxicity was abolished. Interestingly, the interaction of 
Drp1 and CypA was strengthened by TLCK. However, the release of Drp1 from the 
actin cytoskeleton and the following redistribution of Drp1 from the cytoplasm to the 
mitochondria were not prevented.  
In conclusion, the second part of this thesis highlighted trypsin-like serine proteases 
as mediators of glutamate-induced cell death in HT22 cells. The initial activation in 
this PCD pathway is a promising target for therapeutic intervention strategies in 
neurological diseases. 
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6. Zusammenfassung 
Mitochondrien gelten als „Kraftwerke“ der Zelle, da sie in Form von ATP die Energie 
bereitstellen, die für nahezu alle zellulären Prozesse benötigt wird. Zudem sind 
Mitochondrien an einer Vielzahl von biochemischen Mechanismen und 
Signalkaskaden beteiligt, wie z.B. der Aufrechterhaltung der intrazellulären 
Ca2+ Homöostase oder der kontrollierten Bildung reaktiver Sauerstoffspezies. Neben 
diesen Funktionen spielen Mitochondrien eine zentrale Rolle bei Alterungsprozessen 
von Zellen und bei intrinsischen Signalkaskaden des programmierten Zelltods. 
Mitochondrien stellen dabei hochdynamische Organellen dar, die morphologisch 
entweder lange miteinander verbundene Netzwerke ausbilden oder als kleine 
kugelförmige Organellen vorliegen. Es besteht ein hochreguliertes Gleichgewicht 
dieser morphologischen Zustände, das unter pathologischen Bedingungen gestört 
wird und so zur Dysfunktion der Organellen und zum Zelltod beitragen kann. 
Entsprechende mitochondriale Veränderungen sind beispielsweise in Neuronen bei 
altersbedingten neurodegenerativen Erkrankungen wie Morbus Alzheimer, Morbus 
Parkinson, sowie nach akuten Hirnschädigungen durch Schädel-Hirn-Trauma oder 
Schlaganfall nachgewiesen worden. Darüber hinaus wurden sie mit den strukturellen 
und funktionellen Schädigungen der Organellen und der betroffenen Neurone in 
Verbindung gebracht. Post-translationale Proteinmodifikationen, Isomerisierung von 
Proteinen oder Protein-Protein Interaktionen können u.a. der Grund für solche 
mitochondrialen Fehlfunktionen sein und zum Nervenzelltod beitragen.  
Aus einer Vielzahl von Forschungsarbeiten ist bekannt, dass Mitochondrien eine 
zentrale Rolle in den intrinsischen Signalwegen des programmierten Zelltods in 
Neuronen einnehmen, der vor allem durch die Zerstörung der mitochondrialen 
Membranintegrität gekennzeichnet ist. Hierbei ist der wesentliche Schritt die 
Freisetzung des pro-apoptotischen Proteins AIF aus dem mitochondrialen 
Intermembranraum. Daher waren die Hauptziele der vorliegenden Arbeit, neue 
Regulatoren der Mitochondrienschädigung und der Freisetzung von AIF in Modellen 
des programmierten Zelltods zu charakterisieren und diese als mögliche Ziele 
therapeutischer Angriffspunkte zu definieren. In diesem Zusammenhang wurde die 
Beteiligung von zwei Peptidyl-prolyl cis-trans Isomerasen CypA und Pin1 sowie von 
Serinproteasen an mitochondrialen Schädigungsmechanismen untersucht.  
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Die Mehrzahl der Experimente wurde in einer hippokampalen neuronalen 
Mauszelllinie (HT22 Zellen) durchgeführt. Dabei handelt es sich um ein gut 
charakterisiertes Modellsystem für oxidativen Stress in Neuronen, das insbesondere 
für Untersuchungen mitochondrialer Prozesse bei intrinsischen Signalkaskaden des 
programmierten Zelltods hervorragend geeignet ist. Das bedeutendste Merkmal 
dieser Form des Zelltods ist die Freisetzung von AIF aus den Mitochondrien und die 
anschließende Translokation in den Zellkern, in dem AIF eine Schädigung der DNA 
hervorruft. Die Ergebnisse aus den HT22 Zellen wurden zudem in weiteren 
Experimenten im Modell der Glutamat-induzierten Exzitotoxizität in primären 
Neuronen verifiziert. 
Der erste Teil dieser Arbeit zeigt, dass CypA in Neuronen eine wichtige Rolle im 
Glutamat-induzierten Zelltod und der mitochondrialen AIF Freisetzung spielt. 
Glutamattoxizität führt zu einer Translokation von CypA in den Zellkern, wo es mit 
AIF einen pro-apoptotischen Komplex bildet, der zur Schädigung der DNA führt. Die 
verminderte Expression von CypA schützt HT22 Zellen gegen Glutamattoxizität und 
zudem waren infolge der verminderten CypA-Spiegel die Mitochondrien geschützt. 
Eine Hemmung der CypA Expression verhindert ferner den Verlust des 
Mitochondrienmembranpotentials und die Fragmentierung der Organellen als 
typische morphologische Veränderung der geschädigten Mitochondrien sowie die 
Freisetzung von AIF aus dem mitochondrialen Intermembranraum. Weiterhin wurde 
die Lipidperoxidation in den Zellen deutlich abgeschwächt, die in der Spätphase der 
Glutamatschädigung durch mitochondriale Schäden gesteigert wird und die 
Endphase des Zelltods kennzeichnet. 
Andere Untersuchungen dieser Arbeit zeigen, dass Pin1, eine weitere Peptidyl-prolyl 
cis-trans Isomerase, ebenfalls an neuronalen Zelltodmechanismen und 
mitochondrialen Veränderungen beteiligt ist. Der spezifische Pin1 Inhibitor Br57 führt 
zu einer verminderten Empfindlichkeit der HT22 Zellen gegenüber Glutamat. Die 
dadurch bedingte Zunahme der Zellviabilität ist mit mitochondrialen Veränderungen 
assoziiert. Die Applikation von Br57 alleine resultiert einerseits in einer zunehmenden 
Mitochondrienfragmentierung, kann andererseits allerdings die weitere 
Fragmentierung der Mitochondrien, die durch Glutamat hervorgerufen wird, 
verhindern. Die erhöhte Mitochondrienteilung war dabei mit einer leichten Reduktion 
der ATP Spiegel in Br57 behandelten Kontrollzellen verbunden. Jedoch wird der 
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deutliche Abfall der ATP Spiegel, der normalerweise nach Glutamatschädigung 
auftritt, verhindert. Des Weiteren wird der Glutamat-induzierte Zusammenbruch des 
Mitochondrienmembranpotentials durch die Pin1 Inhibition günstig beeinflusst. 
Zusammenfassend zeigt der erste Teil dieser Arbeit, dass beide Peptidyl-prolyl 
cis-trans Isomerasen, CypA und Pin1, in den intrinsischen Signalkaskaden des 
neuronalen Zelltods eine besondere Funktion einnehmen. Dabei sind sie offenbar 
entscheidend an der Regulation der Mitochondrienintegrität und -funktion beteiligt, so 
dass diese PPIs vielversprechende Angriffspunkte für neue neuroprotektive 
Strategien darstellen. 
Der zweite Teil dieser Dissertation befasst sich mit dem Einfluss von aktivierten 
Serinproteasen auf mitochondriale Funktionen und dem daraus resultierenden 
Zelltod. Die Hemmung von Serinproteasen mit TLCK, einem Serinproteaseinhibitor, 
konnte den durch Glutamat-induzierten Zelltod sowohl in HT22 Zellen als auch in 
primären kortikalen Neuronen verhindern. Weiterhin zeigt diese Arbeit, dass die 
Aktivierung von Serinproteasen zu einem sehr frühen Zeitpunkt in dieser Form des 
programmierten Zelltods in HT22 Zellen stattfindet, bereits bevor die Aktivierung des 
pro-apoptotischen Proteins Bid und die daraus folgende Schädigung der 
Mitochondrien einsetzen. Ferner vermindert der Serinproteaseinhibitor TLCK die 
Glutamat-induzierte Lipidperoxidation, pathologische und morphologische 
Veränderungen der Mitochondrien, ATP Depletion sowie die Verminderung des 
Mitochondrienmembranpotentials und den Abfall der mitochondrialen Atmung. 
Interessanterweise wird gleichzeitig durch TLCK die Interaktion zwischen Drp1 und 
CypA verstärkt. Allerdings werden die Freisetzung von Drp1 aus dem 
Aktinzytoskelett und die darauffolgende Translokation von Drp1 aus dem Zytoplasma 
zu den Mitochondrien nicht verhindert.  
Zusammenfassend zeigt der zweite Teil dieser Arbeit, dass Serinproteasen vom 
Trypsintyp den Glutamat-induzierten oxidativen Zelltod in neuronalen HT22 Zellen 
vermitteln. Die initiale Aktivierung von Serinproteasen in diesem Modell des 
programmierten Zelltods ist ein möglicher therapeutischer Ansatzpunkt bei 
neurologischen Erkrankungen und Alterungsprozessen, bei denen oxidativer Stress 
und daraus folgende mitochondriale Schädigungsmechanismen wesentlich zur 
Fortschreitung der pathologischen Veränderungen in den Nervenzellen beitragen. 
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7. Abbreviations 
Abbreviation Full text 
°C Grad Celsius 
µ Micro 
µM Micromolar 
AD Alzheimer’s disease 
AIF Apoptosis-inducing-factor 
ALS Amyotrophic lateral sclerosis 
AMPA 2-amin-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate 
ANOVA Analysis of variance 
ANT Adenine nucleotide translocator 
Apaf1 Apoptosis-protease activating factor 
APP Amyloid precursor 
ATP Adenosinetriphosphate 
AVPI AnnexinV/propidium iodide 
Bak Bcl2 antagonist killer 1 
Bax Bcl2-associated x protein 
BCA Bicinchoninic acid 
Bcl2 B-cell-lymphoma 2 
Bid Bcl2 interacting domain death agonist 
BimEL Bcl-2 interacting mediator of cell death 
BODIPY 4,4-diflouro-5-(4-phenyl1,3-butadienyl)-4-bora-3a,4a-diaza-s-
indacene-3-undecanoic acid  
Bp Base pare 
Br57 Pin1 inhibitor 
Ca2+ Calcium 
CAD Caspase-activated deoxyribonuclease  
CaMK Calcium/calmodulin-dependent kinase 
CARD Caspase recruitment domain 
CCCP Carbonylcyanide-3-chlorophenylhydrazone  
cFLIP Cellular FLICE inhibitor protein 
CHOP CCAAT/enhancer-binding protein-homologous protein 
CMT2A Charcot-Marie-Tooth 2A  
CNS  Central nervous system 
CsA Cyclosporine A 
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CSPs Chymotrypsin-like serine proteases 
CTL Cytotoxic T lymphocytes  
CypA Cyclophilin A 
CypA-/- CypA knock out 
CypB Cyclophilin B 
CypD Cyclophilin D 
Cyps Cyclophilins 
Cytc Cytochrom c 
DAPI 4`, 6-diamidino-2-phenylindole dihydrochloride  
DD Death domain 
DED Death effector domain  
DISC Death-inducing signaling complex 
DMEM Dulbecco’s modified eagle medium  
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid  
DOA Dominant optic atrophy 
Drp1 Dynamin-related protein 1  
DSB Double strand breaks 
DTT DL-Dithiotreitol  
EndoG Endonuclease G 
ER Endoplasmatic reticulum 
ERK Extracellular signal-regulated kinase 
ETC Electron transport chain 
FACS Fluorescence-activated cell sorting 
FADD Fas-associated death domain 
FASL FAS ligand 
FCS Fetal calf serum 
Fis1 Mitochondria fission 1 protein 
FK506 Tacrolimus 
FKBP FK506-binding proteins 
GAPDH Glyceraldehyde-3-phosphate-dehydrogenase  
GSH Glutathione  
h Hour 
H2O2 Hydrogen peroxide 
HBSS Hank`s balanced medium  
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HCl Hydrochloric acid  
HD Huntington’s disease 
HI Hypoxia-ischemia 
Hq Harlequin 
HtrA2/Omi High temperature acquired protein A2 
IAP Inhibitor of apoptosis 
ICAD Inhibitor of CAD 
ICE Interleukin 1β converting enzyme 
IMS Mitochondrial intermembrane space 
IP Immunoprecipitation 
JNK C-Jun N-terminal kinase 
kDa Kilo Dalton  
MAPK Mitogen-activated protein kinase 
MCAO Middle cerebral artery occlusion 
MEM+ Eagle’s minimum essential medium  
Mfn Mitofusin 
MIM Mitochondrial inner membrane 
MLS Mitochondrial localization sequence 
mM Millimolar  
MMP Mitochondrial membrane potential 
MNNG 1-methyl-2-nitro-1-nitrosoguanidine 
MOM Mitochondrial outer membrane 
mtDNA Mitochondrial DNA 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  
NaHCO3 Sodium hydrogen carbonate  
NaOH Sodium hydroxide  
NCI Normalized cell index 
NK Natural killer 
nM Nanomolar 
NMDA N-methyl-D-aspartic acid  
OGD Oxygen glucose deprivation 
Opa1 Optical atrophy 1 
Oxphos Oxidative phosphorylation 
PARP Poly (ADP-Ribose) Polymerase 
PBS Phosphate buffered saline 
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PCD Programmed cell death 
PD Parkinson’s disease 
PEI Polyethylenimine  
PFA Paraformaldeyde  
pH Potentia hydrogenii  
PI Propidium iodide 
Pin1 Protein interacting with NIMA (never in mitosis A)-1 
PPIase Peptidyl-prolyl cis-trans isomerase 
PTP Permeability transition pore 
PVDF Polyvinylidenfluorid  
RNA Ribonucleic acid 
ROCK Rho-associated kinase 
ROS Reactive oxygen species  
RT Room temperature  
SD Standard deviation  
SDS Sodium dodecyl sulfate  
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
siRNA Small interfering RNA 
Smac/Diablo Second mitochondria-derived activator of caspases 
tAIF Truncated AIF 
TBI Traumatic brain injury 
tBid Truncated Bid 
TBS Tris bufferd solution  
TBST Tris bufferd solution with Tween 20  
TCA Tricarboxylic acid cycle 
TE Trypsin-EDTA  
TEMED Tetramethylenethylendiamin  
TLCK Nα-Tosyl-L-lysine-chlormethyl ketone hydrochloride  
TMRE Tetramethylrhodamine ethyl ester 
TNFR1 TNFα receptor 1 
TNFα Tumor necrosis factor α 
TPCK Np-Tosyl-L-phenylalanyl chloromethyl ketone 
TRADD TNF receptor-associated death domain 
TRAIL TNF-related apoptosis inducing ligand 
TRAILR TRAIL receptor 
Abbreviations 
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VDAC Voltage-dependent anioin channel 
XIAP X-chromosomal linked inhibitor of apoptosis 
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